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Abstract 
 Glycosylation is one of the most abundant post-translational modifications of proteins 
and plays a diverse role in biological functions. The role of glycosylation in biological 
processes is a rapidly growing area of research. The growing development of 
glycoproteins as biopharmaceuticals has added to the interest in the characterisation of 
carbohydrate composition of glycoproteins as glycosylation-dependant therapeutic 
effects have been noted. Lectins are proteins of non-immune origin that recognise and 
bind specific carbohydrate structures with a relatively high degree of affinity. They 
represent a convenient biochemical tool to probe the carbohydrate composition of 
glycoproteins. Lectins occur ubiquitously in nature including in Pseudomonas 
aeruginosa, an opportunistic pathogen that produces two carbohydrate binding lectins, 
PA-IL and PA-IIL. The present study is dedicated to one of these lectins, the highly 
studied PA-IIL lectin (also known as LecB). A number of highly conserved homologous 
to PA-IIL have also been identified. PA-IIL was recombinantly expressed in 
Escherichia coli with the addition of a 6HIS affinity tag, separately to the N and C 
termini of the protein, to facilitate purification. Size exclusion chromatography 
established that the addition of an affinity tag to the C termini of PA-IIL affected the 
quaternary structure of the protein and was subsequently shown by HRP assay to affect 
the sugar binding. Optimized expression and purification protocols for the production of 
highly purified N-terminally tagged PA-IIL were then established. Once established the 
cloning, expression and purification protocols of PA-IIL were utilized to express the 
lectin domain of previously uncharacterized homologues, Photopexin A and Photopexin 
B from Photorhabdus luminescens. Once purified, methods for the structural and 
functional characterization of these novel lectins were investigated.   
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1.1 Lectins 
 Lectins are proteins of non-immune origin capable of binding saccharide 
structures with a relatively high degree of specificity and affinity. Originally lectins 
were identified as proteins possessing the ability to agglutinate erythrocytes and other 
types of cells, which in later years was shown to be sugar specific binding. They were 
often termed Hemagglutinins because of this ability. The earliest identified lectin, at the 
turn of the 19th century, is believed to be ricin, isolated from seeds of the castor tree 
(Ricinus communis), presented by Peter Hermann Stillmark in his doctoral thesis in 
1888. Hemagglutinins were reported throughout the following years from numerous 
sources, primarily plants, but very few were purified. The pace of lectin isolation 
increased significantly during the 1970s with the development of affinity 
chromatography for improved lectin isolation (Agrawal, Goldstein 1965). Interest in 
lectins was stimulated when lectins were demonstrated to be potentially valuable tools 
for (i) the detection and characterisation of glycoconjugates (Fisher et al. 1984) (ii) for 
the examination of changes that occur on cell surfaces during physiological and 
pathological processes (Aub, Sanford and Cote 1965) and (iii) for histochemistry of 
cells and tissues (Katsuyama, Spicer 1978). Although reported earlier, the first sugar 
specific mammalian lectin, the galactose specific hepatic asialoglycoprotein receptor 
was not isolated until 1974 (Ashwell, Morell 1974). 
1.2 Lectins of Pseudomonas aeruginosa 
Pseudomonas aeruginosa (P. aeruginosa) is a gram negative aerobic rod belonging 
to the bacterial family Pseudomonadaceae. It is a free living ubiquitous bacterium 
commonly found in soil and water, it also regularly occurs on the surface of plants and 
occasionally on the surface of animals. P. aeruginosa is of interest as it is an 
opportunistic human pathogen with intrinsic resistance to antibiotics and disinfectants. 
It is associated with chronic airway infections and is regarded as a primary cause of 
death in immunocompromised patients and those with cystic fibrosis. Extracts of certain 
strains of P. aeruginosa were found to contain D-galactose binding hemagglutinins 
(Gilboa-Garber 1972) and mannose binding hemagglutinins (Gilboa-Garber, Mizrahi 
and Garber 1977). These hemagglutinins were identified as lectins and named, 
respectively, PA-IL and PA-IIL (also known as LecA and LecB respectively). The 
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carbohydrate binding specificity of these lectins was determined using a variety of 
assays; 
(i) Hemagglutination assay: Based on the lectins ability to agglutinate papin-
treated erythrocytes. The precision of the assay is limited. 
(ii) Peroxidase-binding assay: Based on the lectins ability to interact with both 
cells and the carbohydrate bearing enzyme horse radish peroxidase. This is a 
semi-quantitative assay (Huet, Bernadac 1974). 
(iii) Mitogenic assay: A measurement of mitogenic stimulation in cultures of 
neuraminidase treated lymphocytes.  
The preferential affinity for PA-IL was shown to be: α-D-Gal > D-Gal, β-D-Gal > D-
GalNAc; and PA-IIL was shown to be, L-Fuc > D-Man (and mannan), L-Gal> D-Fru 
(Gilboa-Garber 1982). This present study will concentrate on one of these lectins, 
namely the PA-IIL and its highly conserved orthologs. 
1.2.1 PA-IIL gene 
In a study carried out by Gilboa-Garber, N. et al., (2000) PA-IIL was purified by 
affinity chromatography using D-mannose bearing Sepharose (as outlined in Gilboa-
Garber 1982) and its N-terminal amino acid sequence was obtained by Edman 
degradation. A T-blast search against the P. aeruginosa genome (PA01) coupled with 
genetic analysis identified a single open reading frame (ORF) encoding a 114-amino 
acid protein. The putative protein predicted from this ORF was found to perfectly match 
the query sequence at its N-terminus which was then further confirmed as being the 
ORF of PA-IIL by mass spectrometric analysis. This study found that PA-IIL is a 114 
amino acid protein with a molecular weight of approximately 11.7 kDa. The C-terminus 
of the protein appears to be particularly hydrophobic while methionine is largely absent 
from the N-terminus. A Shine-Dalgarno sequence was located 9 b.p upstream of the 
translation start site (Gilboa-Garber, Katcoff and Garber 2000).  
Identification of the PA-IIL gene facilitated the recombinant expression of PA-
IIL. The protein was successfully cloned into a number of pET vectors and expressed in 
E. coli (DeB3) expression system in a number of studies (Loris et al. 2003, Sabin et al. 
2006, Tielker et al. 2005). Protein was purified over mannose agarose as described by 
Gilboa-Garber, N. et al. (1977). 
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1.3 The crystal structure of PA-IIL 
The PA-IIL lectin has been subject to four crystallographic studies (Loris et al. 
2003, Mitchell et al. 2002, Sabin et al. 2006, Mitchell et al. 2005) and a molecular 
dynamic study (Mishra et al. 2008).These studies yielded several structures: native and 
calcium-free lectin and complexes with monosaccharides.   
Mitchell, E. et al. (2002) were first to report the high resolution crystal structure 
of PA-IIL in a complex with fucose. Single wavelength anomalous diffraction (SAD) 
technique, with the protein crystal soaked in a holmium-containing solution, was used to 
determine the 3-Dimensional (3D) protein structure. The refined crystal structure of PA-
IIL in (i) its carbohydrate-free form, (ii) as a complex with mannose, mannotriose, 
fucose and fructose, and (iii) in its inactive calcium-free form were reported by Loris, R. 
et al. (2003). A study by Mitchell, E. et al. (2005) further refined the crystal structure to 
a resolution of 1.0Å and compared structural results to thermodynamics to investigate 
the fine monosaccharide specificity of PA-IIL. Sabin, C. et al. (2006) elaborated further 
on the work of Mitchell, E. et al. (2005) by expansion of the study to include various 
monosaccharides at high resolution.  
The PA-IIL crystal structure was found to consist of a tetramer of four 
independent subunits. Each subunit contains two Ca2+ ions and binds a fucose ligand 
(see Figure.1.2). PA-IIL was observed to fold as a nine-stranded anti-parallel β-
sandwich with strands 1-5 forming a greek-key structural motif, schematics representing 







Figure 1.1: Schematic of protein folding. 
The red and green arrows represent the β-sheets of the protein. The formations taken by anti-parallel beta 
sheets and anti-parallel sheets in a Greek key motif are represented in a simplified format above.  
 
The greek-key motif of PA-IIL is extended by strands 6-8, which associate with strands 
1 and 4 to form a 5-stranded curved β-sheet. The N-terminal region forms a β-strand, 
referred to as strand 0, that inserts itself between strand 5 and 6 (Figure 1.2). The PA-
IIL tetramer forms a quaternary structure arranged around a pseudo C222 axis of 
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symmetry. The discovery of the involvement of the C-terminal carboxyl group (Gly 
114) of each monomer in the ligand binding site of the neighbouring monomer is the 
most striking feature of this lectin (Mitchell et al. 2005). The C-terminal glycine group 
(Gly114) is involved in calcium co-ordination through hydrogen bonding and using 
experimental and in silico studies results suggest that the glycine also has a significant 









Figure 1.2: Overall structure of P. aeruginosa lectin, PA-IIL.   
(I) Tetrameric structure of the PA-IIL-fucose complex, each monomer shown in a different colour. Stick 
representation of fucose (red) and two calcium ions shown as pink spheres. Each monomer is labelled A, 
B, C and D according to the nomenclature used in the text. (II) Monomer of PA-IIL with numbering of β-
strands according to the greek-key motif (strands 1-5). Ca2+ and fucose shown as (I) (Mitchell et al. 
2002). Images generated using Pymol and PDB file 1UZV.  
 
Three intermolecular interfaces can be discerned in the PA-IIL tetramer. Where A, B, C 
and D represent each respective monomeric subunit of the tetramer (see Figure1.2), the 
interfaces are termed AB, AC and AD (Loris et al. 2003); 
(i) AB interface: two sheets packed onto each other. Primarily a hydrophobic 
interface also includes two phenylalanine side chains and several valine and 
leucine side chains.  
(ii) AD interface: continuous ten-stranded β sheet created via sheet extension, 
hydrophilic in nature. 
(iii) AC interface: seen as an extension of the AD interface. Limited contacts 
between hydrophilic side chains of A and the C promoter, creates the AC 
interface. 
1.3.1 Binding pocket of PA-IIL 
The major feature of the carbohydrate-binding pocket is a pair of calcium ions. 
These calcium ions directly interact with three hydroxyl groups when a monosaccharide 
(I) (II) 
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is bound. This mode of protein/carbohydrate interaction had not previously been 
observed. In addition to the calcium ion interaction, several residues of PA-IIL interact 
directly with the bound monosaccharide via hydrogen bonds (see Figure1.3.); namely 
Ser22 (S22), Asp96 (D96), Asp99 (D99), Asp101 (D101) and Gly114 (G114) from the 
C-terminus of the neighbouring subunit (Mitchell et al. 2002).   
The calcium binding pocket is made up of two calcium binding loops (CBL). 
CBL-1 connects strands 1 and 2 with CBL-2 connecting strands 7 and 8. The C- 
terminus of the adjacent monomer is also involved in the calcium binding loop. The 
calcium ions are bound via five acid groups found within the calcium binding loops. 
Both calcium ions have a classical seven ligand coordination. However there is distinct 
asymmetry in ligand distribution; 
(i) Calcium 1 (as depicted in Figure 1.3): - the calcium ion receives five 
carboxylate and two oxygen ions. 
(ii) Calcium 2 (as depicted in Figure 1.3): - the calcium ion receives three 
carboxylate, two carbonyl and two ligand oxygen atoms. 
The structural role of the calcium ions was investigated by determining the crystal 
structure of calcium-free PA-IIL at 1.2Å resolution (Loris et al. 2003). Loris, R et al. 
(2003) reported that the overall structure of the monomer and the integrity of the 
tetramer were unaffected by the loss of the calcium ions. The only observed structural 
changes are limited to the metal/carbohydrate binding loop Asn95-Asp104 and the C-
terminal residue Gly114. The loop becomes less well ordered most likely due to the 
repulsion of negatively charged side chains that are close together (Loris et al. 2003). It 
has been suggested that calcium ions have a regulatory function in some lectins (Ng, 
Weis 1998, Brewer, Brown and Koenig 1983), as of yet there is no information on any 


















Figure 1.3: Stick representation of amino acids involved in interaction between PA-IIL calcium 
binding loop (blue), the C-terminus (green) of the adjacent subunit, the Ca
2+
 ions (pink spheres) 
and fucose (red).  
Interaction with Ca2+ ions are shown as yellow dotted lines (Mitchell et al. 2002). Image generated using 
Pymol and PDB file 1UZV. 
 
1.3.2 Fine specificity 
While Mitchell, E. et al. (2002) were the first to report the quaternary structure of PA-
IIL and the unique protein/carbohydrate binding mechanism, Loris, R. et al. (2003) 































Figure 1.4: Stick representation of amino acids 
involved in interaction between PA-IIL calcium 
binding loop (blue), the C-terminus (green) of the 
adjacent subunit and [A]fucose (red), [B]mannose 
(cream) and [C] fructose (green). Hydrogen bonds 
shown as dotted blue lines, interaction with Ca2+ ions 
(pink spheres) are shown as yellow dotted lines and van 
der Waals contacts involved are shown as grey dotted 
lines (Loris et al. 2003). Image generated using Pymol 





Loris, R. et al. (2003) compared the crystal structure of the binding pocket of PA-IIL in 
complex with fucose, mannose and fructose. It was found that all three monosaccharides 
bind isosterically via identical interactions with the calcium ions and several side 
chains. Each of the monosaccharides are bound in their lowest-energy confirmation, 
namely, 4C1 for fucose, 
4C1 for mannose and 
2C6 for fructose. In these confirmations, the 
hydroxyl O2, O3 and O4 in fucose are sterically equivalent to O4, O3 and O2 in mannose 
and O3, O4 and O5 in fructose (Figure 1.4). The equivalent oxygen atoms form the direct 
ligands to the two structural calcium ions of PA-IIL. The remaining hydroxyl group and 
aliphatic substituents of the sugar groups determine the difference between the three 
structures (Loris et al. 2003). Differences were found around the C6 methyl group of 
fucose, where a hydroxyl group that was found in the mannose complex was absent in 
the fructose complex. The C6 methyl group of fucose forms favourable hydrophobic 
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equivalent hydroxyl or methyl group is found in fructose a small void is created which 
is not occupied by a water molecule. In mannose the O1 in its β-configuration is the 
equivalent atom, resulting in a less favourable interaction. In fucose, O1 in its α-
configuration makes hydrogen bonds with Ser22 and Asp96. In mannose and fructose-
protein complexes this interaction is replaced by the less favourable van der Waals 
interaction with C6 (mannose) or C1 (fructopyranose). In each instance mentioned in 
the mannose and fructose complexes a hydroxyl group is forced to interact with an 
aliphatic patch so that it cannot fulfil its hydrogen bond potential. Lastly an additional 
hydrogen bond is present in both the mannose and fructose-protein complexes, Ser23 to 
O6 (mannose) and O1 (fructose), for which there is no equivalent in the fucose-protein 
complex. The relatively weak substrate specificity associated with PA-IIL is therefore 
likely to be due to the requirement for the particular stereochemistry of two equatorial 
and one axial hydroxyl group leading to a number of sugars being able to bind (Loris et 
al. 2003). 
PA-IIL exhibits strong affinity for fucose (Ka of 1.5 x 106M-1) (Garber et al. 
1987) and sparingly binds to α-D-mannose. The factors for the high affinity of PA-IIL 
are mostly likely due to the unique protein/carbohydrate bonding using Ca2+ ions. The 
high affinity was investigated by Mitchelle, E. et al. (2005) by (i) thermodynamic study 
of enthalpy and entropy contributions (ii) 1.0 Å resolution crystal structure and (iii) 
study of charge distribution by ab initio calculations. 
Thermodynamic analysis confirmed the relatively high affinity binding of PA-
IIL albeit with values of one order of magnitude lower (association constant (Ka) 1.6 x 
106M-1) then that previously published from equilibrium dialysis study (Garber et al. 
1987). Variation of values may be due to differences between methodological 
approaches or between protein samples. There was a number of different conditions 
between the experimental approach of Mitchell, E. et al. (2005) and Garber, N. (1987), 
such as varying protein concentrations, 0.78mM compared to 1.66 – 3.1µM, differing 
experimental temperature, 25oC compared to 3oC and carried out in different buffering 
solutions, TBS pH 7.5 compared to PBS pH 7.3. This micromolar affinity range is very 
unusual among lectin-monosaccharide interactions. Lectin-protein interactions are 
usually observed in the millimolar range for binding unsubstituted monosaccharides 
(Dam, Brewer 2002). Previously, the highest reported value, Ka value of 9 x 10
3 M-1, 
was for the GalNAc binder from soybean agglutinin (Gupta et al. 1996). The various 
thermodynamic contributions were analysed for PA-IIL/fucose and were characterized 
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by a strong enthalpy of binding, accompanied by a weakly favourable entropy term 
(Mitchell et al. 2005). When compared to classic lectin-monosaccharide interactions, 
the unusual affinity is explained by the relatively high enthalpy of binding and also by 
the absence of an entropy barrier. The favourable entropy of binding is very unusual but 
not unique in protein-carbohydrate complexes where an entropy barrier is generally 
observed (Dam, Brewer 2002). Favourable entropy has previously been observed for the 
binding of glucose by Lens culinaris lectin (Schwarz et al. 1993) and the binding of 
galactose by Erythrina corallodendron lectin (Surolia, Sharon and Schwarz 1996). 
Structural studies of Erythrina corallodendron indicate that favourable entropy may be 
due to the release of two tightly bound water molecules upon galactose binding 
(Elgavish, Shaanan 1998). A similar explanation could apply to the favourable entropy 
found for the PA-IIL/fucose interaction since the native lectin structure contains three 
water molecules tightly bound to the calcium ions that are released by fucose hydroxyl 
groups in complex (Loris et al. 2003).  
The environment of the two close calcium ions was also analyzed by Mitchell, 
E. et al. (2005). There are three fucose hydroxyl groups directly involved in the 
coordination sphere of the calcium ions. Very strong hydrogen bounds are formed by 
two of these hydroxyl groups with acetate from protein side chains with an O-O 
distance of 2.55 (+/- 0.02) Å, a value significantly shorter then that currently observe in 
protein carbohydrate interactions. The acetates from protein side chains that are 
involved in the hydrogen bonds also coordinate the calcium ions. This forms two 
peculiar six-membered ring arrangements, which may be responsible for the strong 
charge delocalization shown by the ab initio calculations. These rings may therefore 
play a major role in the unusually high affinity observed between PA-IIL and the 
monosaccharides.  
Sabin, C. et al (2006) expanded on this study by investigating PA-IIL complexes 
with a number of monosaccharides and their thermodynamics. In this study the 
thermodynamics and crystal structure of PA-IIL with Me-α-Fuc (as investigated by 
Mitchelle, E. et al. 2005), Me-α-L-Gal, Me-β-Ara and Me-α—Fru were investiagted. 
Methyl derivations of monosacchardies were used to avoid problems related to 
anomeric disorder in solution and also give a better potential mimic of real biological 
interactions. The order of preference of affinity of PA-IIL that was observed by 
inhibition of hemagglutination experiments (Garber et al. 1987) was confirmed by this 
study using isothermal titration calorimetry. Quantitatively, PA-IIL affinity for Me-α-
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Fuc is threefold stronger then for Me-α-L-Gal and Me-β-Ara and 140- fold better than 
for Me-α-Man. All complexes formed are driven by enthalpy.  
The role of the moiety at position 5 of the monosaccharide in binding was 
highlighted by Loris, R. et al. (2003). In this study comparison of the crystal structures 
allow the role of the moiety at position 5 of the ring to be explored. Since all other 
contact points between protein-monosaccharide complexes are identical in the different 
complexes, e.g. PA-IIL –Me-α-Fuc, PA-IIL- Me-α-L-Gal etc., the difference in binding 
affinity must therefore be correlated with this particular group. Interactions between 
proteins and carbohydrate generally present a balance of hydrogen bonds and 
hydrophobic contacts. In contrast, the interaction of PA-IIL with fucose is established 
mainly through coordination of calcium ions and hydrogen bonds. The only established 
hydrophobic interaction is between the methyl group at C5 of fucose and the side chain 
of Thr45. When this interaction is weakened, as in the complex with L-Gal, or absent, 
as with Me-β-Ara, the affinity is decreased by 3 fold (Sabin et al. 2006). 
All factors explaining the relatively high affinity of PA-IIL have yet to be fully 
resolved. Mishra, N. et al. (2008) attempted to unravel what causes the PA-IIL high 
binding affinities by using molecular dynamics simulations (MD). MD has been shown 
to serve as a reliable computer simulation method to complement experimental 
observations. 
Comparison of several MD trajectories of PA-IIL lectin either free or complexed 
with L-fucose, Me-D-Ara, D-mannose and D-fructose led to the observation that the 
ligand binding loop distance is shorter in the bound lectin compared with the free lectin. 
This indicates that the loops come closer after the binding of a monosaccharide. The 
geometry of the binding site in PA-IIL complexes show a stabilization effect of the 
monosaccharide site upon binding. The results suggest that the monosaccharide keeps 
the loops closer by the polar hydroxyl group interactions with the binding site via 
calcium ions. It has been demonstrated that hydroxyl group orientation of the 
monosaccharide and the ions within the vicinity of the binding site provide important 
means for the lectin binding (Mishra et al. 2008). 
The root mean square deviations (RMSDs) fits from the MD simulations 
indicate that the water molecule network around the binding pocket in complex seems 
to be one of the important factors influencing the proper orientation of the sugar. There 
is one more water molecule present in the fucose complex compared with other 
complexes which increases the binding affinity. The additional oxygen contributes to 
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the higher binding energy compared with the other saccharides. Calcium ion simulation 
analysis proved that the ions presence and its coordination with protein side chains and 
the monosaccharide are important driving factors for the lectin/carbohydrate binding 
(Mishra et al. 2008).  
 To date, using 3-D crystal structures and molecular dynamic simulations, a 
number of factors have been associated with the relatively high affinity binding of PA-
IIL. The protein crystal structures revealed the unusual protein/carbohydrate binding 
interaction formed by the two Ca2+ ions, the amino acid side chain that co-ordinates the 
Ca2+ ions and the sugar, as a basis for the relatively strong binding affinity. The 
moieties at position 5 and 6 of the monosaccharide ring were also demonstrated to affect 
the binding affinity. The relative contributions of thermodynamic parameters were also 
investigated. A strong entropy barrier is usually observed for classical 
protein/carbohydrate interactions. This strong entropy barrier is absent for PA-IIL due 
to the release of water molecules, which are found more strongly bound in PA-IIL then 
classical carbohydrate sites, upon binding. Favourably enthalpy and the lack of a strong 
entropy barrier are believed to contribute to the high affinity of PA-IIL.  Finally 
molecular dynamic simulations indicate the role played by water molecules and confirm 
the role played by calcium ions in the binding pocket and their contribution to PA-IIL’s 
higher binding energy. 
 
1.4 Biological role of PA-IIL 
1.4.1 Regulation of PA-IIL 
P. aeruginosa produces a wide spectrum of virulence factors and secondary 
metabolites which include such products as alkaline protease, elastase, endotoxin A, 
LasA protease, phospholipase C, exoenzymeS, pyocyanin and hydrogen cyanide (Nicas, 
Iglewski 1985, Preston et al. 1995, Saiman et al. 1992, Hirakata et al. 1995). The 
expression of multiple virulence and survival genes in P. aeruginosa is cell density 
dependant and relies on a cell-cell communication system which is known as quorum 
sensing (Passador et al. 1995). Quorum sensing is the phenomenon whereby the 
accumulation of a low molecular weight, diffusible, signal molecule (also known as a 
pheromone or autoinducer) enables individual bacterial cells to sense when the 
minimum population unit or “quorum” of bacteria has been achieved for a concerted 
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population response to be initiated (Fuqua, Winans and Greenberg 1994). Quorum 
sensing is an example of multicellular behaviour and regulates a variety of physiological 
processes, such as bioluminescence, swarming, antibiotic biosynthesis, plasmid 
conjugal transfer and production of virulence determinants in fish, animal and plant 
pathogens (Hardman, Stewart and Williams 1998). Quorum sensing, due to the large 
number of regulatory systems associated with it, appears to constitute a global 
regulatory system in P. aeruginosa. Whitely, M. et al. (1999) have proposed that up to 
4% of P. aeruginosa genes are regulated by quorum-sensing. N-acylhomoserine 
lactones (AHLs) have been reported to be employed as quorum sensing molecules in P. 
aeruginosa. P. aeruginosa has a sophisticated regulatory hierarchy linking quorum-
sensing to virulence and survival in the stationary phase (Latifi et al. 1996, Pesci et al. 
1997). A quorum-sensing circuit is composed of an AHL synthase enzyme and a sensor-
regulator protein. The AHL synthase enzyme acts on a substrate to produce an AHL 
which then acts on a sensor regulator protein that modulates gene transcription. Two 
separate quorum-sensing circuits, termed the las and rhl systems, are found within P. 
aeruginosa. Each possesses an AHL synthase enzyme, LasI or RhlI and a sensor 
regulator protein, LasR or RhlR. These modulate gene transcription in response to 
increasing AHL concentrations (las AHL: N-(3-oxododecanoyl)-L-homoserine lactone 
(3O-C12-HS2) and rhl AHL; N-butanoyl-L-homoserine lactone (C4-HSL))(Brint, 
Ohman 1995, Gambello, Iglewski 1991, Gambello, Kaye and Iglewski 1993, Latifi et 
al. 1995, Ochsner et al. 1994, Ochsner, Reiser 1995, Williams et al. 1992). 
 
 
Figure 1.5: Quorum-sensing systems found in P. aeruginosa and AHL they respond to. 
The two systems form a hierarchical cascade that coordinate virulence factors and 
stationary phase gene production via the alternative sigma factor RpoS (Latifi et al. 
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1996, Pesci et al. 1997). Each system regulates a regulon comprising of an overlapping 
set of genes. In P. aeruginosa the las system has been shown to directly regulate the rhl 
system. Therefore the las system provides overall coordination of quorum sensing and 
temporal gene expression in response to cell-to-cell communication (Hassett et al. 1999, 
Whiteley, Lee and Greenberg 1999). 
 Both lectins of P. aeruginosa, PA-IL and PA-IIL, are produced at high cell 
density, during the transition to stationary phase. In order to assess if quorum-sensing is 
involved in the production of these lectins, Winzer, K. et al (2000) carried out a study 
on PA-IL and PA-IIL production in various mutated strains of P. aeruginosa (Table 
1.1).  
Table 1.1:  Strains of P. aeruginosa used in the study by Winzer, K. et al. (2000) and the effect 




P. aeruginosa   




PANO67                      NTG mutant 
                                    derived from 
                                     PAO1 
Abolished (Jones et al. 
1993) 
PAOR                          lasR mutant  
                                    derived from  
                                    PAO1 
Late stationary 
phase production 
(Latifi et al. 1996) 
PDO100                      rhlI mutant                           
                                    derived from  
                                    PAO1 
Abolished (Brint, Ohman 
1995) 
PDO111                      rhlR mutant 
                                    derived from 
                                    PAO1 
Abolished (Brint, Ohman 
1995) 
PAO1 rpoS negative   rpoS mutant 
                                    derived from 
                                    PAO1 
Abolished (Jørgensen et al. 
1999) 
 
PA-IL and PA-IIL production was abolished in the P. aeruginosa rpoS mutant. LasRI 
and rhlRI quorum sensing have previously been shown to regulate the stationary phase 
sigma factor RpoS (Latifi et al. 1996). This study indicates that PA-IIL expression is 
RpoS dependant. Strain PANO67 lacks the ability to produce many virulence factors 
and does not produce PA-IL or PA-IIL. When the rhlRI locus was restored by 
transformation, growth phase dependant PA-IL and PA-IIL production was restored. 
This suggests the rhl locus is required for lectin biosynthesis. Further correlation was 
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found by the studying of rhlI negative and rhlR negative strains, PDO100 and PDO111 
(Brint, Ohman 1995). In both strains lectin synthesis was abolished completely (see 
Table 1.1). The mutation of the lasR locus delayed but did not abolish lectin production. 
The LasR mutant strain’s (PAOR) production of lectin was severally down regulated 
such that lectin production could only be detected in the late stationary phase. This 
suggests that RhlR/C4-HSL rather that LasR/3O-C12-HSL is directly responsible for 
controlling lectin expression. This result also suggests that while the las system 
regulates the rhl system, in late stationary phase, the rhlRI can be activated 
independently from LasR/3O-C12-HSL such that loss by mutation of lasR only delays 
but does not abolishe lectin biosynthesis. This study failed to exclude the possibility that 
lectin synthesis was not directly activated by the quorum sensing circuitry but by other, 
as yet unidentified, regulators which are themselves controlled by quorum-sensing 
(Winzer et al. 2000).  
For LuxR-type regulators such as LasR and RhlR, lux box like elements 
constitute the DNA binding site. The presence of a putative lux box upstream of PA-IL 
therefore suggests that it is directly regulated by RhlR. This lux-box like element is 
located 42 b.p upstream of the transcription start codon. Very similar distances have 
been reported for the lux box elements upstream of rhlAB (Pearson, Pesci and Iglewski 
1997), lasB (OPl) (Rust, Pesci and Iglewski 1996) as well as elements upstream of luxI 
in Vitrio fischeri (Egland, Greenberg 1999). The focus of the Winzer, K. et al. (2000) 
study was the lectin PA-IL as the PA-IIL gene was yet to be identified. Gilboa-Garber, 
N. identified and characterized the PA-IIL lectin gene in 2000. Despite the close 
relationship between PA-IL and PA-IIL their genes are widely separated on the P. 
aeruginosa chromosome (approx. 867.5 k.b). Upstream of the PA-IIL translational start 
site three sequences with homology to the lux box, originally described in V. fisheri 
(Devine, Shadel and Baldwin 1989, Rust, Pesci and Iglewski 1996) and similar to that 















Figure 1.6: The three nucleotide sequences (a,b,c) in the upstream region of the PA-IIL gene 
resembling a lux box and compared to that of PA-IL, the lux box of V. fischeri (Gilboa-Garber, 
Katcoff and Garber 2000), and other genes of P. aeruginosa. Image generated using ClustalW align and 
Genedoc. Identical residues highlighted in black. 
Since PA-IL expression can be induced by AHLs and it has been shown that AHL of rhl 
locus effects production of PA-IIL (Winzer et al. 2000) it is possible these sequences 
may be involved in the PA-IIL autoinduction process. The relatively wide distance 
between the PA-IL and PA-IIL genes on the chromosome strongly indicates that the 
coordinate expression of both lectins may be only attributed to the common 
autoinduction process via the lux-like box (Williams et al. 1992). 
1.4.2 Location of PA-IIL 
Glick, J. et al. (1983) found both P. aeruginosa lectins to be located mainly in 
the cytoplasm of planktonic (single cells in suspension) cells. This finding makes it 
difficult to explain lectin mediated cytotoxic and adhesive properties (Adam, 
Schumacher and Schumacher 1997, Bajolet-Laudinat et al. 1994). However, the 
addition of fucose-branched chitosan was found to lead to specific cell aggregation 
which would suggest that PA-IIL may be exposed on the surface of sessile P. 
aeruginosa cells (Morimoto et al. 2001, Tielker et al. 2005). These researchers reported 
on the cellular localization in planktonic and sessile cells (cells not free to move about, 
i.e. attached to surfaces, involved in biofilm formation) and the role of PA-IIL in 
biofilm formation.  
 The biofilm-forming capability of wild type P. aeruginosa PAO1 and PA-IIL 
deficient strain PAI2 were compared over growth periods of 48 and 72 hours at both 
30oC and 37oC. Biofilm formation was monitored by confocal laser scanning 
microscopy (CLSM). Biofilms of the mutant strain were found to be thinner then that of 
the wild type and the surface coverage was also found to be lower at both temperatures. 
Since the same growth rates and maximal cell densities were reached for PAO1 and 
PAI2 this effect was not caused by a general growth defect (Tielker et al. 2005). The 
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subcellular localisation of PA-IIL was determined by comparison of planktonic and 
sessile cells which had been grown in unsaturated biofilms of the type that is also found 
in the lungs of cystic fibrosis (CF) patients suffering from P. aeruginosa infection 
(Lyczak, Cannon and Pier 2002). Cellular compartments were isolated and probed with 
PA-IIL specific antiserum. PA-IIL was detected in the cytoplasm and total membrane 
fraction in both the planktonic and sessile cells. The precise location was further 
investigated by separation of the inner and outer bacterial membrane of sessile cells. 
PA-IIL was found exclusively in the bacterial outer membrane.  The presence of PA-IIL 
on the outer membrane was suggested to be due to the lectin being bound via fucose-
containing structures. This assumption was proven when PA-IIL was detected in the 
supernatant solution after the isolated outer-membrane was incubated with inhibitory 
sugar α-NPF (Garber et al. 1987). When incubated with galactose, for which PA-IIL has 
a low affinity, no lectin was found in the supernatant, i.e. it remains bound to membrane 
and found within the cell pellet. This result was confirmed by mutating PA-IIL which 
rendered it unable to bind (Tielker et al. 2005). In this case PA-IIL can be found in the 
cytoplasm similar to wild type PA-IIL but, unlike the wild type, it is not detected in the 
membrane fraction. Therefore the sugar binding capacity of PA-IIL is essential for outer 
membrane localization. Treatment of wild type PAO1 biofilms with yellow fluorescing 
protein (YFP) labelled PA-IIL demonstrated the binding of PA-IIL to the cells showing 
that carbohydrate receptors on the surface of P. aeruginosa  biofilm cells are accessible 
to PA-IIL (Tielker et al. 2005).  
 This study by Tielker, D. et al. (2005) proves that PA-IIL plays an important 
role in biofilm formation and that PA-IIL is associated to the outer bacterial membrane 
via binding to carbohydrate-ligands. PA-IIL does not contain any of the presently 
known secretion signals and therefore is unlikely to be secreted via typeI pathway or the 
Sec or Tat pathways. As yet a secretion mechanism for PA-IIL has yet to be identified.  
 Since PA-IIL was implicated in biofilm formation it holds potential as a target 
for the prevention of P. aeruginosa biofilm formation. A previous study exploited the 
multivalency of lectins to produce a high affinity synthetic ligand, an octavalent 
dendrimer with galactose. This multivalent dendrimer was shown to inhibit 
hemagglutination induced by the bacterium Streptococcus suis revealing the potential of 
glycol-dendrimers as anti adhesions (Joosten et al. 2004). This precedent suggests that a 
multivalent fucose ligand should be a suitable compound to inhibit P. aeruginosa 
lectins.  
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 The use of glycans as anti-adhesive agents can be found in nature. Immature 
animals (newborns, newly hatched vertebrates or larvae) are very sensitive to bacterial 
infection. In mammals infection is prevented by maternal milks (Newburg, Ruiz-
Palacios and Morrow 2005). The majority of the oligosaccharides found in human milk 
are fucosylated and their production is dependant on enzymes which are encoded by the 
genes associated with the expression of the Lewis Blood groups (Newburg, Ruiz-
Palacios and Morrow 2005). Studies have shown that complex oligosaccharides with 
terminal fucose residues of the Lewis a (Lea) or Lex series are the preferred targets for 
PA-IIL. The Lea active pentasaccharide was found to have 120X higher activity then D-
mannose (Mitchell et al. 2002). The order of preference for PA-IIL including Lewis 
groups was determined to be; Lea active pentasaccharide ≥ sialy Lea tetra- > methyl-α-
Fuc > Fuc and Fucα1-2-Gal (human blood group H active disaccharide) > 2-
fucosyllatose Lex > H type I determinant > Lex glycolope (Galβ1-4[Fucα1-3]GlaNAc > 
sialy Lex tri- >>Man >>>Gal, GalNAc and Glc (Wu et al. 2006). It is unsurprising then 
that PA-IIL was found to display a unique high sensitivity to the fucosylated 
compounds of human milk (Lesman-Movshovich, Gilboa-Garber 2003). The maternal 
secretions contain saccharides in free form or carried on macromolecules (mainly 
glycoprotein) that act as decoys, competitively blocking the bacterial lectin mediated 
adhesion to cells. Avian embryos are protected by avian egg whites in the same manner. 
Glycans in quail eggs were shown to bear terminal mannose residues which are found to 
inhibit PA-IIL (Lerrer, Gilboa-Garber 2001).  
 Royal jelly and honey have been identified as other sources of inhibiting PA-IIL 
glycoproteins. When compared to the inhibition activity of human milk, honey and 
royal jelly would provide similar protection against PA-IIL mediated P. aeruginosa 
infection. The effectiveness of synthetic ligands to inhibit bacterium and the presence of 
fucosylated ligands in nature as decoys and competitive inhibitors suggest synthetic PA-
IIL ligands may act as anti-microbial agents.  
Johansson, E. et al. (2008) developed a library of multivalent fucosyl peptide 
dendrimers as ligands. The library was screened by functional selection. The ligand FD2 
dendrimer (Figure 1.7), consisting of a structure with four fucosyl groups, was found to 
have the highest affinity toward PA-IIL (Figure 1.7, see Table 1.2 for chemical 
structure).  
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Figure 1.7: Schematic of the multivalent fucosyl-peptide dendrimer FD2 
 
The effect of monovalent control ligands, such as fucose, on reduction of biofilm 
formation is weak. Conversely the addition of multivalent dendrimers to culture caused 
a strong reduction, in particular the high affinity dendrimer FD2, which showed 
complete inhibition of biofilm formation at 50µM. The effect of dendrimers on both 
biofilm inhibition and dispersion assays was much stronger then the effect observed 
with monovalent α-NPF. The observed effect was not due to potential toxicity of the 
dendrimers as bacterial growth was unaffected. FD2 was found to not only inhibit 
biofilm formation but in fact caused complete clearance of P. aeruginosa in dispersion 
assays. It was also found to inhibit biofilm formation in several clinical isolates derived 
from CF lungs, suggesting that the inhibition effect is general and supports the potential 
of these dendrimers in a clinical context. 
 Biofilm inhibition was proven to be due to inhibition of PA-IIL binding when it 
was shown that the monovalent control ligand α-NPF inhibited biofilm formation of 
wild type P. aeruginosa PAO1 and deletion mutation PAO1∆PA-IL, but showed no 
effect on biofilm formation of deletion mutation PAO1∆PA-IIL. Similar to α-NPF, no 
effect was seen on PAO1∆PA-IIL biofilm formation by the dendrimer FD2. These 
results support the hypothesis that the effect of FD2 on biofilm formation is due to 
specific binding to PA-IIL (Johansson et al. 2008). 
 This study clearly suggests that multivalent fucosyl-peptide dendrimers may be 
used as ligands to prevent biofilm formation and disrupt existing biofilms of P. 
aeruginosa. The dendrimer created by this group was found to have a 46-fold higher 
affinity over fucose (estimated by isothermal titration calorimetry). Thus, these 
glycopeptide dendrimers represent strong multivalent PA-IIL ligands. The IC50 of FD2 
is approx. 10µM for biofilm inhibition, a 50-fold affinity gain over α-NPF. FD2 was 
additionally tested for cytotoxicity against a human cell line by lactate dehydrogenase 
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(LDH) cytotoxicity assay where it did not show a significant increase in LDH release up 
to 0.1M concentration (Johansson et al. 2008). 
Table 1.2: Synthetic yields of c-fucosyl peptide dendrimers produced by Johansson, E. (2008) and 
Kolomiets, E. (2009). [a] Number of fucosyl groups in the ligand [b] isolated by preparative HPLC [c] 


















2LysHislleNH2 22 9 3104.4 3103.8 
PA9 4 
(cFuc-GluHisTyr)4(LysTyrGlyAsp) 
2LysHislleNH2 22 6 3791.6 3792 
FD2* 4 
(cFuc-LysProLeu)4(lysPheLyslle) 
2LysHislleNH2 38.5 14 3536.34 3536 
FD10 4 
(cFuc-GluThrAsp)4(LysTyrGlyAla) 




2LysHislleNH2 11.7 2.5 5994.53 5994.25 
 
Kolomiets, E. et al. (2009) further chemically refined the high affinity dendrimer FD2 
to the 3rd generation octavalent dendrimer 2G3 (Table 1.2), with an IC50 value of 
0.025µM, determined by enzyme linked lectin assay (ELLA). This N-terminal C-
fucosyl residue represents a potent inhibitor for PA-IIL with a significantly increased 
potency up to 440-fold over fucose. The aqueous solubility of these fucosyl peptide 
dendrimers is generally good in contrast to the other synthetic multivalent fucosyl 
dendrimers reported to date where aqueous solubility is often low. This improves their 
applicability in a clinical setting. A number of observations with regard to the binding 
of PA-IIL were also made in this study. Although the best trivalent dendrimer FD2 is 
cationic, the neutral dendrimer, PA8 (Table 1.2), and anionic dendrimers, FD10 and 
PA9 (Table 1.2) bound almost as well as FD2 indicating that charge is not a primary 
determinant of the binding affinity to PA-IIL. Octavalent dendrimers bound better then 
the mono- or di- C-fucosyl moieties proving multivalency is an important factor for 
binding. Docking studies show that the C-fucosyl groups of the dendrimers adopt 
identical binding modes to fucose with peptide arms protruding form the binding 
pocket. It is these arms that establish specific contacts with the lectin (Kolomiets et al. 
2009). 
The suggestion that PA-IIL plays a role in bacterial adhesion to airway epithelia 
and in biofilm formation (Tielker et al. 2005), features attributed to surface exposure of 
PA-IIL, lead to the hypothesis that the lectins of P. aeruginosa exert some effect on 
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surface exposed proteins. Sonaware, A. et al. (2006) investigated the principle of this 
hypothesis.  
 A PA-IIL deficient mutated strain of P. aeruginosa PAK was created by 
insertional inactivation, whereby a gene is inactivated by the insertion of an unrelated 
fragment of DNA into the cloning sequence of the gene. Since all hypothesised actions 
of PA-IIL are surface related, e.g. biofilm formation and adhesion, any change in 
membrane protein levels was initially examined. Image analysis of 2D-gels revealed 
that a protein spot, identified as PilJ, was down regulated for the PA-IIL mutant. 
Analysis by MS indicate that there was a six fold reduction of this protein expressed in 
the PA-IIL mutant strain compared to the wild type strain while the PA-IL mutant strain 
was unaffected. The down regulation of PilJ was assessed to see if expression was 
effected at the transcriptional level. No significant difference was noted in 
transcriptional activity which suggests that the effect on expression of PilJ took place at 
the post-transcriptional level. No lectin was detected in the wild type membrane 
preparations used for the proteomic studies. This suggests that the lectins may be 
expressed at very low levels or are not found in significant amounts in the outer 
membrane. No carbohydrates were found attached to wild type PilJ protein which 
would imply that PA-IIL does not directly interact with the protein (Sonawane, Jyot and 
Ramphal 2006). 
 Twitching motility is mediated by type IV pili and is controlled by a complex 
chemosensory pathway which includes a number of proteins, PilJ being one of these 
(Whitchurch et al. 2004). Previously, it has been observed in a P. aeruginosa PilJ 
mutant, twitching motility was deficient and no type IV pili were expressed (Kearns, 
Robinson and Shimkets 2001). The twitching motility of PAK wild type was found to 
be normal while a PA-IIL mutant was found to be non-twitching. Twitching motility 
was restored when PA-IIL was complemented back into the mutant indicating that the 
loss of PA-IIL was responsible for loss of twitching motility. The twitching defect was 
also found not to be due to transcriptional change in protein synthesis but is most likely 
due to an inability to assemble surface pili (Sonawane, Jyot and Ramphal 2006).  
 Biofilm formation was compared between the PA-IIL mutant, complemented 
PA-IIL mutant and wild type P. aeruginosa. The PA-IIL was more then 50% defective 
in biofilm formation when compared to the wild type. Biofilm formation was fully 
restored for the PA-IIL compliment indicating the loss of PA-IIL was responsible for 
defective biofilm formation. It was proposed that the defect in biofilm formation may be 
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due to the absence of pili in the mutant.  The PA-IIL mutant was found to be defective 
in type IV secretion, therefore the other secretion systems were examined for defects 
(Sonawane, Jyot and Ramphal 2006).  
 The type II secretory pathway is used to excrete a significant number of proteins 
in P. aeruginosa including alkaline protease, endotoxin A, Las A and Las B (Ball et al. 
2002, Liu 1966, Pavlovskis, Gordon 1972). The PA-IIL mutant was found to have weak 
proteolytic activity when grown on casein-milk agar plates. When levels of LasB were 
examined both the intracellular and secreted LasB were found to be unaltered for the 
PA-IIL mutant. This suggests that the reduced caseinolytic activity is not due to a LasB 
defect. The deficit in caseinolytic activity is presumed to be due to modulation of 
protease IV activity after experiments showed that although secretion and size of LasB 
in the PA-IIL mutant was unaffected, no lactoferrin degradation by protease IV in the 
presence of EDTA was detected. In addition analysis showed that many extracellular 
proteins were absent from the PA-IIL mutant. However, phospholipase and endotoxin A 
secretion were unaffected. No effect was seen on the secretion of ExoS and ExoT which 
are secreted through the type II secretion system (Yahr, Goranson and Frank, Frank 
1997).  
 Lectins have been suggested to be involved in adhesion to respiratory mucins in 
CF patients (Mitchell et al. 2002) but this hypothesis has yet to be demonstrated. The P. 
aeruginosa mutant lacking pili PAK-NP (Saiman et al. 1990) attaches to mucins as 
efficiently as the wild type strain (Ramphal et al. 1991). The PAK-NP mutant lacking 
functional fliD (PAK-NPD), which encodes the flagellar cap protein, was severely 
impaired in mucin adhesion (Arora et al. 1998). These strains were used as controls. 
Both lectin mutants were unimpaired in their ability to bind to CF mucin compared to 
the wild type strain. The PAK-NPD mutant did show a marked defect in its ability to 
bind to the CF mucin. This result conflicts somewhat with results obtained by Chemani, 
C. et al. (2009), who found reduced bacterial loads in vivo in a murine model with the 
loss of the PA-IIL gene.  
 Respiratory mucins contain a number of sugars including fucose, therefore, one 
would predict that if there is surface expression of PA-IIL then mucin binding would be 
a prominent function. This wasn’t demonstrated in this study. The study concluded that 
PA-IIL is involved in multiple functions. It effects expression of PilJ, a member of the 
pilus biogenesis pathway which in turn affects pilus formation. Its role in pili generation 
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would explain its role in biofilm formation in vitro. This study also demonstrates a role 
for PA-IIL in proteolytic activity (Sonawane, Jyot and Ramphal 2006).  
Chemani, C. et al. (2009) carried out a study to determine if lectins may 
contribute to the virulence of P. aeruginosa. The results demonstrated that there is a 
relationship between lectins and P. aeruginosa pathogenicity. PAO1::PA-IL and 
PAO1::PA-IIL mutant strains of wild type P. aeruginosa, PAO1, were produced by 
insertion of a transposon for interruption into the PA-IL and PA-IIL genes. Growth 
curves for the parental strain and mutants showed that there was no major growth defect 
for PAO1::PA-IL and PAO1::PA-IIL mutants. The effect of these mutations was 
examined under a number of conditions. The cytotoxicity of P. aeruginosa PAO1 and 
mutations was evaluated by measuring the LDH release at 4 and 6 hours after infection 
of A549 cells. When compared, the amount of LDH released was statistically larger for 
PAO1 infected cells then that for the mutated strains at 4 and 6 hours. PAO1 induced 
cytotoxicity was significantly reduced by the addition of specific inhibitors (GalNAc 
and Me-α-Gal for PA-IL and Me-α-Fuc for PA-IIL) after incubation for 6 hours 
compared to results for the non-specific lectin inhibitor Glc. Cytotoxicity obtained with 
purified lectin was also significantly decreased when specific inhibitors were added. 
Adherence of bacteria to A549 cells was also examined. The number of adherent 
bacteria to cells was approximately twofold greater for PAO1 infected cells then in 
comparison to PAO1::PA-IL and PAO1::PA-IIL. In vitro analysis in a murine model 
found that PAO1::PA-IL and PAO1::PA-IIL did not have a statistically significant affect 
on mortality rates (Chemani et al. 2009). Incubation of P. aeruginosa with specific PA-
IL inhibitors did decrease mortality. However no difference was observed for the group 
which received the PA-IIL inhibitor, Me-α-Fuc, over the PAO1 infected group. Lung 
injury was also evaluated in vitro. Lung injury was measured by the efflux of the tracer 
protein 125I-albumin from blood to lungs at 6 hours after intraperitoneal instillation or 
from blood into the lungs 16 hours after intraperitoneal injection. The concentration of 
the protein tracer was statistically greater for PAO1 then either mutated strain after both 
6 hours and 16 hours. The concentration of protein tracer could be restored by trans-
complementation of the gene into the mutated strain. Therefore the loss of PA-IL and 
PA-IIL can be said to reduce protein permeability of the lungs. Likewise purified lectins 
induced an increase in permeability. Co-instillation of specific inhibitors with purified 
PA-IIL significantly reduced lung injury when assed by alveolar barrier permeability. 
Bacterial load of lungs 16 hours after instillation of pathogen was also compared 
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between strains. Animals infected with PAO1 showed a significantly higher bacterial 
load then PAO1::PA-IL and PAO1::PA-IIL. Co-administration of lectin specific 
inhibitors with the pathogen reduced bacterial load. Blood culture analysis, after 
instillation of P. aeruginosa, found the number of positive blood cultures statistically 
lower for PAO1::PA-IL and PAO1::PA-IIL then PAO1. Co-instillation of lectin specific 
inhibitors decreased dissemination of bacteria in blood (Chemani et al. 2009). The 
parent strain PAO1 P. aeruginosa was found to have greater cytotoxicity then either of 
the mutants. Although cytotoxicity may be due to multiple factors the cytotoxic effect of 
purified lectins shows that the cytotoxicity is at least in part a result of the lectins. The 
in vivo relevance of PA-IL and PA-IIL suggests that the lectins are not direct or major 
determinants of mortality on their own but could act as important co-factors none the 
less.  
Oligosaccharide-mediated recognition and adhesion are key stages in the early 
phase of P. aeruginosa infection. The reduced bacterial lung loads for PAO1::PA-IL and 
PAO1::PA-IIL would support the hypothesis that lectins act as virulence factors mainly 
in the early phase. Although PA-IIL may not play a direct role in adhesion as reported 
by Sonaware, A. et al. (2006) it does appear to be an indirect factor in bacterial 
adherence. Since PA-IL and PA-IIL have been found to play a major role in biofilm 
formation, modulation of PA-IL and PA-IIL could potentially inhibit initial infection of 
P. aeruginosa and then subsequent biofilm formation at a latter phase as demonstrated 
by the reported successful treatment of a P. aeruginosa airway infection (von Bismarck, 
Schneppenheim and Schumacher 2001) 
1.6 Homologs of PA-IIL 
The availability of the whole genome sequence of an ever growing number of 
bacteria has led to the identification of a number of homologs to PA-IIL (Table 1.3). 
Comparative studies of the molecular basis, properties and function reveal two highly 
homologous proteins to PA-IIL.  
 Ralstonia Solanacearum is a plant pathogen found in soil. It infects more than 
200 plant species from 50 different families causing heavy agricultural crop loss 
(Hayward 1991, Denny 2000). Homology scans using the 114 amino acid sequence of 
PA-IIL as a query identified a 342 b.p open reading frame encoding a PA-IIL like 
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putative protein. This 113 a.a protein, RS-IIL, displays 69% identity and 85% similarity 
to PA-IIL (Sudakevitz et al. 2004). 
 Chromobacterium violaceum is a common inhabitant of soil and water in 
tropical and subtropical regions. It behaves as a saprophyte generally but can 
sporadically become an aggressive opportunistic animal pathogen causing serious 
infections with high mortality rates in immunodeficient human patients (Alves de Brito 
et al. 2004, Sirinavin et al. 2005). Comparison of the C. violaceum genome (Brazilian 
National Genome Project Consortium. 2003) with other organisms reveal R. 
solanacearum as having the highest percentage of ORF similarity (17.4%) followed by 
P. aeruginosa with 9.61%. A homologous ORF to PA-IIL and RS-IIL was found and 






Table 1.3: Homologous lectins; P. aeruginosa PA-IIL, R. solanacearum RS-IIL, C. violaceum CV-
IIL, lectin region P. luminescens Photopexin A (ppxA/L) and lectin region P. luminescens 
PhotopexinB (ppxB/L). Percentage identity (black) refers to the percentage of amino aicds in the 
alignment of the above lectins which are identical between the proteins. Percentage similarity (red) refers 
to the percentage of amino acids in the alignment which are not identical between the proteins but which 
have similar biochemical properties and are considered interchangeable in many situations. Gap character 
(blue) is the number of padding or null characters to match homologous residues, indicated by – in the 
alignments. Statistic report created using ClustalW and GenDoc.  
 
Sudakevitz, D. et al. (2004) carried out crystal structure analysis of RS-IIL. The 
topology and binding pocket of RS-IIL and PA-IIL were found to be very similar. Two 
calcium ions in a classical seven ligand co-ordination were found in the binding pocket 
as was found for PA-IIL. This is corroborated by the complete inhibition of RS-IIL in 
the presence of the metal chelator EDTA (as found for PA-IIL), as EDTA strips Ca2+ 
from the binding pocket. The C-terminus, Gly113, of a neighbouring monomer was 
found to be involved in the calcium and monosaccharide binding, another characteristic 
of PA-IIL binding. All the amino acids of the calcium binding site are strictly conserved 
between PA-IIL and RS-IIL (Figure 1.8) (Sudakevitz et al. 2004). 
 RS-IIL and PA-IIL were found to be inhibited by similar sugars in 
hemagglutinating inhibition assays but differed in their binding affinity ranges. The 
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order for RS-IIL was found to be, D-fructose and D-mannose, L-fucose, L-galactose 
and D-arabinose. The affinity range for RS-IIL to fructose and mannose is comparable 
to that of PA-IIL to fucose. The conserved calcium binding site is the basis of the high 
affinity as it allows three hydroxyl groups to be involved in the co-ordination sphere (as 
seen for PA-IIL, Mitchell et al. 2002). From the crystal studies of PA-IIL interacting 
with different ligands (Loris et al. 2003, Mitchell et al. 2002) it is known that specificity 
for monosaccharides is only partly dependant on the stereochemical arrangement 
required for interacting with the Ca2+ as this was shown to be met by other 
monosaccharides. The specificity difference between RS-IIL and PA-IIL is therefore 
directed by the second loop, the sugar binding loop. The Ser-22-Ser-23-Gly-24 in PA-
IIL is replaced by Ala-22-Ala-23-Asn-24 in RS-IIL (Figure 1.8). Binding of Ser-22 to 
Asp-96 in PA-IIL results in a lack of space in the binding site for the O6 of mannose 
which is then directed towards the surface where it interacts with Ser-23. In RS-IIL the 
Asp-96 is available for hydrogen binding. RS-IIL preference for mannose is the result of 
these stronger hydrogen bonds between O6 and the acidic group of Asp-96 when 
compared with the weaker bond between O6 and the hydroxyl group of Ser-23 in PA-
IIL (Sudakevitz et al. 2004). Small amino acid variations are therefore responsible for 
the differing binding affinities of PA-IIL and RS-IIL.  
 The crystal structure of CV-IIL in complex with Me-α-fuc and Me-α-man was 
produced by Pokorná, M. et al. (2006). The quaternary structure was found to be a 
tetramer very similar to those previously described for PA-IIL and RS-IIL (Sudakevitz 
et al. 2004). The binding mode of CV-IIL was also found to be very similar to both 
these lectins. The binding complex involves two Ca2+ ions and one sugar residue in each 
binding site. All the amino acids involved in calcium binding are strictly conserved 
among PA-IIL, RS-IIL and CV-IIL (see Figure 1.8) and the Ca2+ ions are bound in the 
same manner. As for PA-IIL and RS-IIL the acidic group of the C-terminal Gly113 of 
the neighbouring associated monomer is involved in the binding pocket. The preference 
order for CV-IIL was reported to be; L-fucose>D-arabinose>D-fructose>D-mannose. 
The preference of CV-IIL for fucose is only 6 fold stronger than mannose. Therefore 
this lectin is a fucose/mannose binding lectin, i.e. binding affinity appears somewhere 
between the PA-IIL and RS-IIL affinities. The amino acids of the sugar binding loop of 
CV-IIL, crucial for specificity, lies between those found for PA-IIL and RS-IIL (Figure 
1.8) in terms of degree of sequence symmetry which correlates to the binding specificity 
(Pokorná et al. 2006). The variations in the sugar binding loop are; Ser22-Ser23-Gly24 
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in PA-IIL to Ser22-Ala23-Ala24 in CV-IIL (Zinger-Yosovich et al. 2006).The lower 
affinity binding of CV-IIL to fucose may be due to differences in thermodynamics. 
However at present it is difficult to correlate the thermodynamics and structural 
differences for binding Me-α-Fuc by CV-IIL and PA-IIL (Pokorná et al. 2006). Further 
studies are required to resolve this.  
 
Figure 1.8: Amino acid alignment of protein sequences of P. aeruginosa lectin PA-IIL, R. 
solanacearum lectin RS-IIL and C .violaceum lectin CV-IIL.  
Amino acids involved in monosaccharide binding outlined in red and amino acids involved in calcium 
binding outlined in green. Image generated using ClustalW align and Genedoc. Identical residues 
highlighted in black and similar in grey. 
 
The structural comparison of PA-IIL and RS-IIL revealed the importance of the 
three amino acid motif for specificity (see above). A study by Adam, J. et al. (2007) 
confirmed this observation by constructing mutants replacing each of the amino acids in 
position 22, 23 and 24 of PA-IIL from P. aeruginosa PAO1. The point mutations were 
investigated both structurally by X-ray crystallography and functionally by isothermal 
titration calorimetry (ITC). The point mutations were as follows; Ser22→Ala22 (S22A), 
Ser23 →Ala23 (S23A) and Gly24→Asn24 (G24N).  
 The mutant S22A displays a reversed order of preference between mannose and 
fucose. The affinity of S22A to mannose was found to be 4 times higher compared to 
the wild type protein (Table 1.4., Figure 1.9.). This result confirms the hypothesis that 
S22 holds the main key to affinity determination. Without the hydroxyl group of S22 
there is no steric hindrance blocking the interaction of the sugar with Asp96 (Adam et 
al. 2007). The Ser22A/Me-α-man complex closely resembles the crystal structure of 
RS-IIL lectin/mannoside complex (Sudakevitz et al. 2004). 
 The order of sugar preference for S23A and G24N is the same as that for wild 
type PA-IIL (fucose over mannose preference). The affinity of both mutants to Me-α-
fuc is two fold higher then the wild type protein (Figure 1.9). Increases in affinity are 
due to slight conformational changes of the binding pocket leading to favourable 
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affinities (Adam et al. 2007). This study demonstrates the potential of mutagenesis of 






Table 1.4 [Above]: 
Thermodynamics of 
lectin/sugar binding.   
Comparison of thermodynamic 
binding characteristics for 
different monosaccharides with 
PA-IIL, its mutants, RS-IIL from 
R. solanacearum and CV-IIL 
from C. violaceum. Determined 
by ITC at 250C. PA-IIL values 
obtained from Sabin, C et al. 
(2006) and Perret, S et al. (2005). 
Values obtained for CV-IIL taken 
from  Pokorná, M. et al. (2006). 
 
Figure 1.9 [Left]: Graphical representation of the binding affinities of the P. aeruginosa PA-IIL 
lectin and mutants, C. violaceum lectin CV-IIL and R. Solanacearum lectin RS-IIL, as determined 
by ITC. 
Representation of the equilibrium association constants toward different monosaccharides for wild type 
PA-IIL, PA-LL mutants and the homologs RS-IIL from R. solanacearum and CV-IIL from C. violaceum. 
 
 Homologs to PA-IIL have also been located within the Burkholderia cepacia 
complex (Bcc). The Bcc is a collection of genetically distinct but phenotypically similar 
bacteria that can be divided into at least 9 species (Mahenthiralingam, Vandamme 
2005). Bcc bacteria such as B. cenocepacia and B. multivorans are opportunistic 
pathogens that can cause lung infections in CF patients often resulting in death 
(Mahenthiralingam, Baldwin and Vandamme 2002). Bcc bacteria are found in a variety 
of environments like P. aeruginosa (e.g. soil, water and vegetation) and exchange of 
genetic material has been confirmed between both bacteria (Eberl, Tümmler 2004). It is 
therefore not surprising that several genes coding for lectins or lectin-like domains with 
similarity to PA-IIL have been identified in a number of strains of Bcc. Frequently an 
uncharacterised N-terminal domain is attached to the lectin domain. The genes 
identified as coding PA-IIL like lectins all belong to Bcc that were reported in C.F 
isolates (Lameignere et al. 2008). No single copy gene has been identified, all have 
coded for larger proteins then PA-IIL 
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 Lameignere, E. et al. (2008) carried out a study on the lectin BclA (B. cenocepia 
lectin A), the product of the smallest PA-IIL-like gene from B. cenocepia J2315. The 
BclA gene was identified in five stains of B. cenocepia and one strain of B. ambifaria. 
All Burkholderia BclA protein sequences are very similar, with a 32% identity with PA-
IIL. The calcium binding loop and C-terminal glycine amino acids are conserved 
between all the genes. The amino acids in the sugar binding loop are partially 
conserved; Ser22-Ser23-Gly24 of PA-IIL to Ala22-Ala23-Glu24 of BclA. The presence 
of alanine (22) in place of serine (22) for RS-IIL in the 1st position of the sugar binding 
loop trio is implicated in the higher binding affinity for mannose over fucose. BclA is 
therefore predicted to display a higher preference for mannose binding.  
The Lameignere, E. et al. (2008) study cloned and expressed recombinant BclA. 
A crystal study of BclA revealed the topologies of BclA and PA-IIL to be similar 
including the presence of two Ca2+ ions in the binding pocket and the action of the C-
terminal glycine of the neighbouring subunit in activity. Differences in the peptide 
sequence influence the tertiary arrangement, in particular the addition of N-terminal 
amino acids and a longer loop which would not allow the creation of a dimer-dimer 
interace. Therefore, BclA forms a dimer while PA-IIL forms a tetramer. Surface 
plasmon resonance (SPR) assays (based on the inhibiting power of a monosaccharide on 
binding of circulating BclA to a mannose surface) determined D-mannose to be an 
excellent inhibitor. L-fucose, D-arabinose and L-galactose also inhibit but two orders of 
magnitude weaker then D-mannose. D-galactose did not bind at all. These results were 
confirmed by broad spectrum glycan array analysis performed at the Consortium for 
Functional Genomics. These results show BclA has a strict specificity for 
oligomannose-type N-glycans, only binding to oligosaccharides with a α-mannoside-
capped branch. Specificity for linkage does not appear to be strict (Lameignere et al. 
2008).   
Alignment of 19 of the highest similarity Bcc genes to PA-IIL (identified by 
protein Blast search) found 5 amino acid variations within the sugar binding loop. An 
example of each variation aligned with PA-IIL, RS-IIL and CV-IIL and the conserved 
calcium binding regions is shown in Figure 1.10. While the N-terminus and size of the 
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Figure 1.10: PA-IIL – fucose lectin P. aeruginosa, RS-IIL – mannose lectin R. Solanacearum, CV-
IIL – fucose lectin C. violaceum, BC-IIL – fucose lectin II B. cenocepacia AU1054, Bcep1 – 
Hypothetical protein Bcep18194-B2934 B. cenocepacia spp.383, Bcep2 – Hypothetical protein 
Bcep18194-B2933 B. cenocepacia spp 383. 
Amino acids involved in monosaccharide binding outlined in red and amino acids involved in calcium 
binding outlined in green. Image generated using ClustalW align and Genedoc. Identical residues 
highlighted in black and similar in grey. 
 
 
Little variation of the sugar binding amino acids of Bcc bacteria indicates the most of 
these lectin-like domains are likely to fucose/mannose binders.  
Homologs of greater diversity have also been identified in Photorhabdus 
luminescens. P. luminescens is an insect pathogenic bacterium that lives in symbiosis 
with nematodes that invade insects. On invasion of an insect host by a nematode the 
bacteria is released from the nematode gut and is thought to secrete a range of virulence 
factors that over come the insect while providing a suitable environment for both the 
bacteria and nematode. Among the virulence factors it produces are ‘toxic complexes’ 
which are encoded by several toxic complex (tc) loci or pathogenicity islands (Bowen et 
al. 1998). Surrounding these tc loci are many open reading frames. To formulate 
hypotheses for the putative biological role of such ORFs, work was carried out to model 
the structures on predicted amino acid sequences with conserved motifs (Crennell 
2000). The locus discussed in the study by Crennell, S. et al. (2000) lie upstream of the 






Figure 1.11: The Photopexin locus is found upstream of the toxic complex (tc) locus. PpxA and 
ppxB locus highlighted in red, remaining (grey) locus genes involved in toxic complexes.  
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This toxic complex and upstream ORFs have also been found for P. luminescens strain 
TT01. The locus has two ORFs, namely Photopexin A (ppxA) and Photopexin B (ppxB). 
ppxA is the larger of the two, consisting of 564 amino acids to ppxB with 340 amino 
acids. ppxB has a 65% identity to ppxA. Analysis revealed ppxA to contain internal 
homology within itself. ppxA is composed of two 220 amino acid homologous domains 
and a less similar 100 amino acid C-terminus. The predicted ppxB sequence is 
homologous to the latter two domains of ppxA (one repeating domain and the C-
terminal domain). ppxB could therefore be hypothesised to have a similar function to 
ppxA or may be a tandem (potentially non-functional) duplication of part of ppxA. The 
N-terminal domains of both ppxA and ppxB have significant protein sequence similarity 
to the phosphocholine binding protein limunectin from Limulus amoebocytes. Lesser 
similarities were found to a wide range of matrix metalloproteases (MMPs) and 
collagenases (Crennell 2000).  
 Crennell S. et al. (2000) carried out a number of modelling studies of the N-
terminal domain of ppxA and ppxB. A four-blade β-propeller fold was assigned to these 











Figure 1.12: [A] Ribbon diagram of the N-terminal domain of ppxA, modelled on haemopexin-like 
domain of human matrix metalloproteinase-2 (MMP2), PDB file 1RTG. [B] Ribbon diagram of the 
four bladed β-topology of MMP2, PDB file 1RTG. 
The perpendicular view illustrates the four bladed β-topology. ppxA protein model created using Swiss-
Model and PDB file 1RTG as template. Images generated using Pymol.  
 
This fold was first seen in the structure of the vertebrate haem-scavenging molecule 
haemopexin. This is the first ‘haemopexin-like’ motif identified outside of animal and 
plants. It was therefore speculated that in Photorhabdus ppxA and ppxB may be used 
for host surface attachment or for binding of haem like iron containing compounds 
A B 
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scavenged from the insect host. No predicted structure was assigned to the C-terminal 
domains of ppxA and ppxB in this study as a PSI-Blast search found no significantly 
similar sequences and was therefore excluded from the modelling study. The role and 
structure of these open reading frames are as yet unproven (Crennell 2000). 
 With the identification of the PA-IIL gene (Gilboa-Garber, Katcoff and Garber 
2000) the C-terminal domain of ppxA and ppxB were found to have a significant 
similarity to PA-IIL (Table 1.3), in particular the main calcium-binding loop is highly 
conserved across all three proteins (Figure 1.13). A third protein (Q937N3) of 210 
amino acids was identified from Photorhabdus which also displayed a lectin-like 
domain with homology to PA-IIL. The N-terminal domain does not display similarity 
with any protein of known function (Imberty et al. 2004).  
 
Figure 1.13: Sequence alignment of the lectin-like C-terminal domains of ppxA, ppxB and unknown 
protein Plu4238 from P. luminescens TT01.  
Amino acids involved in monosaccharide binding outlined in red and amino acids involved in calcium 
binding outlined in green. Image generated using ClustalW align and Genedoc. Identical residues 
highlighted in black and similar in grey. 
 
Although the amino acids involved in calcium binding are largely conserved, those 
involved in monosaccharide binding differ far greater then those seen in the Bcc 
species. Since it has previously been shown that a single amino acid change in the sugar 
binding loop can alter the specificity preference it can be hypothesised that the 
homologs found within P. luminescens may have differing sugar specificities to both 
PA-IIL and each other.  
 In summary the PA-IIL like lectin has been identified in a number of bacteria (R. 
solanacearum, C. violaceum, Photorhabdus spp., Burkholderia spp.) and also in 
archaea, Methanopyrus kandleri (Majumder 2006). With the expanding number of 
bacterial genomes currently being sequenced, it is likely that more proteins of the PA-
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IIL family will be identified. These homologs present a natural reservoir of structurally 
similar proteins with potentially a broad range of specificities. With more research these 
proteins could be exploited for protein array development (Hsu, Gildersleevec and 
Mahal 2008) and possible diagnostic tools. 
 
1.7 Commercial applications of lectins 
 It is well recognised that most proteins are subject to post-translation 
modification (PTM), the most abundant and biologically significant PTM being 
glycosylation. Glycoslyation results in the addition of oligosaccharide moieties to 
proteins and cellular macromolecules such as lipids, bacterial cell membranes and 
eukaryotic cell membranes. Oligosaccharides have the potential to be assembled in 
branched structures as well as linearly (Figure 1.14), resulting in glycan 
(oligosaccharide) structures present on glycoconjugates exhibiting greater structural 
diversity than other celluar macromoleucels, e.g. there are 38,016 permutations of 3 
monosaccharides that can theoretically produce a tri-saccharide compared to 64 possible 
permutations of four nucleotides in a three based codon. Adding to the complexity is the 
fact that a single protein can be glycosylated at a number of sites with potential glycan 
heterogeneity at each site. Glycans therefore have an inherent capacity and complexity 






























Figure 1.14: Examples of mammalian glycan structures 
Schematics of representative examples of N-glycans and O-glycans indicated using the symbol 
nomenclature for monosaccharides (see key) to demonstrate the complexity of glycan structures. There 
are a variety of glycan structures not represented.  
 
Glycosylation patterns have implications at a clinical level and at an industrial level in 
the biopharmaceutical industry. 
Problems in the construction of glycan structures have been attributed to a 
number of disease states; Alzheimer’s disease (Huang et al. 2004), auto immune disease 
(Hirschberg 2001), cystic fibrosis (Xia et al. 2005)  and arthritis (Tomana et al. 1994). 
Therefore altered glycoform populations of a given glycoprotein may be diagnostic of 
the disease responsible. Cancer-specific glycan patterns have been identified and now 
account for tumour specific antigens used in diagnostics. Development of rapid and 
high throughput methodologies for the characterisation and detection of altered 
glycosylation patterns on glycoconjugates could greatly enhance clinical research and 
treatment of a variety of diseases. 
Within the drugs industry protein based therapeutics are emerging as the largest 
class of new chemical entities being developed. In biological processes glycosylation 
affects the stability of protein confirmation, immunogenicity, clearance rate and more 
(Sinclair, Elliott 2005). Since different glycoforms can exhibit different biological 
properties it is essential to control glycosylation to maintain the quality of 
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biopharmaceutical molecules. Glycan heterogeneity also has serious implications for 
regulatory compliance and the FDA have indicated that sugar moieties on 
glycoconjugates will in future play a role in regards to license approval. To ensure 
carbohydrate heterogeneity the drugs industry must often implement additional 
expensive downstream purification. Since glycosylation is non-template driven it is not 
possible to predict glycan patterns. Analysis of glycans is therefore on the post-
glycosylation stage. Current glycan monitoring techniques in the drugs industry are 
predominantly off-line and often require significant amounts of sample preparation. 
There has been an emphasis on techniques that require the removal of carbohydrate 
moieties from the molecule that has been glycosylated.  The moieties are then analysed 
by one or more techniques such as chromatography, mass spectrometry or nuclear 
magnetic resonance spectrometry. These methods are expensive to establish and often 
required skilled operators to conduct.  
The ability to characterise and monitor glycosylation of glycoconjugates is 
therefore of great interest for both clinical and commercial reasons. The methods 
currently used are reaching a bottle neck in terms of data analysis. The ability of lectins 
to distinguish between subtle variations of oligosaccharide structures make them 
suitable for the characterisation of glycans. Lectins have been utilised to some degree in 
glycobiology. Lectin Affinity Chromatography (LAC), where a lectin is immobilized, 
traditionally on agarose beads, is now commonly used for glycoprotein purification 
procedures. Multi-lectin affinity chromatography can be used to effect the fine 
fractionation and isolation of specific glycans and protein glycoforms (Wu et al. 2008, 
Yang, Hancock 2005, Geyer, Geyer 2006), often as an initial pre-concentration step 
prior to MS based glycoanalytical procedures. Labelled lectins are also widely used in 
glycoanalytical procedures such as lectin blotting (Zuber, Li and Roth 1998) and 
enzyme linked lectin assays (ELLA) which are analogous to the standard ELISA (Wu et 
al. 2008). The use of lectins in microarrays offers the greatest potential for indept, high 
throughput glycoanalysis and represents a powerful diagnostic tool potentially enabling 
a rapid screening method to detect alterations in glycosylation that may be indicative of 
specific infections or disease states (Pilobello et al. 2005). Lectin microarrays offer a 
number of advantages over traditional methods of glycan characterisation. Lectins can 
analyse in situ without the need for any prior release or sample preparation of glycans. 
Binding of lectins to a glycoprotein can reveal significant structural as well as 
compositional information about the glycan present due to the ability of lectins to 
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distinguish between subtle variations. Binding is dictated by the combination of a 
number of factors (Lis, Sharon 1998, Ambrosi, Cameron and Davis 2005); 
• The overall composition 
• The terminal monosaccharide present 
• The specific positions and anomeric configurations of glycosidic bonds 
between the monosaccharide subunits of the glycan chain 
Additional structural information may also be revealed due to the requirement of lectins 
for multivalent binding. This means binding is not only dependant on the presence of a 
single specific glycan but on the appropriate surface display of multiple glycans 
simultaneously at several independent glycosylation sites. The examination of the 
collective response of arrays of lectins with known carbohydrate binding specificity can 
therefore give detailed information about the overall glycosylation status of a 
glycoprotein. Identification and characterisation of novel lectins with a wide variety of 
carbohydrate binding specificities is critical to the development of highly accurate and 
reproducible lectin microarrays. 
Most widely studied and characterised lectins to date have been those identified 
in plants, consequently most commercially available lectins are plant derived. 
Purification of plant lectins from source is time consuming and costly. Lectins purified 
in this manner often produce low yields of proteins and final preparation can be 
contaminated with a diverse range of biomolecules. For these reasons the purity, activity 
and specificity of commercial lectins available can vary from batch to batch from a 
single supplier or from supplier to supplier. Such inconsistencies complicate the use of 
lectins for glycoprotein analysis (Pilobello, Mahal 2007). Expression inconsistencies 
can be overcome via recombinant expression methodology. Eukaryotic proteins, such as 
plant lectins, often require PTM such as glycosylation. The requirement of PTM and the 
structural complexity of some plant lectins often leads to poor expression or 
inappropriate folding of plant lectins in the preferential host for recombinant protein 
production, E. coli. Expression of these lectins in E. coli usually results in the expressed 
proteins forming insoluble aggregates (Gemeiner et al. 2009). The application of lectins 
for glycoprotein analysis and selective purification has remained restricted to research 
and analytical scale activities due to these problems with the expression of plant lectins. 
Small scale application of lectin microarrays is not suitable for glycan analysis in the 
biopharmaceutical industry.  
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Microbial lectins have been largely unexploited for glycoprotein analysis. A 
huge potential reservoir of microbial lectins and lectin-like proteins has been revealed 
by advancement in genome sequencing and bioinformatics analysis. Microbial lectins, 
in particular, bacterial lectins are likely to be more amenable to expression from E. coli 
due to the more closely related genetic background. Additionally, lectin gene sequences 
can be genetically manipulated to incorporate specific amino acid sequence tags, e.g. six 
histidine codons (6HIS), which enable simple and rapid downstream purification via 
methods like Immobilised Metal Affinity Chromatography (IMAC). This facilitates the 
production of highly purified lectins and the products should therefore exhibit more 
consistent and reproducible specificity and activity. The ability to exploit the E. coli 
expression system to produce large quantities of these lectins, via cost effective and 
standardized protocols could finally lead to the application of lectins for industrial scale 
glycoprotein purification in the biopharmaceutical industry. Recombinant DNA 
techniques can be used to further enhance lectins and facilitate their implementation in 
glycoanalytical platforms, including; 
• Addition of tags to facilitate specific immobilisation chemistries 
• Addition of specific sequence tags and fusion proteins for rapid one-step 
purification and subsequent immobilisation via affinity based procedures 
• Mutagenesis strategies with the intention of enhancing carbohydrate 
binding affinities or altering carbohydrate binding specificities (as 
discussed in Section 1.6) 
Expansion of the number of lectins with a broad range of binding specificities, 
due to novel lectin identification or specific mutagenesis, amenable to large scale 
recombinant expression from E. coli could greatly enhance glycoanalytical techniques, 
in particular within the drugs industry.  
 
1.8 Project aims and objectives. 
The objective of this research project is to clone the gene for PA-IIL from P. 
aeruginosa. Oligonucleotide primers can be designed using the available sequence of 
PA-IIL from GenBank for PCR-based amplification of PA-IIL from chromosomal DNA. 
Upon cloning of the gene the project would focus on the development of a standardised 
method for expression from an E. coli expression system capable of producing active 
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recombinant PA-IIL. This approach for expression has been previously reported, as 
described in Section 1.2.1. If expression of active PA-IIL was possible in an E. coli 
system, large quantities of lectin could be rapidly and consistently produced for 
analysis.  
Following successful expression of recombinant lectin, a standardised method of 
purification could be developed to enable production of yields of large quantities of 
highly purified protein. Recombinant fusion protein tagging system for one-step 
purification is the preferred method of purification. The effect of the addition of a fusion 
tag would be investigated. The optimal storage conditions for the long term storage of 
purified PA-IIL would be identified, facilitating availability of purified recombinant 
PA-IIL for the development of a highly sensitive ELLA assay for the determination of 
specificity. 
 Once standardised protocols for the expression, purification, stabilisation and 
characterisation of specificity are developed novel lectins with high homology to PA-
IIL could be cloned and these standardised methods utilised to characterize their 
specificities.  











2.0 Materials and Methods 
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2.1 Bacterial strains, primers sequences and plasmids 
The bacterial strains, primers and plasmids used in this study are listed in Tables 2.1, 
2.2 and 2.3 respectively. Selected plasmid maps are shown in Figure 2.1 to 2.5.  
 
Table 2.1: Bacterial strains 
 
Strain  Genotype     Features/Uses      Source 
 
Escherichia coli 
XL10-Gold ∆(mcrA),183∆(mcrCB-hsdSMR-mrr), 173          High transformation        Stratagene 
endA1, recA1, relA1, gyrA96, supE44,          efficiency 
thi -1lac, Hte [F´proAB lacIqZ∆M15::Tn10         (Tetr, Cmr) 
(tetR)Amy (camR)]                                                   Expression host 
   
BL21(DE3) F-, dcm lon, ompT, hsdSB(rB-, mB-)gal           Protease deficient       Novagen 
λ (DE3 [lacIq lacUV5-T7 gene 1 indl 
  sam7 nin5]) 
 
JM109  endA1, recA1, gyrA96, thi, hsdR17 (rk
–,                All purpose cloning 
mk
+), relA1, supE44, λ–, ∆(lac-proAB), [F´,          strain, produced        Sigma 
traD36, proAB, lacIqZ∆M15].                                Plasmid DNA 
 
XL1-Blue recA1, endA1, gyrA96, thi-1, hsdR17(rK-,            Promega 




KRX  [F´, traD36, ∆ompP, proA+B+, lacIq, ∆(lac         Protease deficient        Promega 
Z)M15] ∆ompT, endA1, recA1, gyrA96 (N         High transformation 
alr),thi-1, hsdR17 (rk
–, mk
+), e14– (McrA–),            efficiency. 
relA1, supE44, ∆(lac-proAB), ∆(rhaBAD)           Expression host 
::T7 RNA polymerase 
Rosetta  F- ompT hsdSB(rB
- mB
-) gal dcm pRARE2           Capable of expressing      Novagen 
(CamR)               rare codons 
Pseudomonas aeruginosa 
PA01  Wild type                        Dr. Keith 
                                Poole 
Photorhabdus luminescens 
TT01  Wild type            RifR           Dr.David  
                                                                                                                                                         Clarke 
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Table 2.2: Primers (Synthesised by Sigma-Aldrich, U.K.) 
The restriction sites are underlined and non-binding tags are in bold type. The melting temperatures were 
calculated using the formula: Tm = 4(GC) + 2(AT).  
 
Name  Sequence        Tm 





PA-IIL-r AAAACTCGAGGCCGAGCGGCCAGTTGATCACC     73 
PA-IIL-f AAAACCATGGCAACACAAGGAGTGTTCACCC    59 
PA-IIL-r2 AAAAAGATCTGCCGAGCGGCCAGTTGATCACC    73 
PA-IIL-f2 ATGGCAACACAAGGAGTGTTCACCC     68 
QE60PAIIL-r GTACATAGATCTGTTAGCCGAGCGGCCAGTTGATCACC    73 
QEPAIIL-f GGATCCATGGCAACACAAGGAGTGTTC     58 
QEPAIIL-r AAGCTTTTAGCCGAGCGGCCAGTTG     65 
PASY2-r CGATAGAAGCTTTTATGTCAAAGGCCAATTTAAGAACACCAC  62 
PASY2L-f GTACATCGGATCCATGATACGGGTAAATATTGTTTCCAGTTACC  64 
ppxA-r  AAGCTTTCATGATAATGGCCAATTCAAC     58 
ppxA/L-f GGATCCATGAATACCGGTAAACACTGC     55 
ppxB-r  CTGCAGTCAGGACTGTGACCAAATTAACAC    59 
ppxB/L-f GGATCCATGGCAGCACAAATACCGG     60 
ppxB/L.link.f* GGTGGTGGTGGATCCATGACAAATACCGGTAAAC    55 
ppxB/L-link.r* ACCAGAGTGATGGTGATGGTGATGCGATCC     55
  
ppxB/L-linkfix.f*   GCCATTATCGGTGCCAGC      61
  




PAIILStrep-f* CAGTTCGAAAAGGGATCCATGGCAACACAAGGAGTGTTCACCC    >75 
PAIILStrep-r* CGGGTGGCTCCACATAGTTAATTTCTCCTCTTTAATGAATTC   74   
PAIILMU-f* AACGTGCTGGTCAACAACGAGACGGCCGCGACC     >75   
PAIILMU-r* AACCGTCTGGGTGTTGGCCGCGTTGGCGAAGGCGGTGACG     >75  
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Table 2.3: Plasmids 
 
Plasmid  Description       Source 
 
pQE60  Expression vector for C-terminally tagged 6HIS proteins,  Qiagen 
  T5 promoter/lac operon, ampR ColE1 origin. 
pQE30  Expression vector for N-terminally tagged 6HIS proteins,  Qiagen 
   T5 promoter/lac operon, ampR, ColE1 origin. 
pQE30Xa Expression vector for proteolytically removable N-terminally tagged   
6HIS protein T5 promoter/lac operon, ampR,  ColE1 origin  Qiagen 
   
pCR2.1  PCR cloning vector, AmpR, KmR, lacZα, ColE1 origin.   Invitrogen 
pPC6  Expression vector for C-terminally tagged 6HIS proteins,    Invitrogen 
  Ptac promoter, amp
R, ColE1 origin 
Constructs 
pQE60PAIIL pQE60 contain PA-IIL and stop codon prior to 6HIS tag  This work 
pPAIIL3 pPC6 containing PA-IIL      This work 
pQE30PAIIL pQE30 containing PA-IIL      This work 
pQEppxA/L pQE30 containing lectin domain of ppxA gene   This work 
pQEppxB/L pQE30 containing lectin domain of ppxB gene   This work 
pQEpASy2/L pQE30 containing lectin domain of homolog 2 from P.asymbiotica This work 
Mutagenesis 
pQEStrepPAIIL 6His of pQE30.PAIIL replaced with StrepII tag by mutagenesis This work 




















Figure 2.1: pQE60 vector (Quiagen) 
Graphical representation of the 3431 b.p cloning vector pQE60 (Table 2.3) containing the following 
features; The multiple cloning site (MCS) located before the 6HIS amino acid sequence (green) which 
facilitates the translation of a fusion protein having a C-terminal 6HIS tag. Expression under the control 
of the T5 promoter/lac operon (yellow). The β-lactamase gene (red) conferring ampicillin resistance 
(ampr) is located on the vector. The image was generated using BVTech (Section 2.12). 
 
 
















Figure 2.2: pCR2.1 Vector (Invitrogen) 
Graphical representation of the TA cloning vector from Invitrogen, with the position of the 3’ T 
overhands indicted with the letter T. These are located within the lacZα ORF, under the control of the Plac 
promoter (shown in grey). Relavent restricition enzyme sites located within the MCS are displayed, as 
well as the position of the ampicillin (red) and kanamycin (purple) antibiotic resistance cassettes. The 















Figure 2.3: pPC6 vector  
Graphical representation of the 4716 bp cloning vector pPC6 (Table 2.3) showing the relevant MCS 
restriction enzymes sites, the ampicillin resistance gene (ampr) in red and the 6HIS coding sequencing in 
green. The cloning site is situated under the control of the Ptac promotor (yellow). The MCS is located 
before the 6HIS amino acid sequence facilitating the translation of a fusion protein having a C-terminal 



























Figure 2.4: pQE30 vector (Quiagen) 
Graphical representation of the 3461 b.p cloning vector pQE30 (Table 2.3) showing the relevant MCS 
restriction enzymes sites, the ampicillin resistance gene (ampr) in red and the 6HIS coding sequence in 
green. The cloning site is situated under the control of the T5 promotor/lac operator. The MCS is located 
after the 6HIS amino acid sequence which facilitates the translation of a fusion protein having an N-


















Figure 2.5: pQE30Xa vector (Quiagen) 
Graphical representation of the 3509 b.p cloning vector pQE30Xa (Table 2.3) showing the relevant MCS 
restriction enzymes sites, the ampicillin resistance gene (ampr) in red, the Factor Xa protease recognition 
site in blue and the 6HIS coding sequence in green. The cloning site is situated under the control of the T5 
promotor/lac operator. The MCS is located after the 6HIS amino acid sequence and the protease 
recognition site which facilitates the translation of a fusion protein having an N-terminal 6HIS tag which 
can be cleaved by a FactorXa protease reaction. The image was generated using BVTech (Section 2.12). 
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2.2 Microbial media 
All chemicals and reagents were obtained from Sigma-Aldrich unless otherwise stated. 
All chemicals were Analar grade. Microbiological media were obtained from Oxoid. 
Sterilisation was achieved by autoclaving at 121oC and 15 lb/in2 for 20 min, unless 
otherwise stated.   
 
• Luria Bertani Broth (LB) 
 
Used for routine culturing of E. coli. 
  Tryptone  10g 
  Yeast Extract  5g 
  NaCl   10g 
The solution was adjusted to pH 7.0 with NaOH, volume brought to 1L with dH2O and 
sterilised by autoclaving. For solid LB, 15 g/L Technical Agar No.3 (Oxoid) was 
included. 
 
• SOB Medium 
  Tryptone  20g 
  Yeast Extract  5g 
  NaCl   0.5g 
KCL   2.5mM 
dH2O   1L 
pH   7.0 
The solution was sterilised by autoclaving and allowed to cool to 55oC. Sterile solutions 
of MgCl2 (1M) and Mg2SO4 (1M) were added to final concentrations of 10mM. 
 
• Terrific Broth 
Tryptone  12g 
  Yeast Extract  24g 
  Glycerol  4ml 
The volume was brought to 1L with dH2O and sterilised by autoclaving.  
 
• Super Broth 
Tryptone  35g 
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  Yeast Extract  20g 
  NaCl   5g 
The volume was brought to 1L with dH2O and sterilised by autoclaving.  
2.3 Solutions and buffers 
• Tris-EDTA (TE) Buffer 
  Tris-HCL  10mM 
  Na2-EDTA  1mM 
  pH   8.0 
 
• 50x Tris Acetate EDTA (TAE) Buffer 
Tris    242 g/L 
Glacial Acetic Acid  57.1ml/L 
EDTA    100ml/L (of 0.5M stock) 
pH    8.0  
The solution was diluted to 1X with dH20 before use. 
 
• Solutions for the 1, 2, 3 method  
Solution 1: 
  Glucose (0.5M)  1ml 
  Na2-EDTA (0.1M)  1ml 
  Tris-HCl (1M)  0.25ml 
  dH2O    to 10ml 
 
Solution 2: 
  NaOH (1M)   2ml 
  SDS (10%)   1ml 
  dH2O    to 10ml 
The solution was made up fresh every month and stored at room temp. 
 
Solution3: 
  Potassium acetate   3M 
  pH    4.8 
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To 60ml of 5M potassium acetate, 11.5ml of glacial acetic acid and 28.5ml of dH2O was 
added. The resulting solution was 3M with respect to potassium and 5M with respect to 
acetate.  
 
• Gel Loading Dye (6X) 
  Bromophenol Blue  0.25% 
  Xylene Cyanol  0.25% 
  Ficoll (Type 400)  15% 
Made in dH2O and sterilised by autoclaving. Bromophenol blue and/or xylene cyanol 
were used as appropriate. On a 1% agarose gel, bromophenol blue and xylene cyanol 
migrate approximately with the 300 b.p and 4000 b.p fragments respectively. 
 
• TBS buffer 
  Tris-HCl  20mM 
  NaCl   150mM 
  CaCl2   1mM 
  MnCl2   1mM 
  MgCl2   1mM 
  pH   7.5 
 
• TBST buffer 
TBST buffer with made by the addition 0.1% Triton X to TBS  buffer. 
 
• TMB solution 
Citrate buffer: 
  Sodium citrate (0.1M) 3.63 ml 
  Citric acid (0.1M)  1.230 ml 
  dH20    5 ml 
  pH    5.5 
2mg of tetramethylbenzidine (TMB) was dissolved in 200 µl dimethyl sulfoxide 
(DMSO) and then added to 9.8 ml citrate buffer. Solution made up freshly 15 min 
before use. 3 µl 30% H2O2 was added directly before use. 
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• Solutions for in-situ cell lysis 
SDS solution:  
SDS   10 % 
 
Denaturing solution: 
NaOH   0.5M 
NaCl   1.5M 
 
Neutralization solution:  
NaCl   1.5M 
Tris-HCL  0.5M 
pH    7.4  
 
20x SSC:  
NaCl     3M 
Sodium.citrate  300mM 
 
1X Tris Buffered Saline (TBS): 
  Tris-HCl  10mM 
  NaCl   150mM 
pH    7.4 
For TBST, the detergent Trition X-100 was added to a final concentration of 0.1% (v/v) 
 
• Lysis Buffer for Protein Purification 
  NaH2PO4  50mM 
  NaCl   300mM 
  Imidazole  10mM 
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• 5X Sample Buffer for SDS-PAGE 
  Glycerol   50%l (v/v) 
  SDS (10%)   2% (w/v) 
  2-Mercaptoethanol  5% (v/v) 
  Bromophenol Blue  0.1% (w/v) 
  Tris-HCl, pH6.8  62.5mM 
  dH2O    to 10ml 
For native PAGE, SDS and 2-mercaptoethanol were omitted and replaced with the 
equivalent volume of dH2O. 
 
• SDS-PAGE Running Buffer (5X) 
Tris-HCl  15g 
Glycine  72g 
SDS   5g 
dH2O   to 1L 
 For native PAGE, SDS was omitted.  
 
• Coomassie Blue Stain  
Coomassie Blue (R-250) 1g 
Methanol   180ml 
dH20    180ml 
Acetic Acid   40ml 
dH2O    to 400ml 
 
• Coomassie Blue De-Stain Solution  
Methanol   180ml 
dH20    180ml 
Acetic Acid   40ml 
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• Nickel Resin Binding Buffer 
Sodium Phosphate  20mM 
NaCl    500mM 
Imidazole   20-40mM 
pH    7.4  
The optimal imidazole concentration is protein dependent.  
 
• Nickel Resin Elution Buffer 
Sodium Phosphate  20mM 
NaCl    500mM 
Imidazole   40-250mM 
pH    7.4 
The optimal imidazole concentration for elution is protein dependent.  
 
• Stripping Buffer for Nickel IMAC Resins 
Sodium Phosphate  20mM 
NaCl    500mM 
EDTA    50mM 
pH    7.4 
 
• Recharging Buffer for Nickel IMAC Resins 
NiSO4    100mM 
 
Phosphate Buffered Saline (PBS) 1X 
  NaCl    137mM 
  NaH2PO4   4.3mM 
  KCl    2.7mM 
  K2HPO4   1.5mM 
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• Buffers for the preparation of competent cells 
 
TB Buffer for Competent Cells  
  Pipes   10mM 
CaCl2   15mM 
KCl   250mM 
dH2O   to 1L 
pH with KOH  6.7 
 
The pH of the solution was adjusted with KOH. MnCl2 was then added to a final 
concentration of 55mM. The solution was then filter sterilised through a 0.45µm sterile 
filter and stored at 4oC. 
 
RF1 buffer for competent cells (Inoue et al, 1990) 
  RbCl   100mM 
  CaCl2   10mM 
  Potassium acetate 30mM 
  Glycerol  15% (v/v) 
  pH (with HCl)  5.8 
After the pH was adjusted MnCl2 was added to a final concentration of 50mM. The 
solution was filter sterilised through a 0.45µm sterile filter and stored at 40C. 
 
RF2 buffer for competent cells 
 RbCl   10mM 
 MOPS   10mM 
 CaCl2   75mM 
 Glycerol  15% (v/v) 
 pH   6.8 
The pH of the solution was adjusted with KOH. The solution was filter sterilised 
through a 0.45µM membrane and stored at 4oC. 
 
Ethidium bromide stain 
A 10mg/ml stock solution of ethidium bromide in dH2O was stored at 4
oC in the dark. 
For the staining of agarose gels, 100µl of the stock solution was mixed into 1L of dH2O. 
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The staining solution was kept in a plastic tray and covered to protect against light. 
Used ethidium bromide stain was collected and left mixing overnight with a 
deactivating activated charcoal ‘teabag’ (GeneChoice). The clear liquid was disposed of 
routinely, and the ethidium waste was incinerated.  
2.4 Antibiotic 
Antibiotic used was from Sigma. Antibiotic stocks were prepared to a concentration of 
100 mg/ml and stored at -20oC. 
• Ampicillin was prepared in dH2O and was used at a final working concentration 
of 100 µg/ml for solid and liquid media for E. coli.  
2.5 Storing and culturing bacteria 
Strains were stored as glycerol stocks. Duplicate stocks were prepared for each strain 
and stored at -20oC and -80oC. A 1ml aliquot of a late log phase culture was added to 
0.5ml of sterile 80% glycerol (v/v) and stored accordingly. Where hosts were 
harbouring plasmids, the appropriate antibiotic was added to the stock medium. 
Working stocks streaked on LB agar plate, containing antibiotics where appropriate, 
were stored on plates at 4oC for a period up to one week. 
 
2.6 Isolation and purification of DNA 
The two procedures for the isolation of plasmid DNA were variably employed. The 1-2-
3 Method (Section 2.6.1) yielded high quality DNA and was used routinely. The 
HiYield Plasmid miniprep Kit (ISIS) was used to prepare consistently pure and 
supercoiled plasmid DNA, mostly for the purpose of DNA sequencing.  
 
2.6.1. Plasmid Preparation by the 1, 2, 3 Method 
This method was adapted from the procedure described by (Birnboim, Doly 1979). The 
principle of this method is selective alkaline denaturation of high molecular weight 
chromosomal DNA while covalently closed circular DNA remains double stranded. A 
1.5ml aliquot of a bacterial culture grown in selective media was pelleted by 
centrifugation at 13,000 rpm in a microfuge for 5 min. The supernatant was discarded 
and the pellet was re-suspended in 200 µl of Solution 1(Section 2.3). Alternatively, 
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bacterial growth was taken off an LB agar culture plate with a sterile loop and re-
suspended in 200 µl of Solution 1. The re-suspension was left for 5min at room 
temperature. A 200 µl aliquot of Solution 2 (Section 2.3) was added, mixed by inversion 
and placed on ice for 5 min. To this mixture, 200 µl of Solution 3 (Section 2.3) was 
added, the tube mixed by inversion and placed on ice for 10 min. A colt of 
chromosomal DNA formed and was pelleted by centrifugation at 13,000 rpm for 10min. 
The supernatant was transferred to a fresh tube with 400 µl of phenol chloroform 
isoamylalcohol (25:24:1) and mixed by brief vortexing. Upon centrifugation at 13,000 
rpm for 10 min the solution was divided into an upper aqueous layer and lower organic 
layer. The upper layer was removed to a fresh tube and an equal volume of isopropanol 
was added and mixed by inversion. After 10 min on ice the solution was centrifuged for 
20 min at 13,000 rpm to pellet plasmid DNA. The pellet was washed with 70% ethanol 
and centrifuged at 13,000 rpm for 5 min. The ethanol was removed and the pellet was 
dried briefly in a SpeedVac (Savant) vacuum centrifuge. The plasmid DNA was re-
suspended in 50 µl of TE buffer and 1 µl of Ribonuclease A was added to digest co-
purified RNA. Plasmid DNA was stored at 4oC. 
 
2.6.2 Plasmid Preparation by HiYield plasmid miniprep kit 
The kit was used according to the manufacturer’s instructions: 1.5 ml of a bacterial 
culture was transferred to a microfuge tube and was centrifuged at 13,000 rpm for 5 min 
to collect the cells. The supernatant was discarded and the cell pellet was completely re-
suspended in 200µl of re-suspension solution. Alternatively, bacterial growth was taken 
off an LB agar culture plate with a sterile loop and re-suspended in 200µl of re-
suspension solution. 200µl of lysis solution was added and solution mixed by inversion 
to lyse the cells. 350µl neutralisation/binding buffer was added and mixed by inversion. 
The sample was centrifuged at 13,000 rpm for 10 min to precipitate cell debris, lipids, 
proteins and chromosomal DNA. The supernatant was removed and transferred to a spin 
column in a fresh microfuge tube and centrifuged at 13,000 rpm for 1 min to bind the 
plasmid DNA to the filter found within the spin column. The flow through was 
discarded and 750 µl of washing solution was added to the spin column. The column 
was centrifuge at 13,000 rpm for 2 min and the flow through discarded. This was 
followed by further centrifugation at 13,000 rpm for 2 min to dry the spin column. The 
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spin column was transferred to a fresh microfuge tube and 100µl elution buffer was 
added. The DNA was eluted by centrifugation at 13,000 rpm for 1 min. 
2.6.3 Preparation of Total Genomic DNA Using the Wizard Genomic DNA Kit 
The kit was used according to the manufacturer’s instructions with some modifications. 
A 1 ml aliquot of a stationary phase culture was added to a 1.5 ml microfuge tube and 
the cells pelleted by centrifugation at 13000 rpm for 2 min. The supernatant was 
discarded and 600µl of the Nucleic Acid Lysis buffer was added to re-suspend the cells. 
The cells were lysed by incubation at 80oC for 5 min and cooling to room temperature. 
3µl of RNase solution was added to the cell lysate, inverted several times, and incubated 
at 37oC for 15-60 min. To remove the protein in the sample, 200µl of the Protein 
Precipitation solution was added and vortexed vigorously. This was incubated on ice for 
5 min to aid precipitation and centrifuged at 13000 rpm for 3 min. The supernatant was 
transferred to a fresh microfuge tube and 600µl of phenol chloroform isoamylalcohol 
(25:24:1) was added and the suspension was mixed slowly by inversion. The mixture 
was centrifugation at 13,000 rpm for 5 min and the upper aqueous phase was transferred 
to a fresh microfuge tube. 600 µl of phenol chloroform isoamylalcohol (25:24:1) was 
again added and mixed slowly by inversion. After centrifugation at 13,000 rpm for 5 
min the upper aqueous phase was again transferred to a fresh microfuge tube. Phenol 
extraction was carried out by adding 700 µl of chloroform:isoamylalcohol (24:1), 
mixing by inversion and centrifugation at 13,000 rpm for 5 min. The upper aqueous 
layer was transferred to a fresh microfuge tube and 600 µl of room temperature 
isopropanol was added. The sample was mixed gently by inversion until thread-like 
strands of DNA formed a visible mass. The genomic DNA was then pelleted by 
centrifugation at 13000 rpm for 5 min. The pellet was washed twice with 100 µl 70% 
ethanol, air dried and re-suspended in 100 µl of DNA Rehydration Solution overnight at 
4oC. Genomic DNA was stored at 4oC. 
2.6.4 Purification and concentration of DNA samples 
The sample containing the DNA to be precipitated was brought to 400 µl with dH2O. 
400 µl of phenol chloroform isoamyl alcohol (25:24:1) was added and mixed by brief 
vortexing. Upon centrifugation at 13,000 rpm for 5 min the mixture was divided into an 
upper aqueous and lower organic layer. The aqueous layer was removed to a fresh 
microfuge tube with an equal volume of chloroform and mixed by brief vortexing. The 
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tube was centrifuged at 13,000 rpm for 5 min and the upper aqueous layer was 
transferred to a new microfuge tube. A 1/10 volume of 3 M sodium acetate was added 
followed by an equal volume of isopropanol and mixed by inversion. The tube was left 
at room temperature for 60 min and then centrifuged at 13,000 rpm for 20 min to pellet 
the DNA. The pellet was washed with 70% ethanol and then dried briefly in a SpeedVac 
(Savant) vacuum centrifuge. The DNA was re-suspended in 20 – 50 µl of TE buffer. 
 
2.7 Agarose Gel Electrophoresis for DNA Characterisation 
DNA was analysed by electrophoress through agarose gels in a BioRad horizontal gel 
apparatus. Agarose was added to 1X TAE buffer to the required concentration (typically 
0.7-1.2%) and dissolved by boiling. The agarose solution was poured into plastic trays 
and allowed to set with a plastic comb fitted to create sample wells. The 1X TAE buffer 
was also used as the running buffer. Loading dye was incorporated into DNA samples 
to facilitate loading of samples and to give indication of migration distance during 
electrophoresis. Mini-gels were run at 120 Volts for 25 min. Gels were stained by 
immersing in a bath of ethidium bromide for 15min. Gels were then visualised on a UV 
transilluminator (Syngen Gene Snap) coupled with an image analyser to capture the 
image to a PC. On every gel 7 µl of 1 Kb Plus DNA Ladder (Invitrogen) was run as a 
molecular size marker. When DNA was to be excised from the agarose gel (Section 
2.8), SYBR safe DNA gel stain (Invitrogen) was used in preference to ethidium 
bromide. SYBR safe stained gels could be visualised on the Darkreader (blue light 

























Figure 2.6: 1 kB DNA ladder 
Representative imagine of the DNA ladder used in this study. Picture obtained from Invitrogen 
(www.invitogen.com).  
2.8 Isolation of DNA from agarose gels/PCR reactions 
DNA was isolated using HiYield Gel/PCR DNA fragment extraction kit (ISIS). The kit 
was used according to the manufacturer’s instructions. DNA was visualize by the 
addition of SYBR safe (Sigma) to agarose gel and viewing on the Darkreader (blue light 
transilluminator). An agarose gel slice containing DNA was excised. Up to 300mg of 
the agarose gel slice was transferred into a microcentrifuge tube. 500µl of DF buffer 
was added to the sample and mixed by vortexing. The mixture was incubated at 55 oC 
for 10 -15 minutes until the gel slice was completely dissolved. During incubation, the 
tube was inverted every 2-3 mins. A fresh DF column was placed into a collection tube. 
800 µl of the sample mixture from the previous step was applied into the DF column. 
The column was centrifuged at max. 13,000 xg for 30 sec. The flow-through was 
discarded. 500 µl of wash buffer was added and spun for 30 sec. The flow-through was 
discarded and the column was spun again for 2 min at max to dry the column. The 
column was transferred to a fresh microcentrifuge tube. 30 µl of elution buffer or water 
was added to the column. The column was allowed to stand for 2 min until buffer was 
absorbed and then centrifuged for 2 min at full speed to elute purified DNA. 
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2.9 Preparation of high efficiency competent cells 
The two methods used to prepare competent cells were the TB method (Section 2.9.1) 
and the rubidium chloride method (Section 2.9.2). The latter method was favoured for 
its reliability.  
2.9.1 TB method 
This method was described by Inoue, H. et al. (1990). Sterile conditions were used 
throughout. 10 ml of LB broth containing the relevant antibiotics was inoculated with a 
single colony of the desired bacterial strain from a plate stock and cultured overnight at 
37oC. A 1L flask containing 250ml of SOB broth was inoculated with 250µl of the 
overnight culture and incubated at 37oC shaking at 220 rpm. When the culture had 
reached an OD600 of 0.6, the flask was cooled in ice water to stop growth. All 
subsequent transactions took place at 4oC. The culture was transferred to a sterile 250 
ml centrifuge bottle and cells were collected by centrifugation using a Sorvall SLA-
1500 rotor centrifuge at 3,000 rpm for 5 min. The supernatant was decanted and the 
pellet was gently re-suspended in 80 ml of ice cold TB buffer. The suspension was 
placed on ice for 10 min and the cells were again collected by centrifugation as before. 
The supernatant was decanted and the cell pellet was gently re-suspended in 15 ml of 
ice cold TB buffer. DMSO was added drop-wise with gentle swirling to a final 
concentration of 7% (v/v). The suspension was left on ice for 10 min. Aliquots of 800 µl 
of the cell suspension was dispensed into sterile 1.5 ml microfuge tubes. The cells were 
then, using – 80oC ethanol, snap frozen and stored at -80oC. Cells were routinely used 
within a few weeks. 
2.9.2 Rubidium chloride method 
This is an adaptation of the method outline by Hanahan, D. (1985). Sterile conditions 
were used throughout. 10 ml of LB broth containing the relevant antibiotics was 
inoculated with a single colony of the desired bacterial strain from a plate stock and 
cultured overnight at 37oC. A 1 L flask with 250ml of LB broth was inoculated with 250 
µl of the overnight culture and incubated at 37oC shaking at 220 rpm. When the culture 
had reached an OD600 of ~0.5 (early-mid exponential phase) the flask was cooled in ice 
water. All subsequent transactions took place at 4oC. The culture was transferred to a 
sterile 250 centrifuge bottle. The cells were collected by centrifugation at 3,000 rpm for 
5 min (using a Sorvall SLA-1500 rotor). The supernatant was decanted and the cells 
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gently re-suspended in 60ml of chilled RF1 buffer. The suspension was left on ice for 
90 min. The cells were again collected by centrifugation at 3,000 rpm for 5 min. The 
supernatant was decanted and the cells gently re-suspended in 8 ml of chilled RF2 
buffer. Aliquots of 800 µl were prepared in sterile 1.5 ml microfuge tubes and the cells 
were then, using – 80oC ethanol, snap frozen and stored at -80oC. Cells were routinely 
used within a few weeks. 
2.9.3 Transformation of competent cells 
A microfuge tube of cells prepared according to the procedure outlined in Section 2.9.1 
and 2.9.2 was used. An aliquot of competent cells was allowed to thaw on ice. 200 µl of 
the cell suspension was mixed gently with 1-5 µl of plasmid DNA in a sterile microfuge 
tube. The contents of the tube were incubated on ice for 30 min. The cells were heat 
shocked at 42oC for 30 sec and then transferred back onto ice for 2 min. 0.8 ml of LB 
broth was added to the cells followed by incubation at 37oC for 1 hour. A 100 µl aliquot 
of the resulting transformation mixture was plated on an appropriate selective media and 
the plates were incubated at 37oC overnight. 
2.9.4 Determination of competent cell efficiency 
Competent cell efficiency is defined in terms of the number of colony forming units 
obtained per µg of transformed plasmid DNA. A 10 ng/µl stock of pUC18 plasmid 
DNA was diluted to 1 ng/µl, 100 pg/µl and 10 pg/µl. 1 µl of each dilution was 
transformed as described above. The cell efficiency was calculated from the number of 
colonies obtained, taking into account the dilution factor and the fraction of culture 
transferred to the spread plate. 
2.10 TA cloning of PCR products 
PCR products were cloned using Invitrogens Original TA Cloning Kit vector pCR2.1. 
The diagram below shows the concept behind the TA cloning method. The method is 
dependent on the fact that termostable polymerases like RedTaq (Invitrogen) DNA 
polymerase, which lacks 3’-5’ exonuclease activity, leaves 3’ A-overhangs (Figure 2.6) 
on amplified PCR products. PCR products generated with RedTaq DNA polymerase 
have a high efficiency of cloning in the TA cloning system.  
 

















Figure 2.7: Principle of TA cloning 
PCR products amplified by RedTaq polymerase have a deoxyriboadenosine (A) addition at the 3’ end. 
The commercial pCR2.1 vector has been linearised within the lacZα gene and the cleavage site contains 
deoxyribothymidine (T) overhangs. This is complementary to the A overhang of the PCR product 
amplified by RedTaq, and can thus be ligated easily.  
 
PCR products were amplified using a standard PCR reaction mixture (see Section 
2.11.1) and using RedTaq DNA polymerase from Invitrogen, the PCR product was 
subsequently ligated with the TA pCR2.1 vector.  
The ligation was set up as follows; 
 Fresh PCR product  2µl 
 pCR2.1 vector (25ng/µl) 2µl 
 10X ligation buffer  1µl 
Sterile dH2O   4µl 
T4 DNA ligase  1µl 
Total volume   10µl 
The reaction was then incubated at room temperature overnight. Following incubation, 
2-5µl of the ligation mixture was transformed into a suitable host strain and spread onto 
LB agar containing ampicillin (100ug/ml), 40µl of Xgal (40mg/ml) and 4µl of IPTG 
(100mM) to select for transformants by blue/white screening.   
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2.10.1 Blue/white screening of TA clones 
The TA vector pCR2.1 (Figure 2.2) encodes the α-subunit of the LacZ protein. The 
chromosome of the host E. coli strain encodes the remaining Ω subunit to form a 
functional β-galactosidase. This enzyme metabolises the colourless galactose sugar X-
gal to form 5-bromo-4-chloroindole which is bright blue. Transformants of the TA 
clones bearing plasmids with the PCR product were distinguished from transformants 
bearing re-circularised plasmids without inserts by plating on media containing IPTG 
and X-gal. Transformants harbouring plasmids with inserts did not express a functional 
lacZα gene product as the insertion point of the PCR product lies within the lacZα ORF, 
thus disrupting the gene. X-gal is therefore not hydrolysed due to the lack of the β-
galactosidase enzyme production, resulting in white colonies. Transformants harbouring 
re-circularised plasmid DNA without any insert expressed functional lacZα gene 
product and thus X-gal was hydrolysed to produce colonies of a blue colour. The IPTG 
added to the media functions as the inducer to the Lac operon. Bacteria with no vector, 
which also appear white, are suppressed by the addition of an antibiotic in the growth 
media.  
40µl of a stock solution of X-gal (40 mg/ml in dimethylformamide) and 4 µL of 
a stock solution of IPTG (100 mM in water) were spread on the surface of pre-made LB 
agar plates containing ampicillin and the plates were allowed to dry. The X-gal stock 
was stored at -20oC and in the dark in order to prevent damage by light. The IPTG stock 
was stored at -20oC. Transformations were plated out on the LB ampicillin/X-gal/IPTG 
plates and the plates were then incubated at 37oC for 12-16 hours. The plates were then 
removed from the incubator and stored at 4oC for several hours in order to allow colour 
development. Transformants harbouring plasmids with inserts appeared white on X-
gal/IPTG plates. Transformants harbouring re-circularised plasmid DNA without any 
inserts appeared blue on X-gal/IPTG plates White colonies were thus picked from plates 
and screened for the presence of inserts.  
2.11 Enzymatic Reactions 
All enzymes and their relevant buffers were obtained from Invitrogen Life 
Technologies®, New England BioLabs® or Sigma Corporation and were used according 
to the manufacturer’s instructions.  
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2.11.1 Polymerase chain reaction 
PCR reactions (Mullis, Faloona 1987) were carried out using a Hybaid PCR Express 
Thermocycler. 
• Standard PCR reaction Mixture 
Template DNA    1µl 
dNTPs (10mM of each)  1µl 
Primers (25pmd/µl)   1µl of each 
Buffer (10X)    5µl 
dH2O     40µl 
Taq Polymerase    1µl 
• Standard PCR program cycle for RedTaq polymerase reactions 
Stage1:  Step 1: 95oC for 10 min 
Stage 2:   Step1: 95oC for 1 min 
     Step2: Annealing temperature for 30sec 
Step 3: 72oC for 1min for every Kb to be 
synthesised 
Stage 3:   Step 1: 72oC for 10min 
Stage 2 was typically carried out for 30 cycles as per manufacture guidelines. 
• Standard PCR program cycle for Phusion Taq polymerase reactions 
Stage 1:   Step 1:  98oC for 5 min 
Stage 2:  Step1: 95oC for 10 sec 
     Step 2: Tann for 15 sec 
     Step 3: 72oC for 20 sec per Kb to be synthesised.  
Stage 3:  Step 1: 72oC for 10 min. 
A 1 in 3 dilution of Phusion Taq polymerase was carried before use in PCR. All other 
polymerase used neat unless otherwise stated. Stage 2 was typically carried out for 50 
cycles as per manufacture guidelines. 
2.12 Gene manipulation 
A variety of plasmid-based gene cloning approaches such as described by Maniatis, T. 
et al. (1982) were used, employing PCR techniques (Section 2.11.1), restriction 
endonucleases and DNA ligase. 
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2.12.1 Site-specific mutagenesis 
Mutations were introduced into open reading frames on plasmid constructs by PCR 
amplification using complementary phosphorylated primers carrying the desired 
mutation. A standard PCR reaction mixture as shown in Section 2.11.1 was set up. The 
PCR was carried out using the high fidelity Phusion Taq DNA polymerase. The 
standard PCR program cycle for Phusion Taq polymerase reactions was used. Typically 
an extension time of 2 min and 30 sec was used to amplify plasmids of 3.5 kb to 4 kb. 
The template DNA was eliminated by digestion with Dpn I restriction endonucleases. 
Dpn I is biased toward a methylated recognition sequence. It selectively digests the 
template DNA from dam+ E. coli strains over the newly synthesised DNA. The 
amplified plasmid, with the incorporated mutation, is circularisation by ligation which 
was facilitated by the use of phosphorylated primers. 
2.13 DNA sequencing 
Recombinant clones and potential mutants were verified by DNA sequencing. 
Commercial sequencing services were provided by MWG Biotech/Eurofins. Suitable 
sequencing primers for standard vectors were provided as part of the service. Samples 
were sent as plasmid preparations (Section 2.6). 
2.14 Bio-Infomatics 
Nucleotide and amino acid sequences were analysed using a variety of web-based tools.  
• BLAST programs (Altschul et al. 1990) at NCBI www.ncbi.nlm.nih.gov were 
used to identify homologous sequences deposited in GenBank (Benson et al. 
1996). 
• Protein sequences, structure files and tools to calculate protein molecular 
weights and isoelectric points were obtained from the Swiss-Prot database 
(Bairoch, Apweiler 1997) at http://us.expasy.org and the Protein Data Bank 
(PDB) (Berman et al. 2000) at http://www.rscb.org/pdb.  
• Alignments of DNA and protein sequences were performed using the CustralW 
(Larkin et al. 2007) at http://www.ebi.ac.uk and edited using the GeneDoc 
program (Nicholas, Nicholas and Deerfield II 1997) available for download at 
www.psc.edu/biomed/genedoc.  
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• Plasmid maps were constructed using the BVtech program available for 
download at http://www.biovisualtech.com/bvplasmid/downloadpl.htm.  
• DNA sequences were analysed for restriction enzyme sites using the Webcutter 
2.0 tool at http://rna.lundberg.gu.se/cutter2.  
• Tertiary protein structure was predicted by the automated SWISS-MODEL 
server (Schwede et al. 2003), http://swissmodel.expasy.org, and subsequently 
analysed and visualised using the Pymol software (DeLano 2002) available for 
download at http://pymol.sourceforge.net/  
2.15 Protein expression 
An LB plate with the appropriate antibiotic was streaked with a glycerol stock of the 
strain containing the expression plasmid. One colony was selected and used to inoculate 
5 ml of LB broth containing the appropriate antibiotic, and grown overnight at 37oC 
while shaking.  
A 250ml conical flask containing 100 ml of LB broth was inoculated with 1 ml of 
the overnight culture and the appropriate antibiotic added. The culture was incubated at 
37oC, shaking at 220 rpm, until an OD600 of 0.5-0.6 was reached. IPTG was added to a 
final concentration of 50 µM to induce expression. The culture was then either; 
• Allowed to incubate for a defined period, sampling 2ml routinely at hourly 
intervals for time course analysis.  
• Dropped to 30oC and incubated overnight.  
Samples or culture was centrifuged at 5,000 rpm for 5 min (using a Sorvall SLA-1500 
rotor) to pellet the cells. The supernatant was discarded and the pellets were stored at -
20oC. 
2.15.1 Preparation of cleared lysate 
Cell pellets from Section 2.15 were washed with 50 ml per 100ml culture pellet with 
lysis buffer (Section 2.3). The cells were re-suspended in 10 ml lysis buffer and 
disrupted using a 3 mm micro-tip sonicator (Sonics and Materials Inc). Cells were 
subjected to 2.5 sec, 40 kHz pulses for 30 sec while on ice. The cell debris was removed 
by centrifugation at 4,000 rpm for 20 min. The cleared lysate was transferred to a fresh 
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universal container. For smaller samples/cultures, the volumes were reduced in 
correlation to the sample/culture size. 
2.15.2 Colony blot procedure 
Using a multichannel pipette, 400 µl of LB containing the required antibiotic was 
aseptically aliquoted into an autoclaved deep well 96-well plate. Each well was 
inoculated with a single colony obtained from a transformation plate. The 96 well plate 
was sealed with a Breathe-Easy Sealing Membrane (Sigma) and incubated at 37oC, 
shaking at 800 – 1000 I/min overnight. Using a multichannel pipette 10µl of growth 
from each well was aseptically aliquoted to a fresh autoclaved deep well 96-well plate. 
The second 96-well plate was sealed and grown up as described above to ensure that 
there was sufficient growth to proceed with the experiment. An LBamp agar plate 
containing 50µM IPTG was overlaid with a nitrocellulose membrane and an equal 
volume of each overnight culture was spotted from the 96-well plate on the membrane. 
This was incubated at 37oC for eight hours. A set of dishes for colony lysis was 
prepared. Each dish contained a sheet of 3MM paper soaked in of the one of the 
following 
- 10% SDS solution (v/w) 
- Neutralisation solution (X2) 
- Denaturing solution 
- 2x SSC 
Excess fluid was discarded from the filters so that filter was moist but not wet. The 
nitrocellulose membrane was removed from the LBamp plate carefully and placed 
colony side up, on top of each filter, taking care to exclude air bubbles. The filters were 
incubated at room temp. as outlined in Table 2.4. 
 
Solution Time 
SDS 10 min 
Denaturing 5 min 
Neutralization 5 min 
Neutralization 5 min 
2x SSC 15 min 
Table 2.4: Incubation of nitrocellulose membrane for in situ lysis 
Steps carried out on the nitrocellulose membrane of a 96-well clonoy blot. For denaturing, neutralization 
and 2X SSC buffers see Section 2.3. 
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The membrane was then washed twice for 10 min with TBS buffer (Section 2.3) and 
blocked for 1 hr in TBS containing 2.5% BSA. Unbound BSA was removed by washing 
twice for 10 min in TBS-Tween/Triton buffer (Section 2.3). The membrane was finally 
washed for 10 min in TBS buffer before incubation with antibody of 1:10,000 mouse 
anti histidine HRP-labelled antibody for 1 hr. Unbound antibody was removed by 
washing twice with TBS for 10 min each. A SIGMAFast 3,3-Diaminobenzidine (DAB) 
tablet was dissolved in dH2O as per manufactures instruction and poured on the 
membrane. This was left to develop for 2-5 min, and stopped by rinsing twice with 
dH2O. 
2.16 Immobilised metal affinity chromatography (IMAC) 
Immobilised Metal Affinity Chromatography (IMAC) is based on coordinate covalent 
binding between proteins and metal ions. In this work the coordinate binding between 
the metal ion Ni2+ to the amino acid histidine was exploited so that recombinant protein 
containing 6HIS were purified over the metal ion containing nitrilotriacetic acid (Ni-
NTA) resin.  
2.16.1 IMAC purification using Ni-NTA resin 
A 0.5 ml aliquot of Ni-NTA (Amersham) was gently missed with 10ml of cleared lysate 
for 15 min at room temperature or overnight at 4oC. The mixture was poured into a 0.7 
x 15 cm column, and the resin was allowed to settle. The column was then washed twice 
with 10 ml of cell lysis buffer (Section 2.3). Two 10ml washes of lysis buffer 
supplemented with 30 mM imidazole were then passed through the column. 5 ml lysis 
buffer supplemented with 350 mM imidazole was used to elute the final protein. 
Samples taken throughout the procedure were analysed by SDS-PAGE (Section 2.24). 
The imidazole was removed from the eluted protein by buffer exchange (Section 2.20) 
over the FPLC. The purified sample was lyophilized (Section 2.21) and stored at -800C. 
2.16.2 Recharging of Ni-NTA resin 
This column was routinely recharged prior to re-use of the Ni-NTA resin. The used 
resin was poured into a column and washed with 2 column volumes of distilled water, 
followed by 2 column volumes 50% (v/v) ethanol. The resin was then stripped with 3 
column volumns of 100 mM EDTA, pH 8.0. Remaining impurities were removed with 
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2 column volumes of 200 mM NaCl, followed by 2 column volumes of dH2O. 
Hydrophobically bound proteins and lipoproteins were removed by washing with 10 
column volumes of 30% isopropanol for 30 minutes, followed by 10 column volumes 
with water. The resin was the charged by adding 2 column volumes of 100 mM NiSO4. 
The resin was washed again with 2 column volume of dH2O before transfer to a sterile 
universal and stored at 4oC in 20% ethanol. 
2.17 Lectin purification using mannose agarose 
PA-IIL has a high sugar binding affinity for L-fucose and D-mannose (see Chapter 1, 
(Gilboa-Garber 1982)). This binding affinity can be exploited to purify the lectin over 
agarose beads bearing D-mannose. 
A 1ml aliquot of D-mannose agarose (Sigma-aldrich) was poured into a 20 ml 
column and washed with 2 column volumes of water to remove the storage buffer. The 
column was then equilibrated by washing with two column volumes of lysis buffer. 
Cleared cell lysate prepared as outlined in Section 2.15.1 was then added to the column, 
which was allowed to mix for 15 min at room temperature. Unbound material was 
collected as flowthrough, followed by a 20 ml wash using lysis buffer. Lectin elution 
was then facilitated by addition of 5 ml PBS supplemented with 0.3M D-mannose. The 
mannose was removed from the eluted protein by buffer exchange (Section 2.20) over 
the FPLC. The purified sample was lyophilized (Section 2.21) and stored at -800C. 
2.18 StrepTrap™ HP Hiprep™ purification  
StrepTrap™ columns are HiPrep™ columns prepacked with Streptactin sepharose™, 
available from GE healthcare. The StrepTrap column storage buffer (20% ethanol) was 
washed out with 5 column volumes of water and the resin equilibrated with at least 10 
column volumes of lysis buffer (Section 2.3). The protein lysate was filtered through 
0.45µM filter prior to loading onto the column using a syringe fitted with a luer adaptor. 
5 to 10 column volume washes of PBS (Section 2.3) was then passed over the column. 
The protein was eluted by 6 column volumes of 2.5mM desthiobiotin. The desthiobiotin 
was removed from the eluted protein by buffer exchange (Section 2.20) over the FPLC. 
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2.19 Protein concentration 
The two procedures for the quantification of protein were variably employed. The 
bicinchoninic acid assay combines the reduction of Cu2+ to Cu1+ by protein in an 
alkaline medium with the highly sensitive and selective colurimetric detection of Cu1+ 
by bicinchoninic acid. Quantification of the protein concentration by 280nm reading is 
based on a proteins ability to absorb ultraviolet light in solution with absorbance 
maxima at 200-280nm.  
2.19.1 Quantitative determination of protein by BCA assay 
The BCA assay described by Smith, P.K. et al. (1985) was utilised to quantify total 
protein in the range of 20-2,000 µg/ml. All samples were diluted appropriately to 
achieve a concentration within range of the assay. 150 µl of the protein sample was 
added in triplicate to 150 µl ml of BCA reagent (Sigma) and incubated at 37oC for two 
hours. Absorbance was read at 562 nm. Bovine serum albumin (BSA) was used as the 
reference protein. BSA standards (0-2,000 ug/ml) were prepared in dH2O and assayed in 
triplicate to yield a standard curve. Protein concentration of samples was determined 
from this standard curve. 
2.19.2 Quantitative determination of protein by 280nm readings 
Prior to reading all samples were spun down at 13,000 rpm for 10min to minimize any 
debris present in solution that may interfere in the absorbance readings. The UV lamp 
was adjusted to 280nm and allowed to warm up for approx. 15min before use. The zero 
absorbance was calibrated with buffer solution. The absorbance of the protein solution 
was read in triplicate. The concentration of the protein was then calculated using 
Equation 2.1; 
Equation 2.1: Equation for the quantitative determination of protein concentration from 
absorbance readings at 280nm.  
 
Protein conc. (mg/ml) = Abs @ 280nm X path length X extinction co-efficient 
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2.20 Desalting of purified protein using HiPrep 26/10 
desalting column 
The FPLC maximum post column pressure limit was set to 3.5 bar before attachment of 
the HiPrep 26/10 Desalting Column (GE Healthcare). The top of the column was 
attached to the pump outlet no 1 and the bottom of the column was screwed directly into 
the FPLC. Before the first sample application the column storage buffer (20% ethanol) 
was removed, and the column equilibrated with sample buffer. This was done by 
washing with 2 column volumes of water followed by 5 column volumes of sample 
buffer (either water or PBS see Section 2.3). Washing was done at the flow rate 
intended for chromatography, typically 20 ml/min. Samples were collected in 0.5 ml 
fractions in 96-well plates. All buffers and samples were filtered and degassed prior to 
application to the column. 
2.21 Lyophilization 
Samples were aliquoted (0.1 – 1ml) in microfuge tubes and stored at -800C until frozen 
solid. Microfuge tubes were opened and covered with Parafilm which was pierced prior 
to lyophilization. Samples were lyophilized at -45oC and at a vacuum of 25 bars. Once 
lyophilized samples were stored at -800C.  
2.22 Preparation of dialysis tubing 
The required amount of tubing was placed in a 1 L glass beaker and rinsed thoroughly 
with distilled water. The beaker was filled with distilled water and ~ 1 g/L of EDTA 
was added. The beaker was brought to boil. The dialysis tubing was then boiled for 2 
min. The water was allowed to cool and then poured off. The beaker was re-filled with 
fresh distilled water and brought to the boil. The dialysis tubing was boiled again for 2 
min. The water was allowed to cool and poured off. The tubing was thoroughly rinsed 
with distilled water and stored at 4oC in distilled water.  
To perform dialysis the required length of prepared dialysis tubing was washed 
with dH2O, one end was sealed, the protein solution transferred to the tubing and the 
tubing was sealed. The sample was placed in 5L of desired buffer and agitated for 2 
hour at 4oC. The buffer was re-freshed and the tubing was agitated overnight at 4oC. 
The protein solution was removed from the tubing and stored at the appropriate temp.  
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2.23 Periodic treatment of BSA 
50 mM sodium periodate solution made up freshly in dH2O. The sodium periodate 
solution was added to 3% BSA solution made in sodium acetate solution pH 4.0. The 
solution was left in the dark at 4oC for 2-4 hours constantly rocking. The solution was 
then buffer exchanged by dialysis against TBS to remove the sodium periodate. 
2.24 Sodium Dodecyl Sulfate Polyacrylamide Gel 
Electrophoresis (SDS-PAGE) 
Protein samples were analysed by sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE), based on the method outlined by Laemmli, U.K. (1970). 
2.24.1 Preparation of SDS gels 
20% or 15% resolving and 4% stacking polyacrylamide gels were prepared as per Table 
2.5. Gels were cast using an ATTO vertical mini electrophoresis system. Upon addition 
of the TEMED to the resolving gel it was immediately poured and overlaid with 
isopropanol. After polymerisation, the isopropanol was removed and the stacking gel 
added. A comb was inserted into the top of the gel to form loading wells. 
Table 2.5 SDS-PAGE gel recipes 
 
          Solution                                 20% Resolving Gel     15% Resolving Gel      4% Stacking gel 
 
          1.5M Tris-HCl, pH 8.8                                            1.88 ml       1.75 ml    
          0.5M Tris-HCl, pH 6.8                            0.74 ml 
          dH2O                  0.55 ml        1.68 ml             1.83 ml 
          Acrylamdie/Bis-acrylamide 30%/0.8% (w/v)  4.99 ml         3.5 ml  0.4 ml 
          10% (w/v) Ammonium Persulphate                  38 µl          35 µl  15 µl 
          20% (w/v) SDS                    38 µl          35 µl  15 µl 
          TEMED                       8 µl           7 µl                 6 µl 
 
2.24.2 Sample preparation 
To a microfuge tube, 20 µl of sample was added to 5 µl of 5X gel loading dye (Section 
2.3). Samples were boiled for 5 minutes and applied to wells that were flushed of un-
polymerised acrylamide. The insoluble fraction should be applied in the same 
concentration as the soluble fraction, so to the insoluble pellet obtained from a 1ml 
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sample, 20µl of 5X gel loading dye was added, and boiled for 5 min. The sample was 
then diluted with dH2O to the original 1 ml. 
2.24.3 Sample application 
Routinely 15 µl of the prepared sample was applied to the SDS PAGE well. One lane on 
each gel was loaded with 10µl of a relative molecular weight protein marker (Mr) 
solution (SigmaMarker, Sigma, Figure 2.8) consisting of Rabbit Muscle Myosin (205 
kDa), E. coli β-Galactosidase (116 kDa), Rabbit Muscle Phosphorylase b (97 kDa), 
Rabbit Muscle Fructose-6-phosphate Kinase (84 kDa), Bovine Serum Albumin (66 
kDa), Bovine Liver Glutamic Dehydrogenase (55 kDa), Chicken Egg Ovalbumin (45 
kDa), Rabbit Muscle Glyceraldehyde-3-phosphate Dehydrogenase (36 kDa), Bovine 
Erythrocyte Carbonic Anhydrase (29 kDa), Bovine Pancreas Trypsinogen (24 kDa), 
Soybean Trypsin Inhibitor (20 kDa), Bovine Milk α-Lactalbumin (14.2 kDa) and 
Bovine Lung Aprotinin (6.5 kDa). Gels were run at 25 mA for 70 min at room 













Figure 2.8: Wide range SigmaMarker visualised on 15% SDS-PAGE gel. 
A representative image of the wide range protein maker used in this study. Image 
obtained from www.sigmaaldrich.com. 
2.24.4 Gel analysis 
Polyacrylamide gels were removed from the electrophoresis chamber and washed with 
dH2O. Gels were routinely stained for 60 min in a Coomassie Blue stain solution 
(Section 2.3). Overnight de-stained followed using Coomassie Blue de-stain solution 
(Section 2.3). Subsequent soaking in dH2O enhanced the protein bands further. For gels 
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which required a greater degree of sensitivity the silver staining method (Blum, Beier et 
al. 1987) was used as outlined in Table 2.6. 
Table 2.6: Silver staining of SDS PAGE gels 
Step             Duration  Reagent 
Fixing   60 min  30% ethanol, 10% acetic acid (to 100ml) 
Wash   15 min  20% ethanol 
Wash   10 min  dH2O 
Sensitize  1 min  0.1% Sodium thiosulphate (w/v) 
Rinse   2 x 20 sec dH2O 
Sliver stain  30 min  0.1% Silver nitrate, 70 µl of 37% (v/v)            
                         formaldehyde stock    
Rinse   2 x 20 sec dH2O 
Develop  10 min (max) 3% Na2CO3, 50 µl of 37% (v/v) formaldehyde  
                      stock, 0.002% (w/v) Na2S2O2 
Stop   5 min  50 g/L Trizma Base, 2.5% Acetic Acid (v/v) 
2.24.5 Native-PAGE 
For the preparation of Native-PAGE gels, the concentrations outlined in Table 2.5 were 
used with the omission of 20% SDS, and supplemented with the appropriate volume of 
water. The samples to be analysed were not boiled and the sample buffer contained 
neither SDS nor 2-Mercaptoethanol. The gels were run in 1X Native-PAGE running 
buffer (Section 2.3). 
2.25 Size exclusion Chromatography 
The native molecular mass of the recombinant lectins under native conditions were 
determined by size exclusion chromatography (Andrews 1964, Whitaker 1963). Two 
methods were utilised during this study, one manual flow by gravity, the other using 
Fast Protein Liquid Chromatography (FPLC). 
2.25.1 Gravity flow size exclusion chromatography 
The molecular mass of recombinant PA-IIL under native conditions was determined by 
size exclusion chromatography (SEC). A 2.5 x 48 cm Sephadex G-100 gel-filtration 
column (Sigma-Aldrich) was equilibrated with 5 column volumes of PBS (Section 2.3) 
at room temp. 250µl of sample was applied to the column and allowed to flow by 
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gravity through the column. The proteins retention time was monitored by measuring 
eluent absorbance at an OD of 280nm. A standard curve was produced by running a 
number of known standards over the column separately. The standard proteins applied 
were:  
Carbonic Anhydrase.; 200 µl of 10 mg/ml stock 
BSA; 200 µl of 10 mg/ml stock 
Cytochrome C; 200 µl of 5 mg/ml stock 
Ovalbumin; 200 µl of 10 mg/ml stock 
2.25.2 SEC by FPLC 
Before attaching the SEC column to the AKTA Purifier FPLC (Amersham Biosciences) 
the maximum back pressure limit was set according to the manufactures guidelines. The 
column storage valve was disconnected from the gel filtration column, and the top 
connected to pump outlet no. 1. The bottom of the column screwed directly into the 
FPLC. To remove the column storage buffer (20% ethanol) two column volumes of 
water were pumped through the column (Pump P-900, Amersham Biosciences) at a 
flowrate of 1 mL/min (unless otherwise stated). The column was then equilibrated with 
5 column volumes of sample buffer at the same flow rate, before sample application. 
With pump A connected to a stock of degassed sample buffer, 1 mg of sample was 
applied through the sample injection port in a volume of no more than 100 µl, and the 
run commenced, with a constant flow rate of 1 ml/min of buffer A. After sample 
addition, 2.5 column volumes of buffer was passed through the column. The proteins 
retention time was measured using the online Monitor U-900 (GE Healthcare), which 
read the eluent absorbance at OD 280nm. 
2.26 Peroxidase-Binding Assay 
The peroxidase-binding assay is a semi-quantitative assay (Huet, Bernadac 1974) for 
demonstration of PA-IIL interaction with cells. The assay is based on the ability of the 
lectin to combine both with the cells and with the mannose-bearing enzyme horseradish 
peroxidase (Gilboa-Garber, Mizrahi 1973). The assay was carried out in 96 well plate 
format. A 50µL volume of a 10 µg/ml lectin solution was immobilised in each well of a 
NUNC MaxiSorp ELISA plates at 4oC overnight. Each sample was assayed in triplicate. 
The unbound lectin was removed by inverting the plate and the wells were washed with 
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TBS supplemented with 0.1% Triton X four times. A 50µl aliquot of HRP, 
supplemented with 10 mM CaCl2 was then added at a concentration of 10µg/ml and left 
to incubate at room temperature for 1 hour. This was removed by inversion and washed 
with TBST as before. The wells were developed for 2-10min by the addition of 50µl of 
TMB substrate (Section 2.3). The reaction was stopped after 5 min by adding 10% 
H2SO4 and the absorbance was read at 415 nm or 450nm.    
   
2.27 Enzyme Linked Lectin Assays on NUNC MaxiSorp 
plates 
A 50µL volume of glycoprotein was immobilised in each well of a NUNC MaxiSorp 
ELISA plates at 4oC overnight. Each sample was assayed in triplicate, at a concentration 
of 10 µg/ml. The unbound glycoprotein was removed by inverting the plate and the 
wells were blocked with 150 µl of 2.5% BSA in TBS for one hour. This solution was 
then removed by inverting the plate and washing with TBS supplemented with 0.1% 
Triton X four times. A 50µl aliquot of lectin in TBST-BSA 1%, supplemented with 10 
mM CaCl2 was then added at a concentration of 10µg/ml and let incubate at room 
temperature for 1 hour. This was removed by inversion and washed with TBST as 
before. This was followed with 50µl of 1:10,000 mouse anti-histidine antibody as 
appropriate. This was created fresh and diluted with TBST-BSA 1%, and incubated for 
one hour at room temperature. Unbound antibody was removed by inversion and 
washed four times with TBST, before the addition of 50µl of TMB substrate (Section 
2.3). The reaction was stopped after 5 min by adding 10% H2SO4 and the absorbance 
was read at 415nm or 450 nm.  









3.0 Cloning, expression, purification of 
recombinant PA-IIL 
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3.1 Overview 
Samples enriched by a specific protein are rarely easily obtained from natural host cells. 
The Gram-negative bacterium Escherichia coli is one of the most commonly used hosts 
of recombinant heterologous protein expression (Baneyx 1999). It facilitates protein 
expression by its relative simplicity, rapid high density growth rate on inexpensive 
substrates and well characterized genetics which allow for large scale protein 
production. Many variable strains are available as well as a broad range of compatible 
cloning and expression vectors which confer flexible control of protein expression, e.g. 
location of expressed protein, yields, addition of fusion proteins, etc. The primary 
disadvantages of E. coli as an expression system include the inability to perform many 
of the post-translation modifications necessary for eukaryotic proteins, in particular 
glycosylation, and a limited ability to facilitate extensive disulphide bond formation 
(Makrides 1996). Predominately, available commercial lectins are of plant origin. These 
eukaryotic proteins require post-translational modification, preventing the use of the E. 
coli expression system for their production. Plant lectins are therefore often expressed 
from source resulting in poor yields of expressed protein and heterologous glycosylated 
lectin mixtures. Lectins from prokaryotic sources such as PA-IIL do not require post-
translation modification and can therefore exploit the E. coli expression system to 
produce high yields of active recombinant protein to a high level of purity. This chapter 
describes the cloning of the PA-IIL gene from P. aeruginosa and development of a 
recombinant E. coli expression system, capable of producing active recombinant PA-IIL 
at high purity. The optimal conditions for long term storage of PA-IIL were also 
investigated.  
 
3.2 Cloning and expression of the P. aeruginosa lectin PA-IIL 
in E. coli   
In order to determine the optimal systems for the expression and purification of PA-IIL 
in E. coli, the PA-IIL gene was cloned into a number of E. coli compatible expression 
vectors. A number of the resulting constructs introduced tags to the PA-IIL protein. The 
addition of a tag enables simple purification via the IMAC methodology (Section 
2.16.1). However, the addition of tags can also affect activity, stability, solubility and 
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folding and so a range of different tagging systems was evaluated. The cloning of the 
PA-IIL gene into a number of different expression vectors is described in the following 
sections. 
 
3.3 Cloning for expression of untagged recombinant PA-IIL  
The PA-IIL gene was cloned into the Qiagen pQE expression vector pQE60 (Table 2.3, 
Figure 2.1). The pQE60 vector features an optimized hybrid promoter-operator element 
(Bujard, Gentz et al. 1987) consisting of the phage T5 transcriptional promoter and a lac 
operator sequence, which increases lac protein (LacI) binding, enabling repression of 
this strong promoter. The β-lactamase gene conferring resistance to ampicillin (ampR) is 
present on the vector. The pQE60 vector facilitates the translation of a fusion protein 
having a C-terminal 6HIS tag (Figure 3.1.).  
 
Figure 3.1: The multiple cloning site (MCS) of the pQE60 expression vector. 
Schematic outlining the positions of the relevant restriction sites, 6HIS tag and start and stop codons 
found within the MCS of the expression vector pQE60. 
 
 
The P. aeruginosa strain PA01 was obtained from Prof. Keith Poole, and the sequence 
for the organism was obtained from the NCBI data bank, data entry no. NC002516, 
(Stover, Pham et al. 2000). The primers PAIIL-f and QE60.PAIIL-r were designed for 
the amplification of the PA-IIL gene as an NcoI-BglII 350 b.p fragment by PCR. The 
primed region of the PA-IIL gene for which the primers were designed is shown in 
Figures 3.2 and 3.3.  
 
Figure 3.2: Primers used for the amplification of the PA-IIL gene from P. aeruginosa PA01 for 
cloning into the pQE60 vector.  
A point mutation was used to replace the stop codon TAG with the more frequently occurring stop codon 
TAA (base highlighted in red). The enzymatic restriction sites added to the PA-IIL gene are shown 
underlined and labelled.  
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Figure 3.3: Primed region of the PA-IIL sequence from P. aeruginosa PA01 for suitable 
amplification for cloning into the pQE60 vector.  
The start and stop codons of the PA-IIL gene are highlighted in blue. The base mutated by the primer for 
the introduction of the more frequently occurring TAA stop codon in place of the TAG stop codon is 
highlighted in red. 
 
Genomic DNA was prepared from P. aeruginosa (Section 2.6.3) and used as template 
DNA for the amplification of the PA-IIL gene. The PA-IIL gene was amplified with a 
stop codon preventing the fusion of 6HIS to the C terminus of the translated protein 
(Figure 3.4). The conditions used for the PCR are shown in Table 3.1 below. The PCR 
was carried out with the high fidelity Taq polymerase, PhusionTaq (Invitrogen).  
Table 3.1: PCR conditions for the amplification of the PA-IIL gene for cloning to the pQE60 vector. 
Primers PAIIL-f and pQE60.PAIIL-r used for amplification as described above. 
 
PCR Condition 
Annealing Temp. 65oC 
Annealing Time 20 sec 
Extension Time 30 sec 
No. of Cycles 50 
 
The PCR product was cleaned using Gel/PCR DNA fragment extraction kit (ISIS). Both 
the cleaned PCR product and the pQE60 vector (Table 2.3, Figure 2.1) were digested 























Figure 3.4: Schematic of the NcoI/BglII restricted PCR product amplified by PAIIL-f and 
QE60PAIIL-r and a schematic of the MCS of the pQE60 vector restricted by NcoI/BglII.  
The point of restriction is indicated by a black line and break in the sequence. 
 
The linearised pQE60 plasmid DNA was ligated with the purified PA-IIL NcoI/BglII 
fragment. The ligation mixture was transformed into E. coli JM109 cells, and spread 
onto LB amp plates (as outlined in Section 2.9.3). Candidate clones were selected, the 
plasmid DNA was isolated and then analysed by restriction analysis. Clones were 
screened by performing NcoI, BglII and NcoI/BglII double digests on the plasmid DNA 
prepared from each clone. The restriction digests were visualised on 0.7% agarose gels. 
Screening in this manner resulted in the identification of the desired plasmid named 
pQE60.PAIIL. Figure 3.5 below shows the results of the verifying restriction analysis 
on the plasmid.  
 
 
Lane No. Sample 
1 1Kb Ladder 
2 pQE60 uncut 
3 pQE60.PAIIL uncut 
4 pQE60.PAIIL cut NcoI 
5 pQE60.PAIIL cut BglII 
6 pQE60.PAIIL cut 
NcoI/BglII 
7  1Kb Ladder 
 
Figure 3.5: Analysis and restriction of 
plasmid pQE60.PAIIL. 
The insert introduced to the pQE60 vector is small and therefore the band shift between pQE60 and 
pQE60.PAIIL is difficult to see. The restriction digest of the pQE60.PAIIL clone analysed on a 0.7% 
agarose gel (Section 2.7) showed that single restriction with either NcoI and BglII produced a band 
corresponding to the expected (~38000 b.p) linearised plasmid. Double restriction with NcoI/BglII 
excised a band of ~355 b.p resulting in a visible band shift lower of the plasmid which is indicative of the 
presence of the PA-IIL fragment within the clone indicating that the cloning of PA-IIL to the pQE60 
vector was successful.    
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The presence of the correct insert within the pQE60.PAIIL vector (Figure 3.6) was 
further confirmed by DNA sequencing. Translation of protein from this expression 



















Figure 3.6: Schematic of pQE60.PAIIL vector. 
Emphasised region of the pQE60.PAIIL vector outlines the relative positions of the PA-IIL gene, the 
relevant restriction sites, start and stop codon and 6HIS. Image generated using BVtech.  
 
3.4 Cloning for expression of 6HIS tagged recombinant PA-
IIL  
3.4.1 Cloning for the expression of C-terminally 6HIS tagged PA-IIL 
The pPC6 vector has been established as an expression vector within the laboratory. 
This expression vector is based on the pQE60 vector with the T5promoter/lac operator 
replaced by the tac promoter/operator (Ptac). This hybrid promoter-operator element 
consists of the trp promoter and the lac UV5 promoter/operator, which increases lac 
protein (LacI) binding and enables repression of this strong promoter. The β-lactamase 
gene conferring resistance to ampicillin (ampR) is present on the vector. The pPC6 
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Figure 3.7: The MCS of the pPC6 expression vector. 
Schematic outlining the positions of the relevant restriction sites, 6HIS tag (green) and start and stop 
codons found within the MCS of the expression vector pPC6. 
 
The primers PAIIL-f and PAIIL-r2 were designed for the amplification of the PA-IIL 
gene as an NcoI-BglII 353 b.p fragment by PCR. The primed region of the PA-IIL gene 
for which the primers were designed is shown in Figures 3.8 and 3.9.  
  
Figure 3.8: Primers used for the amplification of the PA-IIL gene from P. aeruginosa PA01 for 
cloning into the pPC6 vector.  
The enzymatic restriction sites added to the PA-IIL gene are shown underlined and labelled.  
 
 
Figure 3.9: Primed region of the PA-IIL sequence from P. aeruginosa PA01 for suitable 
amplification for cloning into the pPC6 vector.  
The start and stop codons of the PA-IIL gene are highlighted in blue. The stop codon of the PA-IIL gene 
lies outside the primed region to allow for the fusion of 6HIS to the C-terminus of the translated protein. 
 
Genomic DNA was prepared from P. aeruginosa and used as template DNA for the 
amplification of the PA-IIL gene. The stop codon of the PA-IIL gene lies outside the 
binding region of the primers to facilitate the fusion of 6HIS to the C terminus of the 
translated protein. The conditions used for the PCR are shown in Table 3.2 below.  
 
Table 3.2: PCR conditions for the amplification of the PA-IIL gene for cloning to the pPC6 vector. 
Primers PAIIL-f and PAIIL-r2 used for amplification as described above. 
 
PCR Condition 
Annealing Temp. 68oC 
Annealing Time 30 sec 
Extension Time 30 sec 
No. of Cycles 30 
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The PCR was carried out with the Taq polymerase RedTaq (Invitrogen). RedTaq 
polymerase has a nontemplate-dependent terminal transferase activity that adds a single 








Figure 3.10: PA-IIL NcoI-BglII fragment after PCR amplification by RedTaq polymerase. 
Addition of A overhangs to 3’ terminus of the PA-IIL PCR product by RedTaq are shown in red. The 
relevant restriction sites are indicated. 
 
The commercial pCR2.1 vector (Table 2.3, Fig. 2.2) has been linearised within the 
lacZα gene and the cleavage site contains deoxyribothymidine (T) overhangs. The T 
overhangs are complementary to the A overhangs of PCR products amplified using 
RedTaq polymerase, and can thus be ligated easily. The PCR PA-IIL NcoI-BglII product 
was cleaned and ligated with the linearised TA cloning vector pCR2.1 as outlined in 


































Figure 3.11: Schematic of the intermediate clone formed by TA cloning of the PA-IIL NcoI-BglII 
fragment to the pCR2.1 vector  
[A] Schematic of the PCR PA-IIL fragment amplified by RedTaq polymerase and the linearised pCR2.1 
prepared for ligation. [B] Schematic of the intermediate cloned formed by TA cloning.  The 
complementary T overhangs of the commercial linerized pCR2.1 vector and the A overhangs of the 
RedTaq polymerase amplified PA-IIL NcoI-BglII are highlighted in red. The relevant restriction sites are 
indicated. Image generated using BVtech. 
 
The PCR product was ligated with the TA pCR2.1 vector according to the TA protocol 
(Section 2.10). The resulting ligation was transformed into E. coli JM109 cells, and 
spread onto LB amp plates containing IPTG and X-Gal and the transformants were 
screened using the blue/white screening method as described in Section 2.10.1. White 
colonies were isolated and screened by performing EcoRI digests on plasmid DNA 
isolated from each clone. In this way the desired intermediate TA clone was obtained. 
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Lane No. Sample 
1  1Kb Ladder 
2  pCR2.1 uncut 
3  pCR2.1 cut EcoRI 
4  Inter. TA clone uncut 
5  Inter. TA clone EcoRI 
 
Figure 3.12: Analysis and restriction of the 
intermediate TA vector. 
The restriction digest of the intermediate TA 
clone analysed on a 0.7% agarose gel (Section 
2.7). EcoRI sites are situated on either side of the 
insert point of pCR2.1 (Figure 3.11). A 
restriction digest of the empty pCR2.1 TA clone 
with EcoRI resulted in linearised plasmid with a 
minor band shift. A restriction digest of the intermediate clone with EcoRI excised a band of approx 380 
b.p, circled in red, indicating that PA-IIL fragment is present and therefore the cloning of PA-IIL to the 
pCR2.1 vector was successful.    
 
 
Plasmid DNA was prepared from the intermediate TA vector and digested with 
NcoI/BglII. The digested DNA was separated on a 1% agarose gel and the band 
corresponding to the PA-IIL fragment was purified from the gel Gel/PCR DNA 
fragment extraction kit (Section 2.8). pPC6 was linearised with NcoIBglII and ligated 










Figure 3.13: Schematic of the NcoI/BglII restricted PA-IIL fragment excised from the intermediate 
TA clone and the schematic of the MCS of the pPC6 vector restricted by NcoI/BglII.  
The point of restriction is indicated by a black line and break in the sequence. 
 
 
The ligated DNA was transformed to E. coli JM109 and the transformation was plated 
on LBamp media (as outlined in Section 2.9.3). Candidate clones were selected, the 
plasmid DNA was isolated and then analysed by restriction analysis. Clones were 
377 bp 
  - 84 -
348 bp 
screened by performing NcoI, BglII and NcoI/BglII double digests on plasmid DNA 
prepared from each clone. The restriction digests were visualised on a 0.7% agarose gel. 
Screening in this manner resulted in the identification of the desired plasmid named 




Lane No. Sample 
1  1Kb Ladder 
2  pPAIIL3 uncut 
3  pPAIIL3 cut NcoI 
4  pPAIIL3 cut BglII 
5  pPAIIL3 cut NcoI/BglII 
6  PAIIL3 PCR product 
 
Figure 3.14: Analysis and restriction of the 
pPAIIL3 plasmid.  
The restriction digest of the pPAIIL3 clone 
analysed on a 0.7% agarose gel (Section 2.7) 
showed that a single restriction with NcoI and 
BglII produced a band corresponding to the 
expected (~5000 b.p) linearised plasmid. Double restriction with NcoI/BglII excised a band of ~350 b.p, 
corresponding to the PA-IIL gene. The size of the excised band was confirmed by comparison to the PCR 
product produced by primers PAIIL-f and PAIIL-r2. The insert is indicative of the presence of the PA-IIL 
fragment within the clone indicating that the cloning of PA-IIL into the pPC6 vector was successful.    
 
   
The presence of the correct insert within the pPAIIL3 plasmid (Figure 3.15) was further 
confirmed by DNA sequencing. Translation of protein from this expression vector 




























Figure 3.15: Schematic of pPAIIL3 construct.  
Emphasised region of the pPAIIL3 vector outlines the relative positions of thePA-IIL gene, the relevant 
restriction sites, start and stop codon and 6HIS. Image generated using BVtech. 
 
3.4.3 Cloning for the expression of N-terminally 6HIS tagged PA-IIL 
The PA-IIL gene was cloned into the Qiagen pQE expression vector pQE30 (Table 2.3, 
Figure 2.4). The vector pQE-30 features the same promoter operator system and β-
lactamase gene conferring resistance to ampicillin (ampR) as the pQE60 vector. The 
pQE30 vector facilitates the translation of a fusion protein having an N-terminal 6HIS 
tag (Figure 3.16). 
Figure 3.16: The MCS of the pQE30 vector.  
Schematic outlining the positions of the relevant restriction sites, 6HIS tag and start and stop codons 
found within the MCS of the expression vector pQE30. 
 
The primers QEPAIIL-f and QEPAIIL-r were designed for the amplification of the PA-
IIL gene as a BamHI-HindIII 360 b.p fragment by PCR. The primed region of the PA-
IIL gene for which the primers were designed is shown in Figures 3.17 and 3.18. 
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Figure 3.17: Primers used for the amplification of the PA-IIL gene from P. aeruginosa PA01 for 
cloning into the pQE30 vector. 
The enzymatic restriction sites added to the PA-IIL gene are shown underlined and labelled 
 
 
Figure 3.18: Primed region of the PA-IIL sequence from P. aeruginosa PA01 for suitable 
amplification for cloning into the pQE30 vector.  
The start and stop codon of the PA-IIL gene highlighted in blue. The base mutated by the primer for the 
introduction of the TAA stop codon is highlighted in red. 
 
Genomic DNA was prepared from P. aeruginosa and used as template DNA for the 
amplification of the PA-IIL gene.  The conditions used for the PCR are shown in Table 
3.3 below. The PCR was carried out with the high fidelity Taq polymerase, PhusionTaq. 
   
Table 3.3: PCR conditions for the amplification of the PA-IIL gene for cloning to the pQE30 vector. 
Primers QEPAIIL-f and QEPAIIL-r used for amplification as described above. 
 
PCR Condition 
Annealing Temp. 65oC 
Annealing Time 20 sec 
Extension Time 30 sec 
No. of Cycles 50 
 
The PCR product was cleaned using Gel/PCR DNA fragment extraction kit. Both the 
cleaned PCR product and the pQE30 vector were digested with BamHI/HindIII and the 

















Figure 3.19: Schematic of BamHI/HindIII restricted PCR product amplified by QE30.PAIIL-f and 
QE30.PAIIL-r and schematic of the MCS of the pQE30 vector restricted by BamHI/HindIII.  
The point of restriction is indicated by a black line and break in the sequence. 
 
 
The linearised pQE30 plasmid DNA was ligated with the purified PA-IIL BamHI-
HindIII fragment. The ligated DNA was transformed to E. coli XL10-Gold and the 
transformation was plated on LBamp media (as outlined in Section 2.9.3). Candidate 
clones were selected, the plasmid DNA was isolated and then analysed by restriction 
analysis. Clones were screened by performing BamHI, HindIII and BamHI/HindIII 
double digests on plasmid DNA prepared from each clone. The restriction digests were 
visualised on 0.7% agarose gels. Screening in this manner resulted in the identification 
of the desired plasmid named pQE30.PAIIL. Figure 3.20 below shows the results of the 
verifying restriction analysis on the plasmid. 
 
Lane No. Sample 
1  1Kb Ladder 
2  pQE30 uncut 
3  pQE30.PAIIL uncut  
4  pQE30.PAIIL cut BamHI 
5  pQE30.PAIIL cut HindIII 
6 pQE30.PAIIL cut                                            
BamHI/HindIII 
 
Figure 3.20: Analysis and restriction of the 
pQE30.PAIIL plasmid.  
The restriction digest of the pQE30.PAIIL clone 
analysed on a 0.7% agarose gel (Section 2.7) 
showed single restriction with BamHI and HindIII 
produced a band corresponding to the expected 
(~3800 b.p) linearised plasmid. Double restriction with BamHI/HindIII excised a band of ~350 b.p 
resulting in a visible band shift lower of the plasmid which is indicative of the presence of the PA-IIL 
fragment within the clone indicating that the cloning of PA-IIL into the pQE30 vector was successful.    
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The presence of the correct insert within the pQE30.PAIIL plasmid (Figure 3.21) was 
further confirmed by DNA sequencing. Translation of protein from this expression 
vector results in N-terminal 6HIS tagged PA-IIL. 
 
Figure 3.21: Schematic of pQE30.PAIIL construct.  
Emphasised region of the pQE30.PAIIL vector outlines the relative positions of the PAIIL gene, the 
relevant restriction sites, start and stop codon and 6HIS. Image generated using BVtech. 
 
3.4.4 Cloning for the expression of PA-IIL with a cleavable N-terminal 6HIS tag 
The PA-IIL gene was cloned into the Qiagen pQE expression vector pQE30Xa (Table 
2.3, Figure 2.5). The vector pQE30Xa features the same promoter operator system and 
β-lactamase gene conferring resistance to ampicillin (ampR) as the pQE60 vector. The 
pQE30Xa vector enables the translation of PA-IIL protein with an N-terminal 6HIS 
affinity tag that can be removed after purification via specific digestion by FactorXa 
protease (Figure 3.22). 
Figure 3.22: The MCS of the pQE30Xa vector 
Schematic outlining the positions of the relevant restriction sites, protease recognition site, 6HIS tag and 
start and stop codons found within the MCS of the expression vector pQE30Xa. 
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The primers PAIIL-f2 and QEPAIIL-r were designed for the amplification of the PA-IIL 
gene as a 354 b.p HindIII fragment by PCR. The primed region of the PA-IIL gene for 
which the primers were designed is shown in Figures 3.23 and 3.24. 
 
  
Figure 3.23: Primers used for the amplification of the PA-IIL gene from P. aeruginosa PA01 for 
cloning into the pQE30Xa vector. 




Figure 3.24: Primed region of the PA-IIL sequence from pQE30.PAIIL for suitable amplification 
for cloning into the pQE30Xa vector. 
The start and stop codon of the PA-IIL gene highlighted in blue.  
 
Plasmid DNA was prepared from the pQE30.PAIIL plasmid and used as template DNA 
for the amplification of the PA-IIL gene. The conditions used for the PCR are shown in 
Table 3.4 below. The PCR was carried out with the high fidelity Taq polymerase, 
PhusionTaq.   
 
Table 3.4: PCR conditions for the amplification of the PA-IIL gene for cloning to the pQE30Xa 
vector. 
Primers PAIIL-f2 and QEPAIIL-r used for amplification as described above. 
 
PCR Condition 
Annealing Temp. 65oC 
Annealing Time 15 sec 
Extension Time 30 sec 
No. of Cycles 50 
 
The PCR product was cleaned using Gel/PCR DNA fragment extraction kit. The 
cleaned PCR product was restricted with HindIII and the pQE30Xa vector was 
restricted with StuI/HindIII and the restricted products were cleaned (Figure 3.25). 
Restriction with StuI creates a blunt end to which the blunt end of the PCR product can 
ligate resulting in the loss of the StuI restriction site.  











Figure 3.2515: Schematic of HindIII restricted PCR product amplified by PAIIL2-f and 
QE30.PAIIL-r and schematic of MCS of pQE30Xa vector restricted by StuI/HindIII.  
The point of restriction is indicated by a black line and break in the sequence. 
 
 
The linearised pQE30Xa plasmid DNA was ligated with the purified PA-IIL HindIII 
fragment. The ligated DNA was transformed to E. coli XL10-Gold and the 
transformation was plated on LBamp media (as outlined in Section 2.9.3). Candidate 
clones were selected, the plasmid DNA was isolated and then analysed by restriction 
analysis. Clones were screened by performing StuI, EcoRI, HindIII and EcoRI/HindIII 
double digests on plasmid DNA prepared from each clone. The restriction digests were 
visualised on 0.7% agarose gels. Screening in this manner resulted in the identification 
of the desired plasmid named pQE30Xa.PAIIL. Figure 3.26 below shows the results of 
the verifying restriction analysis on the plasmid. 
 
Lane No. Sample 
1  1Kb Ladder 
2  pQE30Xa.PAIIL uncut 
3  pQE30Xa.PAIIL cut StuI 
4  pQE30Xa.PAIIL cut EcoRI 
5  pQE30Xa.PAIIL cut HindIII 
6 pQE30Xa.PAIIL cut 
EcoRI/HindIII 
7  QE30Xa.PAIIL PCR product 
 
Figure 3.26: Analysis and restriction of the 
pQE30Xa.PAIIL vector.  
The restriction digest of the pQE30Xa.PAIIL clone 
analysed on a 0.7% agarose gel (Section 2.7) found StuI 
did not cut the plasmid which is indicative of the loss of the 
restriction site. Single restriction with EcoRI and HindIII 
produced a band corresponding to the expected (~3800 b.p) linearised plasmid. Double restriction with 
EcoRI/HindII excised a band of ~350 b.p corresponding to the PA-IIL gene. The size of the excised band 
was confirmed by comparison to the PCR product produced by primers QE30Xa.PAIIL-f and 
QE30XaPAIIL-r. The insert is indicative of the loss of the PA-IIL fragment within the clone indicating 
that the cloning of PA-IIL to the pQE30Xa vector was successful.     
348 bp 
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The presence of the correct insert within the pQE30Xa.PAIIL vector (Figure 3.27) was 
further confirmed by DNA sequencing. Translation of protein from this expression 
vector results in recombinant PA-IIL with an N terminal 6HIS tag that can be removed 
after purification via specific digestion by FactorXa protease. 
 
 
Figure 3.27: Schematic of pQE30Xa.PAIIL construct 
Emphasised region of the pQE30Xa.PAIIL vector outlines the relative positions of the PA-IIL gene, 
relevant restriction sites, protease recognition site, start and stop codon and 6HIS. Image generated using 
BVtech. 
3.4.5 Cloning for the expression of StrepII tagged PA-IIL 
A vector that enables the translation of fusion protein having an N-terminal StrepII-tag 
was created in house based on the pQE30 vector. The 6HIS of pQE30.PAIIL were 
replaced by the StrepII tag sequence by site specific mutation. The primers 
PAIIL.StrepII-f and PAIIL.StrepII-r were designed for the incorporation of the StrepII 
sequence in place of 6HIS and the RGS-His epitope by mutagenesis. The presence of 
the RGS-HIS epitope enables the detection of 6HIS tagged protein by the RGS-His 
antibody eliminating the need for a protein-specific antibody. This feature is not 
required for this work and thus the additional bases of the RGS-His epitope were 
removed during mutagenesis. The primed region of the pQE30.PAIIL vector for which 
the primers were designed is shown in Figures 3.28 and 3.29.  
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Figure 3.28: Primers used for the mutation of 6HIS of the pQE30.PAIIL vector to the StrepII tag 
sequence. 
The StrepII sequence was divided between the forward primer and reverse primers. Phosphorylation of 




Figure 3.29: Primed region of the pQE30.PAIIL plasmid for the mutagenesis of the 6HIS tag to a 
StrepII tag to form the pQE30StrepII.PAIIL plasmid. 
The start codon of the PA-IIL gene is highlighted in blue. The bases forming the RGS-His epitope site 
(highlighted in red) were eliminated by the primer sequences. The 6HIS to be mutated is highlighted in 
green. 
 
Plasmid DNA was prepared from the pQE30.PAIIL vector and used as template DNA 
for the site specific mutagenesis.  The conditions used for the PCR are shown in Table 
3.5 below. The use of the high fidelity Taq polymerase, PhusionTaq, enabled full vector 
amplification.   
 
Table 3.5: PCR conditions for the incorporation of StrepII tag in place of 6HIS in the 
pQE30.PAIIL vector. 
Primers PAIIL.StrepII-f and PAIIL.StrepII-r used for amplification as described above. Elongated 
extension time enables full vector amplification.  
 
PCR Condition 
Annealing Temp. 65oC 
Annealing Time 20 sec 
Extension Time 2min 30 sec 
No. of Cycles 50 
 
The PCR product (Figure 3.30) was cleaned using Gel/PCR DNA fragment extraction 
kit. The restriction enzyme DpnI is effective against dam methylated DNA. Treatment 
of the PCR product with DpnI leads to the cutting of the template pQE30.PAIIL while 
the un-methylated PCR product remains intact (see Section 2.12.1).  
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Figure 3.30: PCR product amplified by primers PAIIL.StrepII-f and PAIIL.StrepII-r, using the 
pQE30.PAIIL vector DNA as a template.   
Schematic outlines the positions of the PA-IIL gene, the relevant restriction sites, StrepII tag and start and 
stop codons found within the MCS of the expression vector pQE30.Strep.PAIIL. 
 
Phosphorylation of the primers facilitated ligation of the PCR product to form a plasmid 
which was then called pQE30.StrepII.PAIIL. The ligated DNA was transformed to E. 
coli XL10-Gold and the transformation was plated on LBamp media (as outlined in 
Section 2.9.3). Restriction analysis cannot differentiate between re-circularised template 
DNA and pQE30.StrepII.PAIIL as all restriction sites are identical. The presence of the 
correct insert within the pQE30.StrepII.PAIIL vector (Figure 3.31) was confirmed by 
DNA sequencing. Translation of protein from this expression vector results in N-
terminal StrepII tagged PA-IIL. 
 
Figure 3.31: Schematic of the pQE30.StrepII.PAIIL construct 
Emphasised region of the pQE30.StrepII.PAIIL vector outlines the relative positions of the PA-IIL gene, 
the relevant restriction sites, StrepII tag, start and stop codon. Image generated using BVtech. 
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3.4.5 Mutagenesis of the sugar binding loop of PA-IIL 
A number of lectins of high similarity to PA-IIL have been identified and characterised, 
in particular the mannose binding lectin RS-IIL from R. solanacearum. Alignment of 
the amino acid sequence of PA-IIL and RS-IIL shows a 69% identity and 85% 
similarity between the two proteins (Figure 3.32). 
 
 
Figure 3.32: Amino acid alignment of protein sequences of P. aeruginosa lectin PA-IIL and R. 
solanacearum lectin RS-IIL.  
Amino acids involved in monosaccharide binding outlined in red and amino acids involved in calcium 
binding outlined in green. Identical residues highlighted in black and similar in grey.  Image generated 
using ClustalW align and Genedoc.  
 
Significantly, the three amino acids, Ser22-Ser23-Gly24, identified as directly involved 
in the sugar binding activity of PA-IIL show little similarity to the three amino acids, 
Ala-22-Ala-23-Asn-24, identified as directly involved in the sugar binding activity of 
RS-IIL (Figure 3.32). The differing sugar specificities (PA-IIL preference – L-fucose, 
RS-IIL preference – D-mannose) of PA-IIL and RS-IIL are attributed to the variation 
across these three amino acids. Previous studies, as discussed in Section 1.6 (Adam et 
al. 2007), have point mutated each of the sugar binding amino acids of PA-IIL to those 
found in RS-IIL to investigate the effect on sugar specificity. While the sugar binding 
specificity was found to alter from a preference for fucose to mannose a binding affinity 
directly comparable to that found for RS-IIL was not obtained. In order in investigate 
the effect of the collective mutation of all three amino acids the primers PAIIL.MU-f 
and PAIIL.MU-r were designed to site specifically mutate the PA-IIL gene. A 
diagnostic restriction site, HpaI, was also introduced by the primers into the gene by a 
silent point mutation to facilitate restriction analysis of colonies. The primed region of 
the pQE30Xa.PAIIL vector for which the primers were designed is shown in Figures 
3.33 and 3.34.   
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Figure 3.33: Primers used for the site specific mutation of the PA-IIL gene of pQE30Xa.PAIIL. 
Mutated nucleotides highlighted in red. A silent point mutation for the incorporation of a HpaI diagnostic 
restriction site highlighted in blue.  
 
Figure 3.34: Primed region of the pQE30Xa.PAIIL plasmid for the specific mutagenesis of the PA-
IIL gene. 
The start and stop codons of the PA-IIL gene are highlighted in light blue. The nucleotides to be mutated 
are highlighted in red. The silent point mutation for the incorporation of the diagnostic restriction site 
HpaI is highlighted in dark blue. 
 
Plasmid DNA was prepared from the pQE30Xa.PAIIL vector and used as template 
DNA for the site specific mutagenesis. The conditions used for the PCR are shown in 
Table 3.6 below. The use of the high fidelity Taq polymerase, Phusion, enabled full 
vector amplification.   
 
Table 3.6: PCR conditions for the mutation of the PA-IIL gene within the pQE30Xa.PAIIL vector. 
Primers PAIIL.MU-f and PAIIL.MU-r used for the site specific mutagenesis as described above. 
Elongated extension time enables full vector amplification.  
 
PCR Condition 
Annealing Temp. 65oC 
Annealing Time 20 sec 
Extension Time 2 min 30 sec 
No. of Cycles 50 
 
The PCR product (Figure 3.35) was cleaned and restricted with DpnI which leads to the 
cutting of the template pQE30Xa.PAIIL while the un-methylated PCR product remains 
intact.  
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Figure 3.35: PCR product amplified by primers PAIIL.MU-f and PAIIL.MU-r, using the 
pQE30XA.PAIIL vector DNA as a template. 
Schematic outlines the positions of the PA-IIL gene, the relevant restriction sites, 6HIS tag, protease site, 
mutated nucleotide bases and start and stop codons found within the MCS of the expression vector 
pQE30Xa.PAIILMU plasmid. 
   
The restricted PCR product was again cleaned and the phosphorylation of the primers 
facilitated the ligation of the PCR product to form a plasmid which was then called 
pQE30Xa.PAIILMU. The ligated DNA was transformed to E. coli XL10-Gold and the 
transformation was plated on LBamp media (as outlined in Section 2.9.3). The 
introduction of the unique restriction site, HpaI, provides a means of differentiating 
between pQE30Xa.PAIILMU and re-circularised pQE30Xa.PAIIL. Candidate clones 
were selected, the plasmid DNA was isolated and then analysed by restriction analysis. 
Clones were screened by performing HpaI digests on plasmid DNA prepared from each 
clone. The restriction digests were visualised on a 0.7% agarose gel. Screening in this 
manner resulted in the identification of the desired plasmid named pQE30Xa.PAIILMU. 
Figure 3.36 below shows the results of the verifying 
restriction analysis on the plasmid. 
 
Lane No. Sample 
1  1Kb Ladder 
2  pQE30Xa.PAIILMU uncut 
3  pQE30Xa.PAIILMU cut HpaI 
 
 
Figure 3.36: Analysis and restriction of the pQE30Xa.PAIILMU 
vector 
The restriction digest of the pQE30Xa.PAIILMU clone analysed on a 0.7% agarose gel (Section 2.7) 
found that restriction with HpaI resulted in linearised plasmid. The confirmation of the presence of the 
HpaI restriction site is indicative of the successful mutation of the PA-IIL gene.    
 
The presence of the correct mutations within the pQE30Xa.PAIIL.MU vector was 
confirmed by DNA sequencing (Figure 3.37).  
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Figure 3.37: Schematic of pQE30Xa.PAIILMU construct 
Emphasised region of the pQE30Xa.PAIILMU vector outlines the relative positions of the relevant 
restriction sites, protease recognition site, start and stop codon and 6HIS. The mutated nucleotide bases 
are highlighted in red. Image generated using BVtech. 
 
Translation of protein from this expression vector results in N-terminal 6HIS tagged 





Figure 3.38: The mutated sugar binding loop found for protein expressed from the 
pQE30Xa.PAIILMU vector. 
Upper read; original PA-IIL sequence as expressed from pQE30Xa.PAIIL. Lower read; PA-IIL with 3 
point mutation within the sugar binding loop as expressed from pQE30Xa.PAIILMU. Image created with 
GeneDoc (Section 2.11). 
 
3.5 Preliminary characterization of recombinant PA-IIL 
The pPAIIL3 and QE30PAIIL plasmids were transformed into E. coli XL-10 Gold and 
grown up in LBamp media (as outlined in Section 2.9.3). The culturing conditions for 
both plasmids were as described in Section 2.15. Samples were taken 4 hours after 
induction with 50 µM isopropyl-β-thiogalactopyranoside (IPTG). Samples were lysed 
following the procedure described in methods and materials. Figure 3.39 shows SDS-
PAGE analysis of the soluble protein fractions. Prominent bands corresponding to an 
over expressed protein running at the expected MW of 6HIS C-tag PA-IIL of 12,929 Da 
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and of 6HIS N-tag PA-IIL of 14,062 Da as deduced from their amino acid sequences 















Figure 3.39: Expression of C-terminally and N terminally tagged PA-IIL in E .coli. 
Analysis of cleared lysate samples by 20% SDS-PAGE (Section 2.24). (A): Lane 1, Mr (sizes as in Figure 
2.8); Lane 2, C-terminally tagged PA-IIL (expressed from pPA-IIL3 in E. coli XL10-Gold as outlined in 
Section 2.12). (B):  Lane 1, Mr (sizes as in Figure 2.8); Lane 2, N-terminally tagged PA-IIL (expressed 
from pQE30Xa.PAIIL in E. coli XL10-Gold as outlined in Section 2.12).   
3.5.1 IMAC purification of recombinant PA-IIL  
The addition of a 6HIS tag allows PA-IIL to be purified by single-step 
immobilised metal affinity chromatography, IMAC (Nilsson et al. 1997, Porath et al. 
1975). Purification of 6HIS tagged lectins through IMAC involves exploitation of the 
strong interaction between 6HIS residues in the introduced tag and the two ligand 
binding sites of the Ni2+ ion, which has been immobilised on a solid matrix, in this case 
nitrilotriacetic acid linked to sepharose/sephadex (Ni-NTA). Many cellular proteins 
display histidine residues on their surface which may loosely bind to Ni-NTA resin. 
Washing with low concentrations of imidazole, the active side chain of histidine, 
displaces loosely bound proteins. High concentrations of imidazole are required to 
displace 6HIS tagged recombinant protein. 
Protein was expressed from pPAIIL3 and pQE30.PAIIL, E. coli XL10-Gold, in 
100ml LBamp cultures. Samples were lysed following the procedure described in the 
methods and materials. The elution profiles of the cleared lysate samples of 6HIS C-tag 
and 6HIS N-tag PA-IIL were established within the standard lysis buffer (Section 2.3), 
by carrying out a series of washes supplemented with increasing concentrations of 
(A) (B) 
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imidazole. Figure 3.40 shows SDS-PAGE analysis of the highly purified 6HIS N and C 














Figure 3.40: Analysis by 20% SDS page of PA-IIL purification on Nickel-NTA resin 
Analysis by 20% SDS-PAGE of fractions collected from purification on a nickel-NTA resin of a 100ml 
E. coli lysate containing PA-IIL.(A) Analysis by 20% SDS-PAGE Silver stained (Section 2.24) of 
recombinant 6HIS C-tagged PA-IIL. Lane 1, Mr (sizes given in Figure 2.8); Lane 2, Clear lysate; Lane 3, 
flow-through; Lane 4, wash 1 (80mM imidazole); Lane 5 wash 2 (80mM imidazole); Lane 6, wash 3 
(120mM imidazole) Lane 7, 350mM elution; Lane 8, 350mM elution, Lane 9, Mr. (B) Analysis by 20% 
SDS-PAGE Silver stained (Section 2.24) of recombinant 6HIS N-tagged PA-IIL purification Lane 1, Mr 
(sizes given in Figure 2.8); Lane 2, Cleared lysate; Lane 3, flow-through; Lane 4, wash 1 (30mM 
imidazole); Lane 5, 350mM elution; Lane 6, 350mM imidazole elution. 
 
3.5.2 Biological activity of PA-IIL 
 
PA-IIL has a high affinity for L-fucose and D-mannose as discussed, see Chapter 1 
(Garber et al. 1987). Horse radish peroxidase (HRP) is a mannose bearing compound, 
therefore the ability of PA-IIL to bind to HRP is indicative of sugar specific lectin 
activity. The impact of the addition of 6HIS on the activity of PA-IIL was investigated 
using the semi-quantitative HRP binding assay (see Section 2.26). This assay was used 
to compare the activity of 6HIS N-tagged and C-tagged PA-IIL. Figure 3.41 shows a 
histogram of the PA-IIL activity. 
(A) (B) 
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Figure 3.41: Histogram of PA-IIL activity assessed by Horse radish peroxidase (HRP) assay. 
HRP assay carried out as per Section 2.26. Histogram ; PBS used in place of PA-IIL as a negative control 
(blue). 10 µg/ml of 6HIS N-tagged (yellow) and 6HIS C-tagged (purple) PA-IIL per well. (Error bars 
represent mean ± SD, n = 3). 
 
There was a 1.84 fold increase in activity of 6HIS C-tag PA-IIL over the signal for the 
control compared to a 7.9 fold increase for 6HIS N-tag PA-IIL. Therefore 6HIS N-tag 
PA-IIL has a 4.3 fold greater activity then 6HIS C-tag PA-IIL. The addition of the 6HIS 
residues to the C-terminus of PA-IIL can therefore be said to disrupt binding activity. 
Addition of 6HIS residues to the N-terminus of PA-IIL appeared not to disrupt binding 
activity.  
3.5.3 Relative molecular mass 
To investigate the quaternary structure of the recombinant lectins size exclusion 
chromatography (SEC) was employed using the G-100 Sephadex gel filtration matrix 
(Whitaker 1963). Size exclusion chromatography separates proteins based on molecules 
hydrodynamic radius. Proteins of lower relative molecular mass are retarded within the 
porous resin beads and are thus separated from proteins of larger relative molecular 
mass which are excluded from the small pores. The larger proteins will pass through the 
packed column more rapidly than the smaller proteins and their exact size can be 
determined by comparison with a standard curve created using a set of known standards 
(Figure 3.42). The standards include BSA, Carbonic Anhydrase, Cytochrome C and 
Ovalbumin. Equation 3.1 was used to create the standard curve.   
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Equation 3.1: Formula for the calculation of the Kav  
 
The Kav was then plotted against the log of the MW of each of the standard proteins to 
create a standard curve, see Figure 3.42. The elution profile of each protein on the 













Figure 3.42: Development of size exclusion chromatography standard curve 
The protein molecular weight standard curve was created using size exclusion chromatography with a G-
100 Sephadex column (Section 2.25.1). Void volume (Vo) of 26.4ml was determined from the elution 
volume of blue dextran, and total volume (Vt) was 132ml, determined by elution of bromophenol blue. 
The elution volumes of the protein standards were as follows; BSA (39.6 ml), Carbonic Anhydrase (55 
ml), Ovalbumin (47.3 ml) and Cytochrome C (64.9 ml) as determined by readings at OD280 . These values 
were used to construct a plot of Kav versus log MW. This could be in turn used to calculate the relative 
MW of all lectin samples that were eluted in the MW range of the standards.  
 
Table 3.7: Construction of a protein molecular weigh standard curve for the G-100 Sephadex 










BSA 39.6 ml 66000 4.82 0.13 72407 9.71 
Ovalbumin 47.3 ml 45000 4.65 0.20 43207 -3.98 
Carbonic anhydrase 55 ml 29000 4.46 0.27 25783 -11.09 
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Figure 3.43: Elution of protein standards on a G-100 Superdex column. 
The elution profiles of standard proteins using size exclusion chromatography with a G-100 Sephadex 
column. The optical density at OD280nm of eluted protein is plotted against the elution volume. The elution 
peak volumes were used in the construction of the standard curve (Figure 3.42). The elution profile of 




As outlined in Section 2.25.1, purified 6HIS C-tagged and 6HIS N-tagged PA-IIL, was 
analysed by size exclusion chromatography. In each instance the lectin was suspended 
in PBS, pH7.8, in order to ascertain its multimeric structure under native conditions. 
Samples were applied to the column in 250µl volumes at a concentration of approx. 5 
mg/ml, and the peak heights recorded were converted into relative molecular weights 
using the stand curve created (see Figure 3.42) 
 
Table 3.8: Calculated native MW of recombinant PA-IIL from a G-100 Sephadex column. 
The theoretical monomer size of the subunits of C-tag and N-tag differ due to addition of a protease 






Monomer Size (Da) 
Calculated Molecular 
Weight 
6HIS N-tag PA-IIL 46.8 ml 14,062 44,680 
6HIS C-tag PA-IIL 54 ml 12,929 27,571 
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The calculated molecular weights for each recombinant lectin are provided in Table 3.8. 
Each lectin was run on the column separately and their elution profiles are plotted in 
Figure 3.43. The 6HIS C-tag PA-IIL molecule was found to form a dimer (expected 
MW of dimer 26kDa). The calculated molecular weight of the 6HIS N-tag PA-IIL 
molecule was found to be between a trimer and tetramer (expected MW of a trimer 
42kDa, expected MW of a tetramer 56.5kDa). PA-IIL is a small compact protein that 
would be likely to diffuse through the column at a slower rate then a globular protein of 
the same molecular weight (similar to the globular standards used for the creation of the 
standard curve) and therefore would elute at a greater volume then predicted (Dubin, 
Principi 1989). Therefore 6HIS N-tagged PA-IIL is most likely to be a tetramer.  
 
3.6 Optimisation of expression conditions for recombinant 
expression of PA-IIL in E. coli 
Having elucidated in the previous section that the addition of 6HIS to the C-terminus of 
PA-IIL disrupts the sugar binding activity of the lectin and disrupts the native tetrameric 
structure, addition of 6HIS to the C-terminus was deemed unsuitable. The expression 
conditions for 6HIS N-tagged PA-IIL were further optimised.  
3.6.1 Selection of an E. coli strain for recombinant expression of PA-IIL 
 
E. coli is the most commonly used host for recombinant protein expression. It facilitates 
protein expression by its relative simplicity, rapid high density growth rate on 
inexpensive substrates and well characterized genetics which allow for large scale 
protein production. As the recombinant lectin being investigated is prokaryotic in 
source, the question of eukaryotic PTM requirement in not a consideration in the choice 
of an expression host. The merits of different E. coli genotypes for the expression of 
PA-IIL were investigated and compared for optimal expression of the PA-IIL protein. 
The expression plasmid pQE30.PA-IIL, which expressed 6HIS N-tagged PA-IIL (see 
Section 3.4.2) was transformed into various E. coli strains, namely XL10-Gold, BL21 
(DE3), JM109 and XL1-Blue (Table 2.1). XL1-Blue and JM109 were used routinely in 
this work for the cloning and propagation of plasmid constructs. BL21 (DE3) is a strain 
deficient in the OmpT protease, purportedly allowing higher recovery of heterologous 
recombinant proteins. XL10-Gold contains F factors, which carry the lacIq allele. The 
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lacIq allele is a promoter mutation that expresses the LacI repressor protein at high 
levels, resulting in strong repression of the T5 promoter/lac operon in the absence of 
IPTG. The effect of individual clonal selection was investigated by the methodology 
















Figure 3.44: Effect of colony selection on lectin expression in E. coli   
Colony blot of pQE30.PAIIL plasmid expressed in E. coli by the methodology as described in Section 
2.15.2. Lane 1 and 2, pQE30PAIIL E. coli XL10-Gold; Lane 3, pQE30 E. coli XL10-Gold; Lane 4 and 5, 
pQE30PAIIL E. coli BL21 (DE3): Lane 6, pQE30 E. coli BL21 (DE3): Lane 7 and 8, pQE30PAIIL E. 
coli JM109; Lane 9, pQE30 E. coli JM109; Lane 10 and 11, pQE30PAIIL E. coli XL1-Blue; Lane 12, 
pQE30 E. coli XL1-Blue. Highlighted in red are individual clones that appeared to express higher levels 
of protein then their counter parts and were picked for expression in 10ml of LBamp 
 
A high expressing candidate clone from each strain of E. coli was picked. 10ml 
expression cultures of each clone chosen were grown in LBamp broth containing 50µM 
IPTG at 37oC overnight. Figure 3.45 shows the SDS-PAGE analysis of the soluble and 
insoluble fractions of PA-IIL expression from each E. coli strain. Clear bands 
corresponding to an over expressed protein could be seen corresponding to the expected 
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Figure 3.45: Expression of N- terminal 6HIS tagged PA-IIL from E. coli strains 
Expression carried out from 10ml LBamp cultures as described in Section 2.15.Lane 1, Mr (sizes as in 
Figure 2.8); Lane 2, pQE30PAIIL E. coli XL10-Gold soluble fraction; Lane 3, pQE30PAIIL E. coli 
XL10-Gold insoluble fraction; Lane 4, pQE30PAIIL E. coli BL21 (DE3) soluble fraction: Lane 5, 
pQE30PAIIL E. coli BL21 (DE3) insoluble fraction: Lane 6, pQE30PAIIL E. coli JM109 soluble 
fraction; Lane 8, pQE30PAIIL E. coli JM109 insoluble fraction; Lane 9, pQE30PAIIL E. coli XL1-Blue 
soluble fraction; Lane 10, pQE30PAIIL E. coli XL1-Blue insoluble fraction.  
 
 
3.6.2 Effect of temperature and time on recombinant expression of PA-IIL   
Protein was seen to be over expressed in all four E. coli strains (Figure 3.45). E. coli 
XL10-Gold and BL21 (DE3) are common expression strains. Further optimisation of 
PA-IIL expression was therefore carried out using E .coli XL10-Gold and BL21 (DE3). 
The optimal temperature for expression and the optimal harvest point of PA-IIL were 
investigated by examining the soluble cell extract at set points post-induction when 
cultures were grown at 37oC, 30oC and grown to the point of induction at 37oC while 
protein expression was then carried out at 30oC. Expression of PA-IIL was carried out 
by the methodology outlined in Section 2.15. Cultures were induced with 50µM IPTG 
when an OD600 of 0.5 -0.6 was reached. An initial sample (T0) was taken prior to 
induction and samples were subsequently taken every hour after induction for 6 hours. 
Cultures were then grown overnight after which a final sample was taken. Samples were 
lysed following the procedure described in Section 2.15.1 and the soluble protein 




















Figure 3.46: Expression of N-terminal 6HIS  tagged PA-IIL in E. coli BL21 (DE3) 
Analysis of the expression of the protein PA-IIL from the plasmid pQE30.PAIIL in E. coli BL21 (DE3) 
by 20% SDS-PAGE. (A) Expression at 37oC; Lane 1, Protein marker; Lane 2, cell extract at point of 
induction; Lane 3, 1 hr; Lane 4, 2 hrs; Lane 5, 3hrs; Lane 6, 4 hrs; Lane 7, 5 hrs; Lane 8, 6 hrs; Lane 9, 
overnight culture. (B) Growth at 37oC and expression at 30oC; Lane 1,Protein marker; Lane 2, cell extract 
point of induction; Lane 3, 1 hr; Lane 4, 2 hrs; Lane 5, 3hrs; Lane 6, 4 hrs; Lane 7, 5 hrs; Lane 8, 6 hrs; 














Figure 3.47: Expression of N-terminal 6HIS tagged PA-IIL in E. coli XL10-Gold 
Analysis of the expression of the protein PA-IIL from pQE30PA-IIL in E. coli XL10-Gold by 20% SDS-
PAGE. (A) Growth and induction at A600 of 0.5 – 0.6,  expression at  37
oC; (B) growth at 37oC and 
induction at A600 of 0.5, expression at  30
oC. Lane 1, Mr (sizes given in Figure 2.7 ); Lane 2, point of 
induction; Lane 3, 1 hr induction; Lane 4, 2 hrs induction, Lane 5, 3 hrs induction; Lane 6, 4 hrs 
induction; Lane 7, 5 hrs induction, Lane 8, 6 hrs induction, Lane 9, 24 hrs induction. Location of PA-IIL 
is indicated by arrows.  
 
A decrease in protein yield was noted when PA-IIL was expressed from E. coli BL21 
(DE3) at 37oC overnight. Little or no protein was also found to be expressed by cultures 
grown at 30oC (gels not shown). The growth rate of the cultures at 37oC, 30oC and the 
37oC and 30oC combination, during the exponential phase, were measured by OD600 as 
shown in Figure 3.48.  There was no significant variation in growth rates between those 
cultures found to express soluble protein and those that did not, namely those expressed 
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failure to over express soluble PA-IIL at 30oC was found regardless of E. coli strain 
utilised for expression.  
 
Figure 3.48: Growth curve for expression of N-terminal 6HIS tagged PA-IIL from pQE30.PAIIL in 
E. coli 
Absorbance readings at OD600 taken during expression of PA-IIL from pQE30.PAIIL in E. coli BL21, 
XL10-Gold, JM109 and XL1-Blue with induction using 50uM IPTG. Temperature conditions varied 




The failure to express soluble PA-IIL at 30oC and the decreased yield found for soluble 
PA-IIL expressed from BL21 (DE3) overnight was attributed to the aggregation of PA-
IIL when expressed at high levels. Studies such as Berrow, N. et al. (2006), have found 
that lower temperature tends to be more effective for the expression of soluble protein. 
Expression of PA-IIL at 30oC was likely to have led to greater PA-IIL yields resulting 
in aggregation. BL21 (DE3) was shown to be a leaky expressor, as PA-IIL expression is 
visible in Figure 3.46A and B at time point 0 (Lane 2) prior to induction. Leaky 
expressing of PA-IIL may also have lead to accumulation of a high yield of protein 
resulting in aggregation. E. coli XL10-Gold contains F factors carrying the lacIq allele 
conferring greater control of protein expression. Strong control of protein expression by 
XL10-Gold led to consistent protein expression, as shown in Figure 3.44 by expression 
of protein for every XL10-Gold colony investigated by the colony blot method. 
Expression from E. coli XL10-Gold produced suitable yields of PA-IIL for future work 
while preventing excess protein production leading to aggregation and loss of soluble 
protein. Therefore XL10-Gold was used for all subsequent expression of PA-IIL. 
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3.6.3 Recovery of PA-IIL from the insoluble fraction  
E. coli XL10-Gold was elucidated in the previous section to be the optimal strain for the 
production of PA-IIL. PA-IIL was found to be present in both the soluble and insoluble 
fractions as shown in Figure 3.45. A study by Tsumoto, K. et al. (2003) has shown that 
insoluble proteins that are at least in part in their native conformation may be 
solubilized under non-denaturing conditions to yield active protein by the addition of L-
arginine. Therefore, an attempt was made to solubilize PA-IIL from the insoluble 
fraction using L-arginine. An expression culture was prepared and lysed by the 
methodology outlined in Section 2.15. The cell pellet (i.e. the insoluble protein fraction) 
formed by centrifugation following lysis was retained and resuspended in lysis buffer 
supplemented with L-arginine hydrochloride at various concentrations and left mixing 
overnight at 4oC. The mixture was centrifuged at 13,000 rpm for 10 min and the 
supernatant was removed. The SDS-PAGE analysis of the supernatant and the 









Figure 3.49: SDS PAGE analysis of the effect of L-arginine on the insoluble fraction of PA-IIL 
Analysis of L-arginine treatment of the insoluble PA-IIL fraction. Lane 1, supernatant from insoluble 
fraction treated with no L-arginine; Lane 2, supernatant from insoluble fraction treated with 0.5M L-
arginine; Lane 3, supernatant from insoluble fraction treated with 1M L-arginine; Lane 4, supernatant 
from insoluble fraction treated with 1.5M L-arginine; Lane 5, supernatant from insoluble fraction treated 
with 2M L-arginine; Lane 6, Mr (sizes given in Figure 2.8 ); Lane 7, insoluble fraction treated with no L-
arginine; Lane 8, insoluble fraction treated with 0.5M L-arginine; Lane 9, insoluble fraction treated with 
1M L-arginine; Lane 10, insoluble fraction treated with 1.5M L-arginine; Lane 11, insoluble fraction 
treated with 2M L-arginine 
 
L-arginine had no greater effect on the levels of protein recovered from the insoluble 
fraction than lysis buffer (Figure 3.49) therefore this is not a suitable method to recover 
PA-IIL from the insoluble fraction. 
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3.6.4 Effect of IPTG concentration on recombinant expression of PA-IIL 
Lectin expressed from plasmids derived from the pQE range of expression plasmids are 
under the control of the T5 promoter/lac operator element system, one of the most 
widely used expression systems. This promoter/operator system consisting of the 
coliphage T5 promoter (recognized by the E. coli RNA polymerase) and the lac 
repressor operator sequence which binds the lac repressor and ensures efficient 
repression of the T5 promoter. Expression of T5 promoter/lac operator is repressed by 
the LacI protein. The lacIq allele, present in the E. coli XL10-Gold strain, is a promoter 
mutation that increases the intracellular concentration of LacI repressor, resulting in the 
strong repression. Addition of IPTG, the inducer molecule, inactivates the LacI 
repressor. Thus, the amount of expression from the T5 promoter/lac operator is 
proportional to the concentration of IPTG added. Therefore low concentrations of IPTG 
result in relatively low expression from the T5 promoter/lac operator element and high 
concentrations of IPTG result in high expression from the T5 promoter/lac operator 
element. The IPTG concentration was varied in PA-IIL expression and the amount of 
soluble protein product expressed from T5 promoter/lac operator element was examined 
















Figure 3.50: Effect of varying IPTG concentration on the expression of PA-IIL in E. coli XL10-
Gold 
Analysis of increasing IPTG concentration on the expression of recombinant PA-IIL by 20% SDS-PAGE. 
Lane 1, Protein marker, Lane 2, induction with 0 µM IPTG. Lane 3, induction with 50 µM IPTG. Lane 4, 
induction with 100µM IPTG. Lane5, induction with 250 µM IPTG. Lane 6, induction with 500 µM IPTG. 
Lane 7, Protein marker.   
 
It was deduced from the SDS-PAGE analysis that there was no significant difference 
between the yield of soluble protein produced upon induction with 50 µM IPTG and 
PA-IIL 
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any higher concentration of the compound. Cultures could be induced by higher 
concentrations of IPTG, however to save on reagent 50 µM of IPTG was concluded to 
be the optimal induction concentration.  
3.7 Purification of recombinant PA-IIL 
Purification of histidine tagged lectins through IMAC involves the exploitation of the 
strong interaction between the six histidine residues of the introduced tag and the two 
ligand binding sites of the Ni2+ ion of the Ni-NTA resin. Many cellular proteins display 
histidine residues on their surface, several wash steps are therefore employed using 
imidazole, the active side-chain of histidine, to displace loosely bound proteins. A high 
concentration is then employed to displace the 6HIS tagged recombinant protein.  
3.7.1 Optimisation of IMAC purification 
The elution profile of 6HIS N-tagged PA-IIL was determined using lysis buffer (Section 
2.3) supplemented with increasing concentrations of imidazole up to 350 mM 











Figure 3.51: SDS gel analysis of wash optimisation of PA-IIL silver stain. 
Analysis by 15% SDS-PAGE Silver stained (Section 2.24) of fractions collected from the purification on 
Amersham nickel resin, of cell lysate from a 100ml culture of E. coli expression PA-IIL protein. Lane 1, 
Protein ladder; Lane 2, Cleared lysate; Lane 3, flow-through; Lane 4, 30mM imidazole; Lane 5, 40mM 
imidazole; Lane 6, 50mM imidazole; Lane 7, 80mM imidazole; Lane 8, 100mM imidazole; Lane 9, 
150mM imidazole; Lane 10, 350mM imidazole elution 1; Lane 11, 350mM imidazole elution 2; Lane 12, 
Mr. 
 
From the SDS-PAGE analysis PA-IIL was found to remain bound to the column in the 
presence of imidazole washes up to 50 mM. Washing with a 30 mM imidazole was 
found to sufficiently remove all loosely bound proteins. The standardised procedure to 
PA-IIL 
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purify PA-IIL was established as; two 10 ml 30 mM imidazole wash steps followed by 













Figure 3.52: SDS gel analysis of purified PA-IIL 
Analysis by 20% SDS-PAGE Silver stained (Section 2.24) of recombinant N-terminally tagged PA-IIL 
purification using IMAC (Section 2.13.1). Lane 1, Mr Ladder (sizes given in Figure 2.8); Lane 2, Cleared 
lysate; Lane 3, flow-through; Lane 4, 30mM imidazole wash 1; Lane 5, 30mM imidazole wash 2; Lane 6, 
350mM imidazole elution 1; Lane 7, 350mM imidazole elution 2; Lane 8, Mr Ladder. 
 
SDS analysis reveals PA-IIL forming multimers, appearing as large bands and smears, 
when PA-IIL is highly expressed and purified (see lanes 6 and 7 of Figure 3.52). 
Elongation of boiling time when purified protein was prepared for SDS-PAGE analysis 
(Section 2.24) to 20 minutes resulted in the loss of these bands confirming that they are 
due to multirmer formation and not contamination.  
The average yield of protein from a 100ml culture was found to be 
approximately 1 -2 mg/ml. Expression of PA-IIL was upscaled to a 500ml culture, with 
the purification protocol upscaled in accordance. Ni-NTA resin bed increased to 1ml 
and 30 mM wash volume increased to 30 ml (see Figure 3.53). The average yield of 























Figure 3.53: SDS gel analysis of large scale PA-IIL purification 
Analysis by 15% SDS-PAGE (Section 2.24) of recombinant N-terminally 6HIS tagged PA-IIL 
purification using IMAC (Section 2.16.1). Lane 1, Mr Ladder (sizes given in Figure 2.8); Lane 2, Cleared 
lysate; Lane 3, flow-through; Lane 4, 30mM imidazole wash 2; Lane 5, 30mM imidazole wash 10; Lane 
6, 30mM imidazole wash 20; Lane 7, 30mM imidazole wash 30; Lane 8, 350mM imidazole elution 1; 
Lane 9, 350mM imidazole elution 2. 
 
3.8 Recombinant expression of PA-IIL in E. coli from other 
constructs 
The optimised procedures established for the expression of PA-IIL from pQE30.PAIIL 
were used to express PA-IIL from a number of constructs based on the same pQE 
vectors and utilising the T5 promoter/lac operator system. 
3.8.1 Expression of recombinant PA-IIL in E. coli from pQE60 construct  
The effect of the E. coli strain and the effect of individual clonal selection on the 
expression of untagged PA-IIL (from pQE60.PAIIL, see Section 3.3) was investigated 
by the colony blot method (Section 2.15.2). A high expressing candidate clone from 
each strain of E. coli was picked (see Figure 3.54A). 10ml expression cultures of each 
clone chosen were grown in LBamp broth containing 50µM IPTG at 37oC overnight. 
Figure 3.54B shows the SDS-PAGE analysis of the soluble and insoluble fractions of 
PA-IIL expression from each E .coli strain. Clear bands corresponding to an over 
expressed protein could be seen corresponding to the expected MW of untagged PA-IIL 
at approximately 12 kDa for E .coli XL10-Gold and JM109. 
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Figure 3.54: Colony selection of untagged PA-IIL expressed from pQE60.PAIIL from E. coli 
[A] Lane 1 and 2, pQE60PA-IIL E. coli XL10-Gold; Lane 3, pQE60 E. coli XL10-Gold; Lane 4 and 5, 
pQE60PA-IIL E. coli BL21 (DE3): Lane 6, pQE60 E. coli BL21 (DE3): Lane 7 and 8, pQE60PA-IIL E. 
coli JM109; Lane 9, pQE60 E. coli JM109; Lane 10 and 11, pQE60PA-IIL E. coli XL1-Blue; Lane 12, 
pQE60 E. coli XL1-Blue. Highlighted in red are clones that appeared to express higher levels of protein 
and were picked for expression in 10ml LBamp[B] Lane 1, Mr (sizes as in Figure 2.8); Lane 2, 
pQE60PA-IIL E. coli XL10-Gold soluble fraction; Lane 3, pQE60PA-IIL E. coli XL10-Gold insoluble 
fraction; Lane 4, pQE60PA-IIL E. coli BL21 (DE3) soluble fraction: Lane 5, pQE60PA-IIL E. coli BL21 
(DE3) insoluble fraction: Lane 6, pQE60PA-IIL E. coli JM109 soluble fraction; Lane 8, pQE60PA-IIL E. 
coli JM109 insoluble fraction; Lane 9, pQE60PA-IIL E. coli XL1-Blue soluble fraction; Lane 10, 
pQE60PA-IIL E. coli XL1-Blue insoluble fraction.  
 
 
The high expressing untagged PA-IIL candidate clone from E. coli XL10 Gold was then 
expressed at 100ml using the optimised expression conditions established for 
QE30.PAIIL expression (Section 3.6.2). 
 
3.8.1.1 Purification of recombinant untagged PA-IIL 
The lectin PA-IIL was originally purified using mannose agarose (Gilboa-Garber 1982). 
This method exploited the proteins natural affinity for the carbohydrate D-mannose to 
separate it from other proteins present in the cytoplasm of P. aeruginosa. This technique 
(see Section 2.17) was carried out on the cell extract of a 100 ml culture of E. coli 
expressing the lectin from the pQE60.PAIIL plasmid (Section 3.3). Figure 3.55 shows 
the SDS-PAGE analysis of the successful purification of untagged PA-IIL over 
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Figure 3.55: Purification of untagged Pa-IIL by affinity chromatography using mannose agarose. 
Analysis by 15% SDS-PAGE, silver stained, of recombinant untagged PA-IIL purification by affinity 
chromatography using mannose agarose (Section 2.17). Lane 1, Molecular weight marker; Lane 2, 
Cleared lysate; Lane 3, flow-through; Lane 4-11 potassium phosphate wash 1 - 6; Lane 12, Mr Ladder ; 
Lane 13-15, potassium phosphate wash 7-10; Lane 16-20, 0.3M elution fraction 1-5. 
 
3.8.2 Expression of recombinant PA-IIL in E. coli from pQEStrep construct 
The effect of the E. coli strain and the effect of individual clonal selection on the 
expression of StrepII tagged PA-IIL was investigated by the colony blot method 
(Section 2.15.2). A high expressing candidate clone from each strain of E. coli was 
picked (see Figure 3.56A). 10ml expression cultures of each clone chosen were grown 
in LBamp broth containing 50µM IPTG at 37oC overnight. Figure 3.56B shows the 
SDS-PAGE analysis of the soluble and insoluble fractions of PA-IIL expression from 
each E .coli strain. Clear bands corresponding to an over expressed protein could be 
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Figure 3.56: Colony selection of StrepII tagged PA-IIL from pQEStrepII.PAIIL from E. coli 
[A] Lane 1 and 2, pQE30.StrepPA-IIL E. coli XL10-Gold; Lane 3, pQE30.Strep E. coli XL10-Gold; Lane 
4 and 5, pQE30.Strep PA-IIL E. coli BL21 (DE3): Lane 6, pQE30.Strep E. coli BL21 (DE3): Lane 7 and 
8, pQE30.StrepPA-IIL E. coli JM109; Lane 9, pQE30.Strep E. coli JM109; Lane 10 and 11, 
pQE30.StrepPA-IIL E. coli XL1-Blue; Lane 12, pQE30.Strep E. coli XL1-Blue. [B] Lane 1, Mr (sizes as 
in Figure 2.8); Lane 2, pQE30.StrepPA-IIL E. coli XL10-Gold soluble fraction; Lane 3, pQE30.StrepPA-
IIL E. coli XL10-Gold insoluble fraction; Lane 4, pQE30.StrepPA-IIL E. coli BL21 (DE3) soluble 
fraction: Lane 5, pQE30.StrepPA-IIL E. coli BL21 (DE3) insoluble fraction: Lane 6, pQE30.StrepPA-IIL 
E. coli JM109 soluble fraction; Lane 8, pQE30.StrepPA-IIL E. coli JM109 insoluble fraction; Lane 9, 
pQE30.StrepPA-IIL E. coli XL1-Blue soluble fraction; Lane 10, pQE30.StrepPA-IIL E. coli XL1-Blue 
insoluble fraction.  
 
The high expressing StrepII tagged PA-IIL candidate clone from E. coli XL10 Gold was 
then expressed at 100 ml using the optimised expression conditions established for 
QE30.PAIIL expression (Section 3.6.2). 
 
3.8.2.1 Purification of StrepII recombinantly tagged PA-IIL 
StrepTrap HP columns (GE Healthcare) are pre-packed StrepTactin sepahrsoe columns 
that facilitate one-step-purification of StrepII tagged proteins. StrepII tagged PA-IIL 
was purified over a StrepTrap HP column as outlined in Section 2.18. Figure 3.57 
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Figure 3.57: Purification of StrepII tagged PA-IIL by affinity chromatography 
Analysis by 15% SDS-PAGE Silver stained (Section 2.24) of recombinant StrepII tagged PA-IIL, 
purification over StrepTrap™ HP column (Section 2.18). Lane 1, Mr Ladder (sizes given in Figure 2.8); 
Lane 2, Cleared lysate; Lane 3, filtered clear lysate; Lane 4, flow-through; Lane 5-10 potassium 
phosphate wash 1 - 6; Lane 11, Mr Ladder ; Lane 12-15,  wash 7-10; Lane 16-18, 2.5mM desthiobiotin 
elution fraction 1-3. 
 
3.8.3 Expression and purification of pQE30PAIILMu1 
The expression plasmid pQE30.PAIIL was site-specifically mutated (Section 3.4.5) to 
create the pQE30.PAIIL.MU plasmid. Figure 3.58 shows the expression and 
purification of the mutated PA-IIL using the expression and purification procedures 















Figure 3.58: Purification of PA-IIL mutant from pQE30PAIILMU by affinity chromatography 
using IMAC 
Analysis by 20% SDS-PAGE, silver stained (Section 2.24), of recombinant 6HIS N-tagged PA-IILMU 
purification using IMAC (Section 2.16.1). Lane 1, Mr Ladder (sizes given in Figure 2.8); Lane 2, Cleared 
lysate; Lane 3, flow-through; Lane 4, 30mM imidazole wash 1; Lane 5, 30mM imidazole wash 2; Lane 6 
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3.8.4 Activity of recombinant PA-IIL from pQE constructs. 
The impact of the addition of each tag to PA-IIL was investigated using the semi-
quantitative HRP assay (Section 2.26). The assay is based on the ability of PA-IIL to 
sugar specifically bind to mannose bearing HRP. To ensure any signal obtained was due 
to sugar specific activity 0.3 M fucose was added to competitively inhibit PA-IIL 
binding, therefore quenching any signal produced by specific protein-carbohydrate 













Figure 3.59: Activity of recombinantly tagged PA-IIL 
HRP assay carried out as per Section 2.26. PBS used in place of PA-IIL as a negative control (blue). A 
concentration of 10 µg/ml of PA-IIL used per reaction. The activity was measured at OD415. (Error bars 
represent mean ± SD, n = 3). 
 
The variation of the activity between the alternatively tagged PA-IIL may be due to 
inaccuracies in calculating protein concentration due to the precipitation of the protein 
(as discussed in Section 3.9). The HRP assay indicates that all expressed recombinant 
PA-IIL was active and the activity was due to sugar specific binding.  
 
3.9 Protein stability of recombinant PA-IIL 
PA-IIL was found to precipitate in solution after a short period of time when highly 
purified and stored at both 4oC and -20oC. A number of additives were investigated to 
improve the stability of PA-IIL in solution.  
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3.9.1 Effect of the addition of a 6HIS tag to PA-IIL on protein stability 
The addition of a 6HIS recombinant tag may be contributing to PA-IIL precipitation. 
The addition of a tag with a hydrophilic nature such as 6HIS may mediate protein-
protein interaction leading to precipitation. To ascertain if this is what was occurring 
untagged PA-IIL was expressed and purified (Section 3.8.2, Figure 3.57). Untagged PA-
IIL was found to precipitate when purified and stored at 4oC and -20oC. Precipitation of 
PA-IIL was therefore attributed to be the inherent nature of protein. 
 
3.9.2 Use of stabilizing additives 
Additives are commonly used to stabilize protein during storage, e.g. BSA, glycerol, 
Triton X etc. A preliminary stabilisation study was carried out to investigate the effect 
of a variety of additives on the stability of PA-IIL in solution. 6HIS N-tagged PA-IIL 
was expressed and purified (Figure 3.52). Protein was aliquoted 500 µl per epindorf at 
low concentration (50 – 100 µg/ml) and stored at 4oC. Samples were spun down daily at 
13,000 rpm for 10 min and the presence of visible precipitate pellet noted. The additives 
investigated included, Triton X, KCl, Polyethylene glycol (PEG), BSA, glycerol and 
ethanol at various concentrations. Two additives were found to stabilize PA-IIL for 14 
days and prevent visible precipitation; 40 % glycerol and 1 % ethanol. After 14 days, 
protein storage at 4oC is not recommended.  The confirmation of proteins have been 
found to be stabilized and preferentially hydrated in a glycerol solvent system  (Gekkot, 
Timasheff 1981).The addition of a relatively high concentration of glycerol to PA-IIL 
leads to a high viscosity solution. A highly viscose solution may be problematic in 
future lectin characterisation work e.g. use in ELLA would require increased 
development times etc. Ethanol like glycerol is used as a cryoprotectant for proteins. It 
is preferentially excluded from the surface of proteins while serving to prevent stress 
from denaturing the protein. However, addition of ethanol can create a harsh 
environment and lead to denaturation of protein. PA-IIL has been shown to be a robust 
protein, tolerating temperatures up to 80oC (Gilboa-Garber 1982) as well as extreme pH 
values of 4.5 -11.5 (Tielker 2006). It is unknown wheather homologs of PA-IIL will 
retain its robust nature therefore 1% ethanol was deemed an inappropriate stability 
additive for future work. 
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3.10 Storage conditions 
Both additives identified in Section 3.9, 40% glycerol and 1% ethanol, as the most 
effective stabilization agents for PA-IIL have inherent problems with use. 
Lyophilization, whereby a frozen liquid is vacuum dried to a powder, was identified as a 
possible method of long term storage of PA-IIL. Water is removed from protein by 
freeze drying, therefore removing the proteins ability to precipitate. 
 
Figure 3.60: Histogram of the effect of lyophilization on activity of PA-IIL. 
HRP assay carried out as per Section 2.26. PBS used in place of PA-IIL as a negative control (blue). 10 
µg/ml of 6HIS N-tagged PA-IIL used per well. Lyophilised PA-IIL – blue, untreated PA-IIL – purple. 
(Error bars represent mean ± SD, n = 3). 
 
 
PA-IIL was expressed and purified as outlined in Section 2.15. The purified protein was 
split and half of the sample was aliquoted in 250µL to sterile microcentrifuge tubes and 
lyophilized as outlined in Section 2.21. The effect of lyophilization on the activity of 
PA-IIL was assessed by HRP assay (Section 2.26). There was no significant variation in 
the activity of PA-IIL which was lyophilised and that which was not (Figure 3.60). 
Lyophilization was used subsequently as a storage method for purified PA-IIL. 
3.11 Discussion 
To ensure a high quantity of purified PA-IIL could be produced, as would be required 
for analytical methods such as mass spectrometry and chromatography, PA-IIL 
expression was extensively optimised. Despite some variation on the amino acid level 
(Figure 1.13) it was hoped that the expression conditions in the E .coli expression 
system for PA-IIL would be suitable for the expression of the lectin region of the 
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Photopexins of P. luminescens (see Chapter 4). PA-IIL has previously been expressed in 
E. coli (Loris et al. 2003). This was repeated in Section 3.4, with the inclusion of 6HIS 
to the N and C-terminus of the lectin by the cloning of the PA-IIL gene into the 
pPAIIL3 and pQE30.PAIIL expression plasmids. The affect of 6HIS fusion to both the 
N and C terminus of the PA-IIL gene on lectin activity and structure was investigated 
(Section 3.5). C-terminally tagged PA-IIL was found, by HRP assay, to have poor 
activity (Figure 3.41). The loss of activity correlates with data from PA-IIL 
crystallography studies (Mitchell et al. 2002). It was found that the C-terminal amino 
acid (Gly114) plays a role in the binding pocket of the neighbouring subunit in the 
tetrameric PA-IIL structure (Figure 1.2). Addition of histidine peptides to the C-
terminal glycine disrupts the activity within the binding pocket, impairing the lectins 
ability to bind. The addition of 6HIS to the C-terminus was also found to disrupt the 
tetrameric structure of the lectin. The molecular weight of C-tagged PA-IIL, as 
determined by size exclusion chromatography (Section 3.5.3) was found to be 27kDa 
















Figure 3.61: Three possible dimer formations of C-terminally 6HIS tagged PA-IIL.  
(I) Tetrameric structure of the PA-IIL-fucose complex (Mitchell et al. 2002), each monomer shown in a 
different colour. Stick representation of fucose (red) and two calcium ions shown as pink spheres. Each 
monomer is labelled A, B, C and D according to the nomenclature used in the text. (II) Formation of A-B 
PA-IIL dimer; (II) Formation of A-C dimer; (IV) Formation of A-D dimer. Images generated using 
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Loris, R. et al. (2003) discerned the interfaces within the PA-IIL tetramer. Interactions 
between A-B were found to be hydrophobic, A-D interaction hydrophilic in nature 
while the A-C interface has limited contact between hydrophilic side chains. This 
implies that dimer formation of A-B or A-D is more likely due to stronger bond 
formation then those found for A-C. Size exclusion chromatography cannot determine 
the exact dimer formation. Further work, such as mass spectrometry or density gradient 
ultracentrifugation (Cole, Hansen 1999) would be required to determine this (not done 
in this study). N-terminally 6HIS tagged PA-IIL was found to be active, i.e. addition of 
6HIS to the N-terminus did not affect binding activity (Figure 3.41). The relative 
molecular mass (by SEC) of 6HIS PA-IIL was found to be below the predicted MW of a 
tetramer. However, it is not unusual for a small compact protein, such as PA-IIL, to 
diffuse at a slower rate through a size exclusion chromatography column then the 
globular standards used to establish the linear curve (Dubin, Principi 1989). The N-
tagged PA-IIL was therefore assumed to be a tetramer, i.e. addition of 6HIS to the N-
terminus of PA-IIL did not disrupt the quaternary structure of the protein. 
Having successful active expression of PA-IIL in E. coli from pQE30.PAIIL 
(Section 3.5), the PA-IIL gene was cloned into a number of commercial pQE vectors 
(Qiagen). These are high yield expression plasmids with strong promoter systems. The 
optimal E .coli expression strain for the recombinant expression of PA-IIL was 
determined from four commonly used E. coli strains, BL21 (DE3), XL10-Gold, JM109 
and XL1-Blue. Freshly transformed colonies can posses highly varying expression rates 
of soluble protein. The colony blot method (see Section 2.15.2) was utilised to 
distinguish between freshly transformed clones of pQE30.PAIIL in each of the E. coli 
strains that have high protein expression rates. Figure 3.44 shows the dot blot of the four 
E. coli strains and variation of expression between the clones. XL10-Gold was found to 
have consistent levels of expression, while expression varied greatly for the remaining 
strains. This experiment has its limitations as it does not distinguish between soluble 
and insoluble proteins.  
Further optimisation was carried out on E. coli XL10-Gold and BL21 (DE3) as 
these strains are the more commonly used expression strains. The optimal expression 
temperature and harvest time for fermentation from both of these strains was 
investigated. Expression of PA-IIL overnight from BL21 (DE3) at 37oC found a 
decrease in protein yield. Protein also failed to be expressed when cultures were grown 
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at 30oC, regardless of E. coli expression strain. It is possible that expression at high 
levels of PA-IIL leads to aggregation of the protein within the cytoplasm. PA-IIL was 
found to inherently precipitate when purified (see Section 3.9) and therefore it is not 
unlikely that protein may also aggregate during expression. The BL21 (DE3) strain is 
known to be a leaky expressor as it does not contain the lacIq mutation, which results in 
the overproduction of the Lac reporter gene. Consequently expression from BL21 (DE3) 
can occur without the addition of the repressor binding molecule IPTG (see Figure 3.46 
A and B Lane 2). The leaky expression from BL21 (DE3) may contribute to prolong 
expression of PA-IIL leading to high levels of protein and ultimately aggregation and 
reduced soluble protein yield, as found for overnight expression from BL21 (DE3) at 
37oC. The optimal E. coli expression strain for PA-IIL was therefore determined to be 
XL10-Gold as XL10-Gold contains F factors carrying the lacIq allele conferring greater 
control of protein expression. Strong control of protein expression by XL10-Gold led to 
consistent protein expression (Figure 3.44) at yields suitable for future work while 
preventing excess protein production leading to aggregation and loss of protein.  
SDS-PAGE analysis of the high expression clones identified found the insoluble 
fractions of these cultures showed a significant quantity of PA-IIL present (Figure 3.45). 
This may be due to the degradation of the protein, improper folding, or protein 
aggregation. Attempts to recover PA-IIL from the insoluble fraction by L-arginine had 
no greater effect on the levels of protein recovered from the insoluble fraction than lysis 
buffer (Figure 3.49) therefore this is not a suitable method to recover PA-IIL from the 
insoluble fraction. A sufficient quantity of PA-IIL was expressed to the soluble fraction 
for protein characterisation; therefore no further attempts were made to solublise PA-IIL 
from the insoluble fraction.  
Induction by IPTG was routinely done at 50µM concentration once the OD600nm 
reached 0.5-0.6. The effect of induction with varying levels of IPTG was investigated 
by SDS-PAGE analysis. It was concluded that increasing the IPTG concentration did 
not result in increase yields of recombinant protein being expressed in the soluble 
fraction (Figure 3.50). 
Once the optimal conditions of recombinant protein expression were evaluated, 
a purification strategy was investigated to maximise the recovery of recombinant 
protein from the soluble cell extract while maintaining a high level of purity. IMAC 
purification strategies were employed for the purification of 6HIS tagged lectins. PA-
IIL remained bound to the column in washes up to 50mM imidazole and the final 
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protein was eluted with 350mM imidazole. The high level of purity obtained by using 
IMAC can be seen by the highly sensitive silver stain SDS-PAGE gel, where no 
impurities were detected (see Figure 3.52). The sugar binding ability of PA-IIL was 
exploited for the purification of untagged PA-IIL from E. coli cell extract by affinity 
chromatography. PA-IIL, as expected, bound to mannose agarose and PA-IIL of high 
purity was then eluted with mannose (see Figure 3.55). PA-IIL was also purified by the 
affinity tag StrepII. StrepII tagged PA-IIL was bound to Streptacin sepharose and was 
then eluted by desthiotiotin. The high level of purity obtained by StrepII tag purification 
can be seen in Figure 3.57. The semi-quantitative HRP assay found all purified PA-IIL 
to be active. 
PA-IIL was found to aggregate in a purified state (also noted by Gilbo-Garver, 
N. (1982)). Aggregation was found for wild type untagged PA-IIL, indicating that the 
inclination of PA-IIL to aggregate is an inherent property of the protein and is not 
induced or promoted by the addition of a recombinant tag. A number of combined 
factors may lead to precipitation such as slight changes in temperature, pH, ionic 
strength, protein concentration and hydrophobic and hydrophilic residues on the protein 
surface (Wang 2005). It is generally recommended to work at low ionic strength in 
order to prevent ‘salting’ out of protein and at low concentration of protein as the higher 
the concentration the faster the precipitation. There are a number of known additives 
and methods for improving protein stability and storage although there are tradeoffs 
associated with each method. Examples of these would include; Cryoprotectants such as 
glycerol used to a final concentration of 25-50% are often found to aid stabilization of 
proteins (Gekkot, Timasheff 1981) but may lead to highly viscose solutions.  Dilute 
protein solutions (< 1 mg/ml) are more prone to inactivation and loss of acitivity as a 
result of low-level binding to the storage vessel. Therefore, it is common practice to add 
‘carrier’ or ‘filler’ protein, such as purified bovine serum albumin (BSA), to supplement 
protein solutions to protect against such loss. Polyethylene glycol (PEG) is a chemical 
compound composed of repeating ethylene glycol units. It is commonly available 
commercially as mixtures of different oligomere sizes in broadly or narrowly defined 
molecular weight ranges. PEG is hydrophilic in nature and attachment of PEG to 
proteins decreases aggregation and increases solubility. Detergents (such as Triton X-
100 or Tween20) may also prevent aggregation but often bind strongly to hydrophobic 
proteins. Suitable storage conditions to enhance the stability of PA-IIL in solution were 
investigated. The pH of each solution was kept at pH 7.8 as it is the required pH for 
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future steps with the protein. The detergents Triton X and Tween 20 were also used as 
they too are compatible with future characterization experiments, e.g. ELLAs. A crude 
precipitation study carried out at room temperature with a wide variety of additives 
commonly used for protein storage found that 40% glycerol and 1% ethanol prevented 
the visible appearance of precipitation for the longest period of time. Although both 
glycerol and ethanol stabilize the protein neither are compatible for further 
characterization steps. It is important to note that the addition of a relatively high 
concentration of glycerol will lead to a high viscosity solution. High viscosity may lead 
to problems in use for ELLA assay, e.g. require extra mixing or extended reaction times 
etc., and may be problematic in future surface immobilization strategies. The addition of 
ethanol is considered unsuitable as a generic additive as although the stability of PA-IIL 
is enhanced by the addition of ethanol, PA-IIL has been shown to be a robust protein, 
tolerating temperatures up to 80oC (Gilboa-Garber 1982) as well as extreme pH values 
of 4.5 -11.5 (Tielker 2006). It is unknown wheather homologs of PA-IIL can tolerate the 
presence of ethanol, therefore it was considered an unsuitable additive. 
Lyophilization allows for long-term storage of protein with little threat of 
degradation but the protein must be reconstituted before use and may be damaged by the 
lyophilization process. Activity of lyophilized PA-IIL was not greatly affected by 
lyophilization and reconstituted as determined by the HRP assay (Figure 3.60). This 
method was subsequently used for all protein storage. 
 







4.0 Cloning, expression, purification of 
recombinant Photopexins A and B 
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4.1 Overview 
Two homologs to PA-IIL have been identified in the insect pathogenic bacterium P. 
luminescens (Crennell 2000) as discussed in Section 1.6. The first homolog identified, 
Photopexin A (ppxA), is composed of two 220 amino acid homologous domains and a 
100 amino acid C-terminal domain that has a 58% similarity to PA-IIL (Table 1.3). The 
second homolog identified, Photopexin B (ppxB), is homologous to two domains of 
ppxA, i.e consists of one repeating domain and a 100 amino acid C-terminal domain 
that has a 58% similarity to PA-IIL (Table 1.3). The calcium binding loop is highly 
conserved between Photopexin A and B and PA-IIL. The amino acids involved in 
monosaccharide binding differ across the three proteins (Figure 4.1 and 4.9). From the 
protein alignments it was hypothesised that the homologs found within P. luminescens 
may have differing sugar specificities to both PA-IIL and each other. This hypothesis 
was investigated by the cloning and expression of the C-terminal lectin-like domain of 
Photopexin A (ppxA/L) and the C-terminal lectin-like domain of Photopexin B 
(ppxB/L).   
4.2 Cloning of the P. luminescens lectin region of Photopexin 
A   
The optimal expression and purification protcols of PA-IIL in E. coli were established 
as discussed in Chapter 3. Protein sequence alignment identified the C-terminal domain 
of ppxA as having significant similarity to PA-IIL (see Section 1.6, Figure 4.1). While 
the amino acids involved in calcium binding are conserved across the proteins, those 
involved in sugar binding vary (Figure 4.1). The impact of this variation in the sugar 
binding loop was investigated by cloning of the lectin region of Photopexin A 
(ppxA/L). The significant sequence similarity between PA-IIL and ppxA/L suggested 
that ppxA/L could be cloned, expressed and purified under similar conditions as PA-IIL. 
The cloning and expression of ppxA/L under the optimised conditions for PA-IIL is 
discussed in the following section.  
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Figure 4.1: Amino acid alignment of PA-IIL and Photopexin A (ppxA) from P. luminescens.  
Amino acids involved in monosaccharide binding highlighted in red and amino acids involved in calcium 
binding highlighted in green. Image generated using ClustalW align and Genedoc. Identical residues 
highlighted in black and similar in grey. 
 
Optimal cloning and expression of PA-IIL was carried out using the Qiagen pQE 
expression vector pQE30. The pQE30 vector was therefore utilised for the cloning of 
ppxA/L. The pQE-30 vector (Table 2.3, Figure 2.4) features the T5 promoter/lac 
operator element and the β-lactamases gene conferring resistance to ampicillin (ampR). 
The pQE30 vector facilitates the expression of a fusion protein having an N-terminal 
6HIS tag. The Photopexin A protein can be viewed as a 450 amino acid N-terminal 
protein fused to a smaller 114 amino acid C-terminal lectin. Since the C-terminal lectin 
can tolerate this large N-terminal fusion the addition of a 6HIS tag to the N-terminus of 
the lectin domain should not greatly affect the lectin activity. 
Figure 4.2: The multiple cloning site (MCS) of the pQE30 vector.  
Schematic outlining the positions of the relevant restriction sites, 6HIS tag and start and stop codons 
found within the MCS of the expression vector pQE30. 
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The P. luminescens TTO1 strain was provided by Dr. David Clarke, UCC, and the 
sequence for the organism was obtained from the NCBI data bank, data entry no. 
NC_005126, (Duchaud et al. 2003). The primers ppxA/L-f and ppxA-r were designed 
for the amplification of the lectin region of the ppxA gene as a BamHI-HindIII 348 b.p 
fragment by PCR. The primed region of the ppxA gene for which the primers were 
designed is shown in Figures 4.3 and 4.4. 
 
 
Figure 4.3 Primers used for the amplification of the lectin region of the Photopexin A (ppxA/L) from 
P. luminescens TTO1 for cloning into the pQE30 vector.  
The enzymatic restriction sites added to the ppxA/L gene are shown underlined and labelled. Mutated 
nucleotides for the addition of a start codon are highlighted in red. 
 
 
Figure 4.4: Primed region of ppxA/L sequence from P. luminescens TTO1 for suitable amplification 
for cloning into the pQE30 vector. The stop codon of ppxA/L is highlighted in blue. The bases mutated 
by the primer for the introduction of a start codon is highlighted in red. 
 
Genomic DNA was prepared from P. luminescens and used as template DNA for the 
amplification of the ppxA/L gene. The conditions used for the PCR are shown in Table 
4.1 below. The PCR was carried out with the high fidelity Taq polymerase, PhusionTaq. 
 
Table 4.1: PCR conditions for the amplification of the ppxA/L gene for cloning to the pQE30 vector. 
Primers ppxA/L-f and ppxA-r used for amplification as described above. 
 
PCR Condition 
Annealing Temp. 50oC 
Annealing Time 20 sec 
 Extension Time 30 sec 
No. of Cycles 50 
 
The PCR product was cleaned using Gel/PCR DNA fragment extraction kit. Both the 
cleaned PCR product and the pQE30 vector were digested with BamHI/HindIII and the 
restricted products cleaned (Figure 4.5).  










Figure 4.5: Schematic of BamHI/HindIII restricted PCR product amplified by ppxA/L-f and ppxA-
r and schematic of the MCS of the pQE30 vector restricted by BamHI/HindIII.  
The point of restriction is indicated by a black line and break in the sequence. 
 
The linearised pQE30 plasmid DNA was ligated with the purified ppxA/L BamHI-
HindIII fragment. The ligated DNA was transformed to E. coli JM109 and the 
transformation was plated on LBamp media (as outlined in Section 2.9.3). Candidate 
clones were selected, the plasmid DNA was isolated and then analysed by restriction 
analysis. Clones were screened by performing BamHI, HindIII and BamHI/HindIII 
double digests on plasmid DNA prepared from each clone. The restriction digests were 
visualised on 0.7% agarose gels. Screening in this manner resulted in the identification 
of the desired plasmid named pQE30.ppxA/L. Figure 4.6 below shows the results of the 
verifying restriction analysis on the plasmid. 
 
Lane  Sample 
1 1Kb Ladder 
2 pQE30.ppxA/L uncut  
3 pQE30. ppxA/L cut BamHI 
4 pQE30. ppxA/L cut HindIII 
5 pQE30.ppxA/L cut 
BamHI/HindIII 
 
Figure 4.6: Analysis and restriction of 
pQE30.ppxA/L. 
The restriction digest of the pQE30.ppxA/L 
clone analysed on a 0.7% agarose gel 
(Section 2.7) showed that single restriction 
with either BamHI and HindIII produced a 
band corresponding to the expected (~3800 
b.p) linearised plasmid. Double restriction with BamHI/HindIII excised a band of ~350 b.p resulting in a 
visible band shift lower of the plasmid which is indicative of the presence of the ppxA/L fragment. 
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The presence of the correct insert within the pQE30.ppxA/L vector (Figure 4.7) was 
further confirmed by DNA sequencing. Translation of protein from this expression 
vector results in N-terminal 6HIS tagged ppxA/L. 
 
Figure 4.7: Schematic of pQE30.ppxA/L plasmid.  
The emphasised region of the pQE30.ppxA/L vector outlines the relative positions of the ppxA/L gene, 
the relevant restriction sites, start and stop codon and 6HIS. Image generated using BVtech. 
 
Three nucleotides were found to differ between the sequenced pQE30.ppxA/L clone, 
(confirmed in both forward and reverse reads) and the sequence obtained for ppxA from 
Genebank (Figure 4.8).  
 
Figure 4.8: Alignment of nucleotide sequence of pQe30.ppxA/L and ppxA sequence obtained from 
GeneBank.  
Start and stop codons highlighted in orange, 6HIS codon highlighted in green. Variation in nucleotide 
bases highlighted in red. 
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The variation of nucleotides resulted in a silent mutation of a serine (S) to threonine (T), 
a threonine (T) codon for an alternative threonine (T) codon and a glutamic acid (E) to 
an aspartic acid (D) (Figure 4.9). The variation between the sequence obtained from 
Genebank and the sequence from pQE30.ppxA/L may be due to single-nucleotide 
polymorphism (SNP). A SNP denotes a single nucleotide change in a genome that 
differs between members of a species. SNPs have been more widely associated with 
human disorders (Hirschhorn et al. 2002). SNPs do not always impact the activity of a 
protein although a variety of SNPS have been discovered that enhance the pathogenicity 
of bacteria highlighting the need to study SNP of bacteria (Weissman et al. 2003). The 
SNPs of ppxA/L are located outside the key locations, sugar binding loop and calcium 
binding loop, and due to the similar nature of the nucleotides involved it was theorized 




Figure 4.9: Amino acid alignment of protein sequences of the expected ppxA sequence obtained 
from Genebank and the DNA sequencing reads obtained fro pQE30.ppxA/L. 
Differing amino acid highlighted in red, start codon highlighted in orange, 6HIS tag highlighted in green. 
Image generated using ClustalW align and Genedoc. Identical residues highlighted in black and similar in 
grey. 
 
4.3 Cloning of the P. luminescens lectin region of Photopexin 
B  
Protein sequence alignment identified the C-terminal domain of Photopexin B (ppxB) as 
having significant similarity to PA-IIL (Section 1.6). The amino acids involved in 
calcium binding are conserved across these proteins while those involved in sugar 
binding vary (Figure 4.10). The impact of this variation in the sugar binding loop was 
investigated by cloning of the lectin region of ppxB. The significant sequence similarity 
between PA-IIL and ppxB/L suggest that ppxB/L could be cloned, expressed and 
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purified under the same conditions as PA-IIL. The cloning and expression of ppxB/L 
under the optimised conditions for PA-IIL is discussed in the following sections.  
 
Figure 4.10: Amino acid alignment of PA-IIL and Photopexin B (ppxB) from P. luminescens  
Amino acids involved in monosaccharide binding highlighted in red and amino acids involved in calcium 
binding highlighted in green. Image generated using ClustalW align and Genedoc. Identical residues 
highlighted in black and similar in grey. 
 
4.3.1 Cloning of the lectin region of Photopexin B 
The expression vector pQE-30 was shown to be a suitable vector for cloning of the PA-
IIL gene and the lectin region of the ppxA gene as outlined in Sections 3.2 and 4.2. It 
was therefore chosen for the cloning of the lectin region of the Photopexin B (ppxB/L). 
The pQE30 vector facilitates the translation of a fusion protein having an N-terminal 
6HIS tag. The Photopexin B protein can be viewed as a 227 amino acid N-terminal 
protein fused to a smaller 113 amino acid C-terminal lectin. Since the C-terminal lectin 
can tolerate this large N-terminal fusion the addition of a 6HIS tag to the N-terminus of 
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Figure 4.11: The MCS of the pQE30 vector.  
Schematic outlining the positions of the relevant restriction sites, 6HIS tag and start and stop codons 
found within the MCS of the expression vector pQE30. 
 
The primers ppxB/L-f and ppxB-r were designed for the amplification of the lectin 
region of the ppxB gene as a BamHI- PstI 348 b.p fragment by PCR (as outlined in 
section 2.11.1). The primed region of the ppxB gene for which the primers were 
designed is shown in Figures 4.12 and 4.13. 
 
Figure 4.12: Primers used for the amplification of the ppxB/L gene from P. luminescens TTO1 for 
cloning into the pQE30 vector.   
The enzymatic restriction sites added to the ppxB/L gene are shown underlined and labelled. Mutated 
nucleotide for the addition of a start codon is highlighted in red. 
 
 
Figure 4.13: Primed region of the ppxB/L sequence from P. luminescens TTO1 for suitable 
amplification for cloning into the pQE30 vector. 
The stop codon of ppxB/L is highlighted in blue. The base mutated by the primer for the introduction of a 
start codon is highlighted in red. 
 
Genomic DNA was prepared from P. luminescens and used as template DNA for the 
amplification of the ppxB/L gene.  The conditions used for the PCR are shown in Table 
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Table 4.2: PCR condition for the amplification of the ppxB/L gene for cloning to the pQE30 vector. 
Primers ppxAB/L-f and ppxB-r used for amplification as described above 
 
PCR Condition 
Annealing Temp. 65oC 
Annealing Time 20 sec 
Extension Time 30 sec 
No. of Cycles 50 
 
The PCR product was cleaned using Gel/PCR DNA fragment extraction kit. Both the 
cleaned PCR product and the pQE30 vector were digested with BamHI/PstI and the 












Figure 4.14: Schematic of BamHI/PstI restricted PCR product amplified by ppxB/L-f and ppxB-r 
and schematic of the MCS of the pQE30 vector restricted by BamHI/PstI  
The point of restriction is indicated by a black line and break in the sequence. 
 
The linearised pQE30 plasmid DNA was ligated with the purified ppxB/L BamHI-PstI 
fragment. The ligated DNA was transformed to E. coli JM109 and the transformation 
was plated on LBamp media (as outlined in Section 2.9.3). Candidate clones were 
selected, the plasmid DNA was isolated and then analysed by restriction analysis. 
Clones were screened by performing BamHI, PstI and BamHI/PstI double digests on 
plasmid DNA prepared from each clone. The restriction digests were visualised on 0.7% 
agarose gels. Screening in this manner resulted in the identification of the desired 
plasmid named pQE30.ppxB/L. Figure 4.15 below shows the results of the verifying 
restriction analysis on the plasmid. 
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Lane No. Sample 
1 1Kb Ladder 
2 pQE30.ppxB/L uncut  
3 pQE30.ppxB/L cut BamHI 
4 pQE30.ppxB/L cut PstI 
5 pQE30.ppxB/L cut BamHI/PstI 
 
 
Figure 4.15: Analysis and restriction of the 
pQE30.ppxB/L vector.  
The restriction digest of the pQE30.ppxB/L 
clone analysed on a 0.7% agarose gel (Section 
2.7) showed that single restriction with either 
BamHI and PstI produced a band 
corresponding to the expected (~3800 b.p) 
linearised plasmid. Double restriction with 
BamHI/PstI excised a band of ~350 b.p resulting in a visible band shift lower of the plasmid which is 
indicative of the presence of the ppxB/L fragment within the clone indicating that the cloning of ppxB/L  
to the pQE30 vector was successful.    
 
The presence of the ppxB/L gene within the pQE30 vector resulting in the 
pQE30.ppxB/L plasmid (Figure 4.16) was further confirmed by DNA sequencing. 




Figure 4.16: Schematic of pQE30.ppxB/L plasmid.  
The emphasised region of the pQE30.ppxB/L vector outlines the relative positions of the ppxB/L gene, the 
relevant restriction sites, start and stop codon and 6HIS. Image generated using BVtech. 
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4.3.2 Addition of linker region 
The failure to purify 6HIS tagged proteins by IMAC is commonly attributed to the 
inaccessibility of the tag due to it being buried as a result of protein fold or tightly 
bound via interaction with adjacent residues of the protein surface. The insertion of a 
linker peptide to distance the 6HIS tag from the protein has been shown to be a potential 
solution (Loughran et al. 2006). A linker was therefore introduced into the 
pQE30.ppxB/L vector to aid in protein purification via the 6HIS tag (as discussed in 
Section 4.5). The primers ppxB/L-link.f and ppxB/L-link.r were designed to insert a 
linker into the pQE30.ppxB/L.The primed region of pQE30.ppxB/L vector for which 
the primers were designed is shown in Figures 4.17 and 4.18. 
 
Figure 4.17: Primers used for the insertion of a linker sequence to the pQE30.ppxB/L vector. 
The linker sequence, highlighted in orange, was dived between the forward primer and reverse primer. 




Figure 4.18: Primed region of the pQE30.ppxB/L plasmid for the addition of a linker region to the 
ppxB/L fragment. 
The start codon of the PA-IIL gene is highlighted in blue, the 6HIS is highlighted in green. 
 
Plasmid DNA was prepared from the pQE30.ppxB/L vector and used as template DNA 
for the addition of a linker to 6HIS ppxB/L.  The conditions used for the PCR are shown 
in Table 4.3 below. The use of the high fidelity Taq polymerase, PhusionTaq, and 
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Table 4.3: PCR conditions for the incorporation of a linker to the pQE30.ppxB/L vector. 
The primers ppxB/L-link.f and ppxB/L-linkr.r were used for amplification as described above. Elongated 
extension time enables full vector amplification.  
 
PCR Condition 
Annealing Temp. 65oC 
Annealing Time 20 sec 
Extension Time 2 min 30 sec 
No. of Cycles 50 
 
The PCR product (Figure 4.19) was cleaned using Gel/PCR DNA fragment extraction 
kit. The restriction enzyme DpnI is effective against methylated DNA. Treatment of the 
PCR product with DpnI leads to the cutting of the template pQE30.ppxB/L while the 




Figure 4.19: PCR product amplified by primers ppxB/L-link.f and ppxB/L-link.r, using the 
pQE30.ppxB/L vector DNA as a template.   
Schematic outlines the positions of the ppxB/L gene, the relevant restriction sites, linker region, 6HIS tag 
and start and stop codons found within the MCS of the expression vector pQE30.ppxB/L.link. 
 
Phosphorylation of the primers facilitated ligation of the PCR product to form a plasmid 
which was then called pQE30.ppxB/L.link (Figure 4.20). The ligated DNA was 
transformed to E. coli XL10-Gold and the transformation was plated on LBamp media 
(as outlined in Section 2.9.3). Restriction analysis cannot differentiate between re-
circularised template DNA and pQE30.ppxB/L.link as all restriction sites were 
identical. 
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Figure 4.20: Schematic of the pQE30.ppxB/L.link plasmid 
Emphasised region of the pQE30.ppxB/L.link vector outlines the relative positions of the ppxB/L gene, 
linker region, the relevant restriction sites, StrepII tag, start and stop codon. Image generated using 
BVtech. 
 
DNA sequencing of the pQE30.ppxB/L-link plasmid revealed the linker was 
successfully incorporated into the plasmid. The sequencing also revealed the loss of a 
single nucleotide base (Figure 4.21). The loss of this nucleotide resulted in a frame shift 
and errors in protein translation.  
 
 
Figure 4.21: Sequence alignment of predicted ppxB/L linker sequence from GenBank with 
sequence from pQE30.ppxB/L-linker vector.  
Stop and start codons highlighted in red, 6HIS tag highlighted in yellow and linker sequence highlighted 
in green. Loss of the single nucleotide highlighted in blue.  
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4.3.3 Addition of a single nucleotide to pQE30.ppxB/L.link 
 
Primers, ppxB/L-linkfix-f and ppxB/L-linkfix-r, were designed to correct the loss of the 
nucleotide. The primed region of pQE30.ppxB/L.link vector for which the primers were 
designed is shown in Figures 4.22 and 4.23. 
 
 
Figure 4.22: Primers used for the insertion of a nucleotide base to the pQE30.ppxB/L.link plasmid. 
The additional nucleotide to be inserted is highlighted in red. Phosphorylation of the 5’ terminus of the 
primers facilitates ligation of the PCR product.   
 
Figure 4.23: Primed region of the pQE30.ppxB/L.link construct for the addition of a nucleotide 
base to the ppxB/L.link fragment. 
The region into which the nucleotide was inserted is underlined in red. 
 
Plasmid DNA was prepared from the pQE30.ppxB/L.link vector and used as template 
DNA for the insertion of a nucleotide base to the ppxB/L.link fragment.  The conditions 
used for the PCR are shown in Table 4.4 below. The use of the high fidelity Taq 
polymerase, PhusionTaq, and optimised elongated extension time, enabled full vector 
amplification.   
 
Table 4.4: PCR conditions for the incorporation of a nucleotide to the pQE30.ppxB/L.link vector. 
The primers ppxB/L-linkfix.f and ppxB/L-linkfix.r were used for amplification as described above. 
Elongated extension time enables full vector amplification.  
 
PCR Condition 
Annealing Temp. 65oC 
Annealing Time 20 sec 
Extension Time 2 min 30 sec 
No. of Cycles 50 
 
The PCR product was cleaned using Gel/PCR DNA fragment extraction kit. The PCR 
product was restricted with the DpnI restriction enzyme leading to the cutting of the 
template pQE30.ppxB/L.link while the PCR product remains intact (as outlined in 
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Section 2.12.1). Phosphorylation of the primers facilitated ligation of the PCR product 
to form a plasmid which was then called pQE30.ppxB/L.link. The ligated DNA was 
transformed to E. coli XL10-Gold and the transformation was plated on LBamp media 
(as outlined in Section 2.9.3). Restriction analysis cannot differentiate between re-
circularised template DNA and pQE30.ppxB/L.linkfix as all restriction sites were 
identical. The presence of the correct sequence within the pQE30.ppxB/L.linkfix 
plasmid was confirmed by DNA sequencing. Translation of protein from this expression 
vector results in N-terminal 6HISlinker tagged ppxB/L. 
 
4.4 Expression and purification of Photopexin A lectin region 
 
4.4.1 Effect of E. coli host strain on the recombinant expression and purification of 
ppxA/L 
 
Recombinant 6HIS N-tagged ppxA/L was expressed from the pQE30.ppxA/L plasmid 
from E. coli XL10-Gold using the standard procedures established for the expression 
and purification of 6HIS N-tagged PA-IIL (as outlined in Section 2.15). A 
pQE30.ppxA/L expression culture was prepared and cleared lysate sample was obtained 
as per the methodology described in Section 2.15.1. ppxA/L was purified by IMAC 
purification over Ni-NTA resin (Section 2.16.1). The elution profile of 6HIS N-tagged 
ppxA/L was determined using lysis buffer (Section 2.3) supplemented with increasing 
concentrations of imidazole up to 350 mM imidazole. The resulting profile is shown in 






















Figure 4.24: SDS PAGE analysis of wash optimisation of ppxA/L 
Analysis by 15% SDS-PAGE of recombinant 6HIS N-tagged ppxA/L, expressed from pQE30.ppxA/L 
construct E. coli XL10-Gold, purification using IMAC (Section 2.16.1). Lane 1, Mr (sizes given in Figure 
2.8); Lane 2, Cleared lysate; Lane 3, flow-through; Lane 4, 30mM imidazole wash; Lane 5, 40mM 
imidazole wash; Lane 6, 60mM imidazole wash, Lane 7, 80mM imidazole wash; Lane 8, 100mM 
imidazole wash; Lane 9, 120mM imidazole wash; Lane 10, 160mM imidazole wash; Lane 11, 350mM 
elution buffer. 
 
From the SDS-PAGE analysis ppxA/L was found to remain bound to the column in the 
presence of imidazole washes up to 60 mM. Washing with a 30 mM imidazole was 
found to sufficiently remove all loosely bound proteins. The standardised procedure to 
purify ppxA/L was established as; two 10 ml 30 mM imidazole wash steps followed by 
elution with 5 ml 350 mM imidazole buffer. Relatively low yields of ppxA/L were 
purified from a 100ml culture (~0.2-0.3mg). Expression of ppxA/L in larger scale 
(500ml culture), using lysosome (1mg/ml) for improved lysis, was found to increase 































Figure 4.25: SDS-PAGE analysis of large scale ppxA/L purification. 
Analysis by 15% SDS-PAGE of recombinant 6HIS N-tagged ppxA/L, expressed from pQE30.ppxA/L 
construct E. coli XL10-Gold, purification using IMAC (Section 2.16.1). Lane 1, Mr (sizes given in Figure 
2.8); Lane 2, Cleared lysate; Lane 3, flow-through; Lane 4, 30mM imidazole wash 1; Lane 5, 30mM 
imidazole wash 10; Lane 6, 30mM imidazole wash 20, Lane 7, 30mM imidazole wash 30; Lane 8 - 10, 
350mM imidazole elution buffer. 
 
In both small and large scale, the yield of recombinant ppxA/L was roughly 20% of that 
obtained for recombinant PA-IIL under the same conditions. The pQE30.ppxA/L 
plasmid (Figure 4.15) was transformed into the E. coli strain KRX. KRX (Table 2.1) is 
an E. coli strain deficient in OmpT and OmpP proteases, purportedly allowing a higher 
recovery of heterologous recombinant protein. Protein expression levels in KRX were 
also reported to be as high as levels found for the ‘leaky’ expressor strain BL21 (DE3). 
A number of freshly transformed clones were randomly selected and 10ml expression 
cultures of each clone chosen were grown in LBamp broth containing 50µM IPTG at 
37oC overnight. Figure 4.26 shows the SDS-PAGE analysis of the soluble fractions of 
ppxA/L expression from E. coli KRX. Clear bands corresponding to an over expressed 























Figure 4.26: Expression cultures from the pQE30.pppxA/L plasmid from E. coli KRX.  
Analysis by 15% SDS-PAGE of recombinant 6HIS N-tagged ppxA/L expressed from the pQE30.ppxA/L 
plasmid E. coli KRX. Lane 1, Mr (sizes given in Figure 2.8); Lane 2 -8, Cleared lysate of clone 1-7. 
 
Expression cultures of 100 ml and 500 ml were prepared as described in Section 2.15. 
Cleared lysate samples were obtained from these expression cultures and analyzed by 
SDS-PAGE (Figure 4.27). This analysis found no over expression of protein in the 














Figure 4.27: Expression of recombinant ppxA/L from pQE30.ppxA/L plasmid from E. coli KRX. 
Analysis by 15% SDS-PAGE of recombinant 6HIS N-tagged ppxA/L, expressed from pQE30.ppxA/L 
plasmid E. coli XL10-Gold and KRX. Lane 1, Mr (sizes given in Figure 2.8); Lane 2, Cleared lysate 100 
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Wada, K. et al. (1992) established the codon usage of E. coli from GenBank genetic 
sequence data. Codons that occurred in E. coli with a frequency of <1% were arbitrarily 
defined as rare codons (Table 4.5).  
Table 4.5: Codons used by E. coli at a frequency of <1%. 
The E. coli codon frequency was obtained by Wada, K. et al. (1992). Kane, J.F. (1995) identified a subset 




A study by Kane, J.F. et al. (1995) identified a subset of rare codons whose presence in 
large numbers may lead to transcriptional problems leading to a reduction in quantity 
and quality of protein synthesised. Analysis of the ppxA/L sequence found that the 
protein has a composition of 6% of rare codons found within the subset related to poor 
protein composition (Figure 4.28). Expression of rare codons can be improved by use of 
a host containing a plasmid with the appropriate tRNA. The E. coli strain Rosetta carries 
a plasmid which facilitates rare codon expression. 
 
 
Figure 4.28: E. coli bias relative to the codons of recombinant ppxA/L   
The nucleotide sequence coding for ppxA/L as found for pQE30.ppxA/L. The amino acids corresponding 
to codon with a frequency less then <1% as outlined in Table 4.5, are highlighted in green. The subset of 
codons considered rare in E. coli are highlighted red. 
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The pQE30.ppxA/L plasmid was transformed into the E. coli Rosetta strain (as outlined 
in Section 2.9.3). A number of cultures were prepared and cleared lysate samples were 
obtained by the methodology described in Section 2.15.1. Figure 4.29 shows the SDS-












Figure 4.29: SDS-PAGE analysis of the expression of recombinant ppxA/L from E. coli Rossetta 
strain 
Analysis by 15% SDS-PAGE of recombinant 6HIS N-tagged ppxA/L from the pQE30.ppxA/L plasmid in 
E. coli Rosetta. Lane 1, Mr (sizes given in Figure 2.8); Lane 2 -9, Cleared lysate of clone 1-8. 
 
 
From the results above it was concluded that the use of Rosetta strain E. coli did not 
significantly improve expression of ppxA/L. 
4.4.2 Effect of induction point on the expression of ppxA/L 
Cultures of E. coli XL10-Gold and KRX containing the pQE30.ppxA/L expression 
plasmid were induced (with 50µM IPTG) at various times from OD600 of 0.6 to 1.2 to 
investigate the effect, if any, that time of induction had on expression. Cleared lysate 






















Figure 4.30: Effect of induction time on ppxA/L expression 
Analysis of ppxA/L expression in E. coli XL10-Gold (A) and KRX (B) as outlined in Section 2.24, from 
pQE30.ppxA/L (Figure 4.5) by 15% SDS PAGE. Point of induction monitor by measuring OD at 600nm 
Lane 1, Mr (sizes given in Figure 2.8); Lane 2 OD600 of 0.6; Lane 3, OD600 of 0.8; Lane 4, OD600 of 1.0; 
Lane 5, OD600 of 1.2  
 
Induction of pQE30.ppxA/L cultures after an OD600 0.6 was found not to significantly 
increase the yield of ppxA/L expressed. The standard protocol for the expression and 
purification of recombinant ppxA/L to obtain sufficient quantities for future work was 
established to be largely similar to PA-IIL;  
Expression: Growth of pQE30.ppxA/L E. coli KRX at 37oC to OD600 0.6, 
induction with 50 µM IPTG and expression at 30oC overnight  
Purification: 100ml x 2 cultures, 30 ml 30 mM imidazole wash, elution with 
350 mM imidazole elution buffer.  




































Figure 4.31: SDS analysis of the purification of 6HIS N-tagged ppxA/L by IMAC  
Analysis by 15% SDS-PAGE, silver stained, of recombinant 6HIS N-tagged ppxA/L purification using 
IMAC (Section 2.16.1). Lane 1, Mr Ladder (sizes given in Figure 2.8); Lane 2, Cleared lysate; Lane 3, 
flow-through; Lane 4, 30mM imidazole wash; Lane 5,  350mM imidazole elution . 
 
4.4.3 Biological activity of ppxA/L 
The activity of ppxA/L was determined by ELLA (as outlined in Section 2.27). ppxA/L 
was found to bind to BSA. The binding specificity of ppxA/L is unknown. The lectins 
within the PA-IIL superfamily are predominately fucose or mannose binding lectins. 
Therefore the soluble sugars fucose and mannose were added to competitively inhibit 
the binding activity of ppxA/L to BSA. Both fucose and mannose were found to quench 
the binding activity (Figure 4.32), therefore the binding activity can be said to be sugar 
specific. ppxA/L was also stripped of Ca2+ ions through the addition of the chelating 
agent EDTA resulting in the loss of binding activity. This confirms that ppxA/L has a 
























Figure 4.32: Histogram of ppxA/L activity assessed by ELLA 
ELLA carried out as per Section 2.27. Histogram; PBS used in place of ppxA/L as blank control. 2.5% 
BSA placed in each well and 10 µg/ml of 6HIS N-tagged ppxA/L allowed to react with each well. The 
effect of the removal of the calcium ions from the lectin binding pocket by EDTA on lectin binding to 
BSA was evaluated. Removal of the calcium ion resulted in a loss of binding signal, confirming that Ca+ 
ions are required for binding. The binding signal was also found to be quenched in the presence of 0.5 M 
fucose and mannose. The binding signal was therefore attributed to sugar specific binding. (Error bars 
represent mean ± SD, n = 3). 
 
4.4.4 Protein stability of purified recombinant ppxA/L 
Similar to PA-IIL, ppxA/L was found to precipitate in solution after a short period of 
time when highly purified. For long term storage ppxA/L was lyophilised (see Section 
2.21). For short term storage (> 1 day) ppxA/L was found to be most stable at room 
temperature.  
 
4.5 Expression and purification of Photopexin B lectin region 
Recombinant 6HIS N-tagged ppxB/L was expressed from the pQE30.ppxB/L plasmid 
(Figure 4.16) in the E. coli strain KRX as this strain was found to be the optimal 
expression strain for ppxA/L. A number of freshly transformed clones from 
pQE30.ppxB/L E. coli KRX were randomly picked. 10ml expression cultures of each 
clone chosen were grown in LBamp broth containing 50µM IPTG at 37oC overnight. 
Figure 4.33 shows the SDS-PAGE analysis of the soluble fractions of ppxB/L 
expression from E. coli KRX. A clear band corresponding to an over expressed protein 














Figure 4.33: Expression cultures from pQE30.ppxB/L plasmid from E. coli KRX  
Analysis by 15% SDS-PAGE of recombinant 6HIS N-tagged ppxB/L from the pQE30.ppxB/L plasmid in 
E. coli KRX. Lane 1, Mr (sizes given in Figure 2.8); Lane 2 -9, Cleared lysate of clone 1-8. 
 
A 100ml expression culture of clone 8 was carried out as described in Section 2.15. The 
elution profile for the purification of ppxB/L was investigated with a series of washes 
containing increasing concentrations of imidazole (up to 350mM). The resulting profile 















Figure 4.34: Purification of 6HIS N-tagged ppxB/L by IMAC 
Analysis by 15% SDS-PAGE, of recombinant 6HIS N-tagged ppxB/L purification by IMAC (Section 
2.16.1). Lane 1, Mr Ladder (sizes given in Figure 2.8); Lane 2, Cleared lysate; Lane 3, flow-through; 
Lane 4, 30mM imidazole wash; Lane 5,  40 mM imidazole wash; Lane 6, 60 mM imidazole wash; Lane 
7-8, 350mM imidazole elution 1 and 2. 
 
The elution profile indicates that ppxB/L is not binding to the Ni-NTA resin as all 
protein is seen to be in the flowthrough and wash fractions. In order to make the poly-
his tag more accessible a linker was cloned into the pQE30.ppxB/L plasmid to form the 
ppxB/L 
ppxB/L 
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pQE30.ppxB/L.link plasmid (Figure 4.20). The pQE30.ppxB/L.link vector was 
transformed into the E. coli strain XL10-Gold. A number of clones were expressed and 
cleared lysate samples were obtained from each culture as outlined by the methodology 
described in Section 2.15.1. Figure 4.35 shows the SDS-PAGE analysis of the soluble 
fractions of ppxB/L expression from E. coli XL10-Gold. No clear bands corresponding 

















Figure 4.35: Expression cultures of pQE30.ppxB/L-link from E. coli XL10-Gold  
Analysis by 15% SDS-PAGE of recombinant 6HIS N-tagged ppxB/L expressed from pQE30.ppxB/L.link 
construct E. coli XL10-Gold. Lane 1, Mr (sizes given in Figure 2.8); Lane 2 -9, Cleared lysate of clone 1-
8 
 
A 100ml expression culture of ppxB/L from the pQE30.ppxB/L.link vector was carried 
out and cleared lysate was obtained (Section 2.15) and purified over Ni-NTA resin as 






















Figure 4.36: Purification of recombinant ppxB/L from the pQE30.ppxB/L.link construct  
Analysis by 15% SDS-PAGE, silver stained, of recombinant 6HIS N-tagged ppxB/L-link purification 
using IMAC (Section 2.16.1). Lane 1, Mr Ladder (sizes given in Figure 2.8); Lane 2, Cleared lysate; Lane 
3, flow-through; Lane 4, 30mM imidazole wash; Lane 5-8,  350mM imidazole elution 1-2. 
 
A purified protein band is visible, although yield of protein appears very low, running 
between the 6.5 and 14.2 kDa markers (Figure 4.36) at approximately 8-10 kDa. The 
predicted molecular weight of 6HIS N-tagged ppxB/L is 14,185 Da respectively as 
deduced from the amino acid sequence. The expected protein size and the protein size 
found by SDS-PAGE gel analysis did not correlate. The pQE30.ppxB/L-link vector was 
DNA sequenced to confirm the sequence of the ppxB/L gene. DNA sequencing 
identified a frame shift in the pQE30.ppxB/L.link plasmid leading to the early 
introduction of a stop codon (Figure 4.21). The plasmid pQE30.ppxB/L.linkfix was 
cloned to correct the frame shift (see Section 4.3.3). The pQE30.ppxB/L.linkfix plasmid 
was transformed into the E. coli strains KRX and XL10-Gold (see Section 2.9.3). A 
number of freshly transformed clones of pQE30.ppxB/L.linkfix from each strain of E. 
coli were randomly selected. 10ml expression cultures of each clone chosen were grown 
in LBamp broth containing 50µM IPTG at 37oC overnight. Figure 4.37 shows the SDS-









  - 152 -
Figure 4.37: Expression of pQE30.ppxB/L.linkfix from E. coli strains KRX and XL10-Gold  
Analysis by 15% SDS-PAGE of recombinant 6HIS-linker N-tagged ppxB/L expressed from 
pQE30.ppxB/L.linkfix plasmid from E. coli strain [A] KRX and [B] XL10-Gold. Lane 1, Mr (sizes given 
in Figure 2.8); Lane 2 -11, Cleared lysate of clone 1-10; Lane 12, Mr Ladder 
 
No prominent band indicating the over expression of a protein of expected M.W of 
13.87 kDa was found within the soluble fractions when ppxB/L.link was expressed 
from the pQE30.ppxB/L.linkfix plasmid in either of the E. coli strains KRX or XL10-
Gold. The insoluble fractions of XL10-Gold pQE30.ppxB/L.linkfix cultures were 











Figure 4.38: Expression of recombinant ppxB/L.link from the pQE30.ppxB/L.linkfix E. coli XL10-
Gold insoluble fraction  
Analysis by 15% SDS-PAGE of recombinant 6HIS-link N-tagged ppxB/L expressed from 
pQE30.ppxB/L.linkfix plasmid E. coli strain XL10-Gold, insoluble fraction. Lane 1, Mr (sizes given in 
Figure 2.8); Lane 2 -11, Cleared lysate of clone 1-10; Lane 12, Mr Ladder 
 
No significant quantity of recombinant ppxB/L was found within the insoluble fraction. 
Recombinant ppxB/L-link was expressed from the pQE30.ppxB/L.linkfix plasmid from 
E. coli XL10-Gold using the standard procedures established for the expression and 
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purification of ppxA/L. Expression cultures were prepared as per the methodology 
described in Section 2.15.1. A cleared lysate sample was obtained from the 
pQE30.ppxB/L.linkfix expression culture as outlined in Section 2.15.2. The yields of 












Figure 4.39: Purification of recombinant  ppxB/L.link  by IMAC 
Analysis by 15% SDS-PAGE, silver stained, of recombinant 6HIS N-tagged ppxB/L.link purification 
using IMAC (Section 2.16.1). Lane 1, Mr Ladder (sizes given in Figure 2.8); Lane 2, Cleared lysate; Lane 
3, flow-through; Lane 4, 30mM imidazole wash; Lane 5-8,  350mM imidazole elution 1-2. 
4.6 Physiochemical characterisation of ppxA/L 
To determine the quaternary structure of recombinant 6HIS N-terminally ppxA/L, size 
exclusion chromatography was employed using a manually poured Toyopearl HW-55S 
(Tosoh Biosciences, Germany) and a pre-packed 25ml Superdex™ 75 column (GE 
Healthcare) (as outlined in Section 2.25). Size exclusion chromatography separates 
proteins based on molecules hydrodynamic radius. Proteins of lower relative molecular 
mass are retarded within the porous resin beads and are thus separated from proteins of 
larger relative molecular mass which are excluded from smaller pores. The larger 
proteins pass through the packed column more rapidly than the smaller proteins and 
their exact size can be determined by comparison with a standard curve created using a 
set of known standards.  
4.6.1 Determination of lectin size using a Toyopearl HW-55S column  
Toyopearl HW-55S resin is a column matrix composed of a methyl-methacrylate and 
has no carbohydrate component (such as that found in Sepharose) and is therefore 
suitable for examination of carbohydrate binding molecules such as lectins. An HW55S 
Toyopearl resin size exclusion chromatography column was manually poured. It is not 
ppxB/L 
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uncommon for air-pockets or ineffective packing to occur during this process and as a 
result an additional validation step was carried out. The effectiveness of the packing 
procedure was validated by injecting a 0.5ml 0.1% (v/v) actone sample onto the column 
(Figure 4.40) and the column plate count (N) was then determined.  
 
 
Equation 4.1: Equation to determine theoretical plates (N) for validation of Toyoperal HW-55S 
column. 
 
The values for Ve and V1/2 were measured from the acetone elution profile below and 












Figure 4.40: Determination of the column efficiency of the HW55S Toyopearl column. 
The elution profile of acetone (0.1% w/v) using size exclusion chromatography with Toyopearl HW55S 
column. The OD280nm of eluted acetone is plotted against the elution volume. Void volume (elution 
volume of acetone) was determined to be 111.66ml.  
 
The number of theoretical plates was determined, using the equation outlined in 
Equation 4.1, to be 6962, which was within the operable range (3500 – 10000) for this 
resin (as outlined in the Toyopearl Instruction manual).  The columns performance was 
checked regularly as manually poured columns are susceptible to compaction over time. 
Once validated a standard curve was created using five known standards; bovine serum 
albmin (BSA), ovalbumin, bovine carbonic anhydrase, cytochrome C and myoglobin. 
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The Kav value, determine by equation 3.1, was plotted against the log of the MW of 
each protein to create a standard curve (Figure 4.41). The molecular weight range of the 
standards encompassed the predicted molecular weight of monomeric and tetrameric 
ppxA/L. 
Figure 4.41: Development of size exclusion chromatography standard curve for the Toyopearl 
HW55S column. 
The protein molecular weight standard curve was created using size exclusion chromatography, with the 
Toyopearl HW55S column. Void volume (Vo) of 42.42 ml was determined from the elution volume of 
blue dextran, and total volume (Vt) was 111.66 ml, determined with acetone. The elution volumes of 
protein standards are given in Table 4.5. These values were used to calculate the relative MW of all lectin 
samples that were eluted in this range. The Kav value was calculated using Equation 3.1. 
 
 
Table 4.6: Construction of a protein molecular weight standard curve for the Toyopearl HW55S 










Cytochrome C 74.2 12400 4.09 0.85 11339 8.56 
Myoglobin 70.71 17600 4.25 0.69 20047 -13.90 
Carbonic 
Anhydrase 68.25 29000 4.46 0.60 28353 2.23 
Ovlbumin 64.62 45000 4.65 0.47 44256 1.65 

































Figure 4.42: Elution of protein standards from the Toyopearl HW-55S SEC column  
The elution profiles of standard proteins using size exclusion chromatography with the Toyopearl HW55S 
column shown in black, the elution profile of ppxA/L shown in red. The optical density at OD280nm of 
eluted standard proteins was plotted against the elution volume. The elution volume for each standard 
protein was used in the construction of the stand curve (Figure 4.38).  
 
 
Having successfully created a standard curve for the Toyopearl SEC column, with an R2 
value for the curve of 0.98,  the relatitvie molecular mass of ppxA/L could be estimated. 
The elution profile of purified recombinant ppxA/L over the Toyopearl column 
consisted of two elution peaks, one of which lies outside of the range of the standard 
curve (Figure 4.42).  
 





monomer size (Da) 
Calculated 
MW 
ppxA/L 1st peak 64.24 13,949 46185.3 






Elution volume (ml) 
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To determine if protein-carbohydrate binding was occurring between ppxA/L and the 
column matrix the lectin was applied to the column under normal conditions in the 
presence of the competing sugar, D-mannose, for which ppxA/L is predicted to bind. 




Figure 4.43: The adsorption OD280nm of ppxA/L through the Toyopearl HW-55S column in the 
presence/absence of mannose.  
The elution profile of ppxA/L is highlighted in blue, the profile of ppxA/L in 0.2M D-mannose is 
highlighted in green. Peak maxima are 67.69/61.69 and 86.92/78.31 respectively. 
 
It was found that there was some variation between the elution volumes of ppxA/L in 
mannose replete and deplete conditions (Figure 4.43). The variation between the 
profiles is attributed to some compression of the resin. The column resin was packed 
using PBS. Alteration of the mobile phase, such as the addition of mannose, changes the 
properties of the mobile phase, e.g. viscosity of the buffer, and results in additional 
compression of the resin. Additional compression of the resin leads to a reduced bed 
height and reduced elution times.  The variation of elution profiles therefore is not due 
to the inhibition of the sugar-specific interaction with the column matrix as the presence 
of the two peaks persists. The secondary peak present in the elution profile of ppxA/L 
does not appear to be due to sugar-specific interaction. Toyopearl HW55S was deemed 
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an unsuitable resin for the determination of the molecular weight of ppxA/L as it 
appeared as though the protein was non-specifically interacting with the resin. An 
alternative resin was investigated for suitability of determination of the molecular 
weight of ppxA/L. 
4.6.2 Determination of lectin size using a Superdex™ 75 column 
A second gel filtration matrix was used to examine the protein size of ppxA/L. 
Superdex is composed of a highly cross-linked agarose beads, to which dextran is 
covalently bonded and has no carbohydrate element. The prepacked Superdex™ 75 
10/100 column from GE Healthcare, separates proteins based on their relative size and 
has a globular protein separation range of 3,000 – 70,000 Da. A molecular weight 











Figure 4.44: Development of size exclusion chromatography standard curve for the Superdex 75 
high performance column.  
The protein molecular weight standard curve was created using size exclusion chromatography, with the 
Superdex 75 column. Void volume (Vo) of 7.56 ml was determined from the elution volume of blue 
dextran, and total volume (Vt) was 19.13 ml, determined with acetone. The elution volumes of protein 
standards are given in Table 4.8. These values were used to calculate the relative MW of all lectin 
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Table 4.8: Construction of protein molecular weight standard curve for the Superdex 75 high 









BSA 9.19 66000 4.82 0.14 69132 4.75 
Ovlbumin 10.07 45000 4.65 0.22 45574 1.23 
Carbonic 
Anhydrase 11.26 29000 4.46 0.32 25942 10.54 
Myoglobin 12.08 17600 4.25 0.39 17595 -0.03 




Figure 4.45: Elution of protein standards from the Superdex column 
The elution profiles of standard proteins using size exclusion chromatography with the Superdex column 
shown in black, the elution profile of ppxA/L shown in red. The optical density at OD280nm of eluted 
standard proteins was plotted against the elution volume. The elution volume for each standard protein 
was used in the construction of the stand curve (Figure 4.43).  
 
Having successuflly created a standard curve for the Superdex column (Figure 4.46), the 
relatitvie molecular mass of ppxA/L could be estimated. As outlined in Section 2.25.2, 
100 ul of a freshly purified ppxA/L was buffer exchanged to PBS and was analysed 
under native conditions to ascertain its multimeric structure. The peak heights of the 
elution profiles were converted into relative molecular masses using the standard curve 
created (see Figure 4.47).  
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ppxA/L  12.63(±0.04) 13,949 13,560  0.97 
 
The molecular weight calculated by measuring the average elution volume at which the 
maximum peak height was eluted from four separate runs found ppxA/L to be just 
below the predicted size of a monomer. It is theorized that as the standard curve was 
created using globular proteins it serves as only a rough estimate as to the size of non-
globular shaped proteins, and ppxA/L can therefore be said to be approximately a 
monomer.  
The lectin ppxA/L was found to produce a two peak elution profile representing 
a monomer and a multimer, when the lectin was run over the Superdex column in the 
presence of imidazole (350 mM from the elution buffer). Figure 4.46 shows the elution 
profile of ppxA/L in the presence of imidazole. When ppxA/L was purified and 
analysed by SDS PAGE a multimer band can be seen to be present which run at approx 
55-66 kDa (Figure 4.24). This correlates with the molecular weight determined by size 
exclusion chromatography which was estimated at 63.7 kDa (see Table 4.10). Imidazole 
has been recognized as a potential new additive for the stabilization of proteins and has 
been demonstrated as a suitable catalyze for in vitro re-folding (Shi et al. 2007). 































Figure 4.46: Elution profile of ppxA/L in 350mM imidazole elution buffer (Superdex 75 column 
matrix) 
The two peak elution profile of ppxA/L using SEC with the Superdex 75 column. The optical density of 
OD280nm of the eluted protein plotted against the elution volume.  
 
 











ppxA/L Peak 1 9.8 63,739 13,949 4.57 
ppxA/L Peak 2 12.8 11,221 13,949 0.80 
 
 
The calculated relative molecular masses obtained for both peaks of ppxA/L in the 
presence of imidazole are not accurate but an approximation. They were calculated 
using a standard curve created with a running buffer of PBS. In order to obtain accurate 
results a standard curve created with a running buffer containing imidazole would be 
required. Although the calculated relative molecular masses cannot be said to be exact it 
does imply that ppxA/L is capable of forming multimers.  
4.7 Discussion  
The pQE vectors from Qiagen were found to be suitable expression vectors for the 
expression of PA-IIL. The cloning and optimal expression of PA-IIL was predominately 
carried out using the expression vector pQE30. Therefore ppxA/L was cloned into the 
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pQE30 vector. Sequence confirmation of pQE30.ppxA/L plasmid found three points of 
nucleotide variation between the sequence obtained for pQE30.ppxA/L and the 
GeneBank sequence of ppxA. These single nucleotide polymorphisms (SNP) resulted in 
two amino acid changes within the ppxA/L protein. The third variation alters the codon 
from ACA to ACG, both codons for threonine. These SNP variations in amino acid 
sequence result in a threonine found in place of a seriene and an aspartic acid in place of 
a glutamic acid (Figure 4.8). Serine and threonine are both classified as nucleophilic in 
nature and differ in an additional CH2 group present on threonine. Glutamic acid and 
aspartic acid are both classified as acidic in nature and differ in two additional CH2 
groups on glutamic acid (Figure 4.47). 
 
Figure 4.47: Schematic of amino acid structures found to vary between pQE30.ppxA/L and the 
Genebank ppxA sequence. 
The structures of the amino acids found to vary between the sequence found for pQE30.ppxA/L and the 
sequence obtained for ppxA from GeneBank. 
 
 
The amino acids found to vary were not present within the conserved calcium binding 
loop or the sugar binding loop and the amino acids found within the ppxA/L protein are 
similar in nature to those found within the GeneBank sequence of ppxA (Figure 4.47). It 
is therefore hypothesised that the variation of amino acid would not impact the binding 
activity or structure of ppxA/L to a significant degree. The variation between the 
sequences is likely due to minor genomic sequence variation which have been found in 
both human and bacterial genomes (Hirschhorn et al, 2002, Weissman et al. 2003). 
ppxB/L was also cloned into the pQE30 plasmid. Additional cloning steps were carried 
out to introduce a linker and for the insertion of a nucleotide base to facilitate correct 
expression and purification. The pQE30 vector facilitates the translation of a fusion 
protein having an N-terminal 6HIS tag. The lectin region within ppxA can be viewed as 
a 12.39 kDa protein with a 50.84 kDa protein fused to the N-terminus. The lectin region 
within ppxB can be viewed as a 12.24 kDa protein with a 25.42 kDa protein fused to the 
N-terminus. Therefore the fusion of 6HIS to the N-terminus of ppxA/L and ppxB/L was 
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not expected to affect the binding activity of the lectins.  Despite some variation on the 
amino acid level the optimised conditions for the expression of PA-IIL in the E. coli 
expression system were utilised for the expression of the lectin regions of both ppxA 
and ppxB.  
The pQE30.ppxA/L plasmid was transformed into the E. coli strain, XL10-Gold, 
the optimal expression strain identified for PA-IIL. ppxA/L was found to be expressed 
using this strain under the optimised conditions found for PA-IIL. An IMAC 
purification strategy was investigated to maximise the recovery of recombinant protein 
from the soluble cell extract while maintaining a high level of purity. ppxA/L, like PA-
IIL, was found to stay bound to the column in the presence of 60mM imidazole and 
final protein was eluted with 350mM imidazole. The high level of purity obtained by 
using IMAC can be seen by the highly sensitive silver stain SDS-PAGE gel, where no 
impurities were detected (Figure 4.24). Some multimer formation does appear as a 
larger upper band on this gel. Although ppxA/L could be expressed and purified to a 
high level the yield of protein recovered was significantly lower than yields obtained for 
a similar expression of PA-IIL. To improve the protein yield the pQE30.ppxA/L 
plasmid was transformed to the E. coli strain KRX. KRX is a protease deficient E. coli 
strain with expression levels reported to be as high as levels found for BL21 (DE3). The 
use of E. coli KRX did significantly improve expression of soluble ppxA/L (Figure 
4.27, Lane 3). Attempts to upscale ppxA/L expression to 500 ml resulted in the loss of 
soluble protein (Figure 4.27, Lane 4). Expression of high yields of PA-IIL was found to 
result in a loss of soluble protein, attributed to aggregate formation. ppxA/L, like PA-
IIL was found to inherently precipitate when purified. It was therefore hypothesised that 
the large scale expression of ppxA/L (from 500 ml) lead to high yields of protein 
production resulting in aggregate formation and loss of soluble protein.  
The pQE30.ppxA/L plasmid was also transformed into the E. coli strain Rosetta. 
The frequencies with which different codons appear in genes in E. coli are different 
from those derived from other organisms. The frequency of specific codons is also 
reflected in the amount of specific tRNA, i.e. tRNA which recognizes rarely used 
codons is present in low amounts. Therefore genes that contain codons which are rare in 
E. coli may be inefficiently expressed.  Amino acid sequence analysis of ppxA/L found 
the gene to be composed of 6% rare codons which may effect protein translation. The E. 
coli strain Rosetta carries a plasmid which facilitates rare codon expression. The use of 
Rosetta strain E. coli did not significantly improve expression of ppxA/L (Figure 4.29). 
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The poor protein expression was therefore not attributed to the presence of rare codons 
within ppxA/L. Further optimisation of expression parameters was therefore required.   
The effect of induction time on protein expression was investigated at various 
points from OD600 0.6 to 1.2. The induction of cultures after an OD600 of 0.6 did not 
significantly increase the yield of ppxA/L expressed. Subsequently 100ml E. coli KRX 
expression cultures of ppxA/L were pooled, typically two pooled, for purification to 
recover suitable protein yields for future work. The high level of purity obtained by 
using IMAC purification can be seen by the highly sensitive silver stain SDS-PAGE 
gel, Figure 4.31. ELLA found ppxA/L to be active.  
The pQE30.ppxB/L plasmid was transformed into the E. coli strain, KRX, the 
optimal expression strain identified for ppxA/L. ppxB/L was found to be expressed 
using this strain and under the optimised PA-IIL conditions. When an IMAC 
purification strategy was investigated to maximise the recovery of recombinant protein 
from the soluble cell extract the protein did not bind to the Ni-NTA resin. The structure 
of Photopexin B is as yet unknown. The 6HIS tag may be unavailable due to steric 
hindrance of the protein folding. Addition of a linker may allow the 6HIS tag to become 
more available for binding. A linker was cloned into the pQE30.ppxB/L plasmid 
following the 6HIS tag and prior to the ppxB/L gene. The addition of a linker was found 
to improve binding of ppxB/L to the Ni-NTA resin so that protein could then be 
purified. The IMAC purification strategy established for ppxA/L and PA-IIL was used 
to purify ppxB/L. However, upon purification the molecular weight of the purified 
protein was found to be smaller than predicted. SDS-PAGE gel analysis shows the 
protein running between 6.5 kDA and 14 kDA marker. The predicted molecular weight 
of 6HIS N-tagged ppxB/L was calculated to be 14.2 kDa. Sequence confirmation of the 
clone found a nucleotide base to be missing leading to a frame shift and the premature 
presence of a stop codon. The missing nucleotide base is absent from a string of five A 
bases. Studies have revealed that nucleotide repeats generally contract during PCR 
because of the loss of repeat units (Clarke et al. 2001). The missing nucleotide was 
therefore attributed to an error during PCR. Primers were designed to correct the loss of 
the nucleotide and the resulting clone, pQE30.ppxB/L.linkfix, was confirmed by DNA 
sequencing. Protein expressed and purified over Ni-NTA resin from the 
pQE30.ppxB/L.linkfix plasmid was found to be, approximately, the correct molecular 
weight namely 14.19 kDa predicted from the amino acid sequence. However the yield 
of protein recovered from a 100 ml cell extract was found to be relatively low. Protein 
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was not found to be present in the insoluble fraction indicating that poor protein 
expression was not due to aggregation of protein in the insoluble fraction but due to low 
protein expression. The yield of expressed ppxB/L was insufficient to carry out further 
characterisation studies of the lectin. To improve the protein yield of ppxB/L further 
optimisation such as clonal selection is required. There was not sufficient time during 
the course of this study to carry out this work.  
The relative molecular mass and possible quaternary structure of ppxA/L under 
native conditions was investigated by size exclusion chromatography using two 
columns with differing matrices. Initial size exclusion chromatography was carried out 
using the HW-55S Toyoperal matrix. Noticeable on the HW-55S traces of ppxA/L is the 
presence of two elution peaks, one of which lies outside the size range of the standard 
curve. The second peak was not attributed to contaminants as silver stained gels show 
ppxA/L to be relatively highly purified. Nor was it attributed to a lectin-carbohydrate 
interaction as ppxA/L was found to elute similarly from the column in the presence and 
absence of mannose. Toyopearl HW55S resin was deemed unsuitable for use with 
ppxA/L as presence of two peaks in the elution profile indicated the protein was 
interacting with the resin. An alternative matrix was used to investigate the native 
structure of ppxA/L. A gel filtration study using the Superdex 75 column was carried 
out. In PBS ppxA/L was found as a monomer (Table 4.9). The calculated molecular 
mass of ppxA/L (MW of ~ 13.56kDa) was consistently smaller than the molecular mass 
predicted from the amino acid sequence (MW of ~13.95kDa). It is theorized that as the 
standard curve was created using globular proteins it serves as only a rough estimate as 
to the size of non-globular shaped proteins such as ppxA/L. This feature was also found 
for the PA-IIL run over a Sepadex G-100 column. Of note is the formation of ppxA/L 
multimers in the presence of imidazole. This was also noted in the SDS-PAGE gel 
analysis (Figure 4.24). The fusion of a 50.84 KDa protein to the N-terminus of the lectin 
domain of Photopexin A in its native state suggests that no such multimer formation 
would be possible in nature. It may be theorized that the formation of multimers is an 
evolutionary relic of the protein as other members of the PA-IIL family, e.g. CV-IIL 
and RS-IIL (Sudakevitz et al. 2004), as well as PA-IIL have a native tetrameric 












5.0 Determination of carbohydrate binding 
protein specificity using the Enzyme linked lectin 
assay (ELLA) 
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5.1 Overview 
The PA-IIL and ppxA/L lectins are described in Chapter 3 and 4. Characterisation of 
PA-IIL and ppxA/L with respect to glycan binding specificity was performed using a 
series of specificity analysis experiments. Traditionally, lectins are characterised using a 
hemagglutination inhibition assay, however the ELLA (Section 2.27) is proving a more 
useful method for glycobiologists as it provides more detailed information about both 
lectin specificity and affinity. Preliminary attempts to carry out the hemagglutination 
assay with PA-IIL failed to agglutinate rat erythrocytes. Further work was not carried 
out on this assay due to the lack of access to alternative erythrocytes and the 
unsuitability of the assay for the determination of the specificity of monomeric lectins, 
such as ppxA/L.  
5.2 Enzyme Linked Lectin Assay 
The ELLA is a modified ELISA in which the primary antibody has been replaced by a 
tagged lectin and the protein target is a glycoprotein. The ELLA technique is a simple 
microarray that has been proven to be suitable for the detection of specific carbohydrate 
units, either directly on immobilised glycoproteins or indirectly by inhibition with 
soluble sugars (McCoy, Varani and Goldstein 1983). In this study, the binding 
specificity of the lectins was determined by the ability of a lectin to bind to a set of 
known glycoproteins. The 6HIS affinity tag which was used to purify the protein was 
utilised in the ELLA as a target for a secondary antibody. Alternative purification tags, 
such as StrepII, may also act as targets for antibodies. The principle of a typical ELLA 
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Figure 5.1: Schematic outlining steps involved during ELLA. 
HRP-bound antibody facilitates the detection of binding. The addition of the HRP substrate, tetramethyl 
benzidine (TMB), to the HRP-bound antibody results in a colour change which can be measured.   
 
Background signals and false positives may occur in ELLAs and are due to the non-
specific interaction of reagents with each other, and also to their adherence to residual, 
non-saturated sites on the solid surface of the microwells. Addition of blocking reagents 
offers an efficient strategy for minimizing the non-specific background binding. After 
coating with a specific ligand the blocking agent is added to block any excess solid 
surface to avoid unspecific immobilisation of succeeding reagents. A typical blocking 
agent would be a neutral or inert macromolecule, large enough to establish a stable 
attachment to the surface, yet small enough to find its way between the previously 
bound ligand. Prior to investigating lectin interaction with known glycoproteins a 
number of different blocking agents were investigated to minimize signal-to-noise ratio 
and enable accurate detection of gylcans using lectins.  
5.2.1 Bovine serum albumin (BSA) as a blocking agent 
BSA is a un-glycosylated protein, commonly used as a blocking agent which has been 
shown to be an efficient reagent for saturating the surface of Nunc microwells (Steinitz 
2000).  However, BSA is purified from a complex protein source and therefore may 
contain interfering glycoproteins, such as globulins, causing false positives (Afrough, 
Dwek and Greenwell 2007). When microwells were saturated with 2.5% BSA and 
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probed with 10µg/ml PA-IIL as outlined in Section 2.27, PA-IIL was found to bind to 










Figure 5.2: Comparison of recombinant PA-IIL binding to BSA solutions from differing suplliers  
Comparison of the binding activity of PA-IIL to BSA from two manufactures, Sigma-Aldrich and Fisher, 
both Fraction V purifications of a purity of ≥ 98%. A control, lacking the addition of lectin, was run in 
tandem to the BSA. Assayed by the activity of a HRP-linked secondary antibody (OD415nm). (Error bars 
represent mean ± SD, n = 3). 
 
There was some variation in the binding signal between the two BSA batches. This was 
attributed to a greater efficiency of the purification treatment in one company over the 
other although this may also vary batch to batch. The binding signal of both BSA 
batches was deemed too high for use in an ELLA as the lectin-glycoprotein binding 
signal would be obscured by the lectin-blocking agent binding signal.  
The sugar specificity of PA-IIL was reported to be L-Fuc > D-Man, L-Gal> D-
Fru (Gilboa-Garber 1982). The binding of PA-IIL and ppxA/L to a BSA solution was 
investigated through the addition of soluble sugars, glycoproteins and EDTA during the 
ELLA. Invertase is a yeast glycoprotein glycosylated with a carbohydrate content of 
50% (w/w), composed primarily of high mannose structures. Glucose oxidase is a 
glycoprotein glycosylated with a carbohydrate content of 16% (w/w) of which 80% 
(w/w) is composed of high mannose structures. PA-IIL binding has been shown to be 
dependent on the presence of Ca2+ (Mitchell et al. 2002). ppxA/L binding is 
hypothesised to be dependent on the presence of Ca2+ due to the high conservation of 
the calcium binding loop in ppxA/L.  Stripping the lectins of Ca2+ using EDTA 
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Figure 5.3: Determination of recombinant PA-IIL and ppxA/L binding to 2.5% BSA  
Quantitative detection of lectin bound to BSA assayed by the activity of a HRP-linked secondary 
antibody (OD415nm). The effect of the removal of the calcium ions from the lectin binding pocket by 
EDTA on lectin binding to BSA was evaluated. Loss of signal after treatment with EDTA indicates 
binding is sugar specific. The inhibition of PA-IIL binding signal to BSA by the addition of 0.3M fucose 
and galactose and 2mg/ml of invertase and glucose oxidase confirms that binding activity is sugar 
specific. The inhibition of ppxA/L binding to BSA by the addition of 0.5M fucose and mannose confirms 
that binding activity is sugar specific. (Error bars represent mean ± SD, n = 3). 
 
 
If the binding signal of PA-IIL or ppxA/L to BSA was due to non-specific protein-
protein interaction, treatment of the lectin with EDTA would not be expected to quench 
the binding signal as was observed (Figure 5.3). The degree of quenching of the binding 
signal of PA-IIL as shown in Figure 5.3, by the addition of soluble sugars and 
glycoproteins correlates with the sugar specificity determined by Gilboa-Garber, N. 
(1983). Due to the higher mannose structure content of invertase, it would be expected 
to quench the carbohydrate specific binding signal of PA-IIL more efficiently the 
glucose oxidase. Sugar specificity of ppxA/L is unknown, however the addition of both 
fucose and mannose significantly quenched the binding signal. Therefore PA-IIL and 
ppxA/L are binding to the BSA solution, or a contaminant carbohydrate within the BSA 
solution, due to sugar specific binding. In order to eliminate the problem caused by 
carbohydrate contamination a BSA solution was treated with sodium periodate prior to 


















Figure 5.4: Comparison of the activity of recombinant PA-IIL and ppxA/L with untreated and 
sodium periodate treated 2.5% BSA in ELLA 
Quantitative detection of lectin bound to untreated and sodium periodate treated 2.5% BSA assayed by 
the activity of a HRP-linked secondary antibody (OD450nm). The sodium periodate treatment on lectin 
binding signal was compared. Lectin binding was reduced on treated BSA.  (Error bars represent mean ± 
SD, n = 3). 
 
Treatment of BSA with sodium periodate did reduce the binding signal obtained for PA-
IIL-BSA and ppxA/L-BSA by 30% - 50% (Figure 5.4). However, halving of the 
binding signal did not cause a sufficient reduction to allow for the sensitive and accurate 
detection of specific protein-carbohydrate interactions.  
The specific interaction of PA-IIL and ppxA/L with BSA, which was reduced 
but not eliminated by periodate treatment, makes BSA an unsuitable blocking reagent 
for analysis of these lectins. 
 
5.2.2 Non-protein blocking agents 
There are advantages to using non-protein blocking agents as they can replace complex 
mixture blocking agents, such as BSA, with a single pure compound. The use of pure 
compounds over complex mixtures may make an important contribution to 
standardization and since they are not purified from a protein source they are not 
contaminated by interfering proteins. Two such commonly used non-protein blocking 
agents are polyvinylpyrrolidone (PVP) and polyvinyl alcohol (PVA). PVP was used as a 
suitable blocking agent for immunochemical studies by Rodda, D.J. et al. (1994). PVA 
was used as a non-protein blocking agent on nitrocellulose membranes (Harvey 1991). 
The optimal conditions for the use of PVA in enzyme immunoassays (EIA) were 
established by Haycock, J.W. (1993). This study established PVA to be four fold better 
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allows for efficient binding to the hydrophobic polystyrene while more effectively 
exposing its hydrophilic substituents compared to PVP (Haycock 1993). Two 
commercial ELISA buffers were also examined as potential blocking agents; SYNBlock 
ELISA blocking buffer (AbD seroTec) and Carbo-Free ELISA blocking buffer (Vector 
Labs). When wells were saturated by each of the blocking agents and probed with 
10µg/ml of PA-IIL as outlined in Section 2.27, PA-IIL was found to interact with all of 
the blocking agents to a high degree. Quenching of the binding signal of PA-IIL by the 
addition of fucose indicated that the binding signal for each of the non-protein blocking 















Figure 5.5: Comparison of blocking reagents in ELLA with recombinant PA-IIL 
Quantitative detection of lectin bound to a number of blocking agents assayed by the activity of a HRP-
linked secondary antibody (OD450nm). The blocking agents investigated were 1% polyvinylpyrrolidone 
(PVP), 1%  polyvinyl alcohol (PVA), 2.5% BSA (Sigma-Aldrich), SYNBlock ELISA blocking buffer 
(SYN, AbD seroTec) and Carbo-Free ELISA blocking buffer (C.F, Vector Labs). (Error bars represent 
mean ± SD, n = 3). 
 
A number of the non-protein blocking agents were also probed with 10 µg/ml ppxA/L 
to establish if ppxA/L behaves in the same manner as PA-IIL (Figure5.6). 
 

















Figure 5.6: Comparison of blocking reagents in ELLA with recombinant ppxA/L 
Quantitative detection of lectin bound to a number of blocking agents assayed by the activity of a HRP-
linked secondary antibody (OD450nm). The blocking agents investigated were 1% polyvinylpyrrolidone 
(PVP), 1%  polyvinyl alcohol (PVA), 2.5% BSA (Sigma-Aldrich) and SYNBlock ELISA blocking buffer 
(SYN, AbD seroTec). (Error bars represent mean ± SD, n = 3). 
 
The addition of mannose does not quench the binding signal of ppxA/L to any of the 
non-protein blocking agents implying that the binding is due to non-specific binding. 
However, the binding signal of ppxA/L to BSA, which was previously found to be 
quenched by the addition of sugar (Figure 5.3), was not quenched during this 
experiment. During the course of this work lyophilization was regularly utilised for long 
term storage of proteins. However over a period of time the lyophilizer was found to 
operate poorly and ultimately break down. When the lyophiliser was operating poorly it 
is believed to have resulted in heating of the protein when drying. The heating of the 
protein could lead to denaturation. This could result in unfolding of the protein and 
exposure of hydrophobic and hydrophilic sites leading to non-specific binding as 
observed for ppxA/L-BSA binding in Figure 5.6. Heating of PA-IIL would not result in 
the same degree of denaturation as PA-IIL has been shown to be a robust protein, 
tolerating temperatures up to 80oC (Gilboa-Garber 1982). The activity of ppxA/L was 
further investigated using the alternative ELLA format, the HRP assay (see Section 
2.26). In this format the lectin is bound to surface of an ELISA plate, HRP was then 
added to determine if the lectin could bind to this mannose bearing compound. If HRP 
can be bound by sugar-specific activity the addition of soluble sugars resulting in the 
quenching of binding signal would be indicative of lectin sugar preference. The 
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principle of a typical HRP assay is outlined in Figure 5.7, however since ppxA/L was 
previously found to bind to BSA no blocking was carried out. The lack of a blocking 
agent may result in a higher signal-to noise ratio but in this instance a qualitative result 
will suffice, i.e. the confirmation of the presence of non-specific binding, over a 
quantitative result so a higher signal-to-noise ratio can be tolerated. 
 
 
Figure 5.7: Schematic outlining steps involved during HRP assay 
 
Since the binding specificity of ppxA/L is unknown the presence of non-specific 
binding was confirmed by attempting inhibition with a compound previously 

























Figure 5.8: Inhibition of ppxA/L binding to HRP by 2.5% BSA 
Quantitative detection of ppxA/L bound to a constant concentration of HRP in the presence of 2.5% BSA. 
The constant concentration of HRP was 10µg/ml. The addition of BSA did not quench the binding signal 
indicating that binding is due to non-specific interaction. (Error bars represent mean ± SD, n = 3). 
 
 
The BSA solution preparation failed to quench the ppxA/L-HRP signal (see Figure 5.8) 
and non-specific binding was further confirmed by attempts to inhibit the interaction of 
ppxA/L to HRP by soluble sugars or glycoproteins (Figure 5.9 and 5.10). The binding 


















Figure 5.9: Inhibition of ppxA/L binding to HRP by soluble sugars 
Quantitative detection of ppxAL bound to a constant concentration of HRP in the presence of various 
sugars. The constant concentration of HRP used was 10µg/ml. The addition of soluble sugars did not 
quench the binding signal confirming that binding is due to non-specific interaction. (Error bars represent 





















Figure 5.10: Inhibition of ppxA/L binding to HRP by glycoproteins 
Quantitative detection of ppxAL bound to a constant concentration of HRP and inhibition with a constant 
concentration of various glycoproteins. The constant concentration of HRP used was 10µg/ml, while the 
constant concentration of glycoprotein was 1mg/ml. The addition of glycoprotein did not quench the 
binding signal confirming that binding is due to non-specific interaction. (Error bars represent mean ± 
SD, n = 3). 
 
Due to the instability of ppxA/L it was necessary to lyophilize the protein directly after 
production. The loss of a facility to lyophilise the protein meant there was no means of 
storing the protein and therefore no further testing on blocking agents or binding to 
glycoproteins could be carried out. 
 
5.3 Discussion  
Of the common ELISA blocking agents investigated, (BSA, PVA, PVP, SYNBlock, 
Carbo-Free) none were found to be suitable for use in an ELLA with PA-IIL and 
ppxA/L binding. All of these blocking agents resulted in high signal-to-noise ratio, 
leading to false positives and loss of the ability to discern subtle signal variation. No 
definitive comment can be made on the binding specificity of ppxA/L due to the 
complications introduced by faulty equipment. Without the ability to lyophilize ppxA/L 
the protein could not be suitably stored and therefore extensive studies of binding 
affinity could not be carried out. Preliminary results indicated that ppxA/L bound to 
BSA, and may therefore exhibit a similar binding pattern to blocking reagents as found 
for PA-IIL. Although other blocking agents may be investigated, there are a number of 
alternative approaches to investigation of lectin binding affinities known that may be 
preferential to ELLA. 
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Calorimetry has evolved over several hundred years, giving rise to modern 
techniques. Development of microelectronics and advancements in instrument design 
has radically improved the sensitivity of calorimetry techniques. Isothermal titration 
calorimetry (ITC) is one such technique employed to investigate the thermodynamics of 
ligand macromolecule interaction. A typical ITC experiment is carried out by the 
stepwise addition of one of the reactants, e.g. ligand, into the reaction cell of the 

















Figure 5.11: Illustration of the configuration of an isothermal titration calorimetry (ITC) reaction 
cell 
The cell is filled with protein (red), while the injection syringe which also stirs the solution to insure 
proper mixing is filled with a ligand solution (green). At specific time intervals a small volume of the 
ligand solution in injected into the cell, resulting in the characteristic titration heat effects. 
 
When substances, such as proteins, bind heat is generated or absorbed proportional to 
the amount of ligand that binds to the protein. Measuring heat fluctuations allows 
accurate determination of binding constants, reaction stoichiometry, enthalpy and 
entropy (Leavitt, Freire 2001). Using ITC the complete thermodynamic profile of 
molecule interaction can be determined in a single experiment. A thorough review by 
Dam, T.K. et al. (2002), outlines numerous studies of plant and animal lectins that 
utilised ITC for the determination of thermodynamic properties such as binding affinity. 
Perret, S. et al. (2005) used ITC analysis to examine the binding of PA-IIL to human 
milk oligosaccharides. The ITC values obtained for ligand affinity were found to be in 
agreement with the specificity range established by ELLA. This result indicates that 
ITC is a suitable alternative to the use of ELLA for carbohydrate binding determination. 
The effect of point mutation of the amino acids found within the sugar binding loop of 
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PA-IIL was also investigated using ITC (Adam et al. 2007). The point mutations were 
shown to alter the binding affinity and sugar preference of the lectin (see Section 1.6).  
ITC does not require the use of a blocking agent making it an attractive option for the 
analysis of PA-IIL and homologs to PA-IIL. The primary disadvantage of ITC is that 
protein activity obtained in solution. ELLA results indicate protein activity on a solid 
surface. For diagnostic and industrial application lectins will most likely be used on a 
solid surface. ITC could facilitate initial characterisation of binding specificity and 
binding mode of a lectin which may potentially aid in the identification of a suitable 
blocking agent for optimisation of a sensitive ELLA.  
Surface plasmon resonance (SPR) is an optical phenomenon that provides a non-
invasive, label-free means of monitoring binding interactions between an injected 
analyte, such as a glycoprotein, and an immobilized biomolecule, such as a lectin, in 
real time. Although there are several SPR-based systems (Schuck 1997, van der Merwe, 
Barclayt 1997) the most widely used system is BIAcore, GE HealthCare (Raghavan, 
Bjorkman 1995). The BIAcore system contains a sensor microchip, a laser light source 
emitting polarized light, an automated fluid-handling system and a diode-array position-
sensitive detector as shown in Figure 5.12. The BIAcore chip consists of a glass 
support, an overlaid gold film as SPR is based on the peculiar properties of the 
interaction of polarized light with thin metal films of aluminium, silver or gold films 
(Turbadar 1959) and a matrix to which biomolecules can be coupled. Proteins can be 
immobilized to various kinds of surface via diffusion, adsorption/absorption and 
covalent cross-linking. Attachment of proteins via any of these methods leads to 
attachment of proteins to the surface in a random fashion which can lead to alteration of 
native protein confirmation, reduction in activity and make binding sites inaccessible to 
probes. Attachment via affinity tags, such as the 6HIS tag utilised in this work, 
facilitates uniform attachment to the surface. The basis of SPR detection is; 
• Lectin immobilised on a sensor chip in a layer in contact with a thin metal film, 
typically gold 
• Glycoprotein in solution is passed over the layer 
• Glycoprotein is retained by interacting with the lectin leading to an increase in 
organic matter leading to a proportional increase in refractive index which is 
observed as a shift in the resonance angle. 
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The layer close to the metal film is monitored in real time facilitating determination of 


















Figure 5.12: Schematic of the Surface Plasmon Resonance (SPR) system found in the BIAcore 
system 
 
SPR has previously been demonstrated as a valuable tool for the characterisation of 
lectins and in particular the binding domain (Vornholt, Hartmann and Keusgen 2007). 
Shinohara, Y. et al. (1997), demonstrated that the affinity constants calculated from 
SPR experiments with immobilized lectin were in good agreement with those obtained 
by using classical methods. SPR has some advantage over ITC as data on translation 
states can be obtained. This information can be used for the characterisation of the 
mechanism of complex formation. ITC provides no direct information on the 
translational states of protein binding. SPR also consumes less reagents, however SPR 
assays are significantly longer then those for ITC experiments, involving, for example 
optimisation of immobilization conditions which can also consume significant amounts 
of reagents (Wear, Walkinshaw 2006).  
Frontal affinity chromatography (FAC) can be used to characterise the binding 
of lectins. The original principle of FAC was derived by Kasai, K. et al (1975). 
Advances in technology have since lead to automated FAC systems (Nakamura-
Tsuruta, Uchiyama and Hirabayashi 2006). A number of systems enabling sensitive 
monitoring of eluted glycan have been teamed with FAC; radioisotope (RI) (Ohyama et 
al. 1985), mass spectrometry (MS) (Schriemer et al. 1999) and fluorescence detection 
(FD). RI requires radio labelling of glycan which can pose a hazard to human health and 
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MS requires modification of glycans with appropriate alykyl reagent necessary to 
increase ionization efficiency in MS. FAC-FD with pyridylaminated (PA)-glycans 
offers the greatest ease of use. The principle of this technique is (outline in Figure 5.13); 
• Diluted fluorescently labelled glycan solution is continuously applied to a lectin-
immobilized column 
• If the glycan has no affinity (blue) its elution front (V0) is detected immediately 
• If the glycan has affinity (red) with the immobilised lectin its elution front (V) is 
retarded 
The retardaration is due to repeated interaction with the immobilized lectin as it passes 
through the column. Excess glycan is passed over the column until the glycan 
concentration reaches a ‘plateau’ that corresponds to the initial concentration [A0].  
 
Figure 5.13: Schematic of Frontal Affinity Chromatography (FAC) – Fluorescence detection (FD) 
system. 
[A0] is the initial glycan concentration expressed in M. 
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Equation 5.1: Basic equation of FAC to determine the dissociation constant (Kd) of lectins 
Where Bt is an effective ligand content (expressed in mol) of the lectin immobilised column, V and V0 are 
elution front volumes of analyte and a control substance respectively, and [A0] is the initial concentration 
of analyte. 
 
The advantages of FAC-FD system include (Hirabayash 2008);  
• High throughput 
• Accurate and reproducible 
• Simplicity of apparatus 
The disadvantages of FAC-FD system include (Hirabayash 2008); 
• Immobilization of lectin to matrix might result in modification (reduction) of 
binding 
• Relative large amount of lectin required even on minature column 
• Crude samples cannot be analysed 
• Determination of Bt, only a small repertoire of saccharide derivatives have a 
UV-sensitive group. 
An alternative format of the typically used FAC-FD, whereby a carbohydrate is 
immobilized on a column and a fluorescently tagged lectin passed over the column, 
could also be potentially used to determine the binding specificity of the lectins. If the 
lectin has no affinity to the immobilized carbohydrate its elution front would be 
detected immediately. If the lectin has affinity with the immobilised carbohydrate its 
elution front would be retarded. Since lectins can easily be recombinantly tagged by 
GFP (Waldo et al. 2004) this format is not limited to the small repertoire of saccharide 
derivatives with a UV-sensitive group that traditional FAC-FD is limited to. A potential 
disadvantage of this format is that it consumes more reagent, i.e. lectin, however the 
development of a high yield recombinant expression system would overcome this 
problem and the addition of a fusion protein, such as GFP, may affect the activity of a 
lectin. The purification of untagged PA-IIL over immobilized carbohydrate column of 
mannose agarose (see Section 3.8.1.1, Figure 3.55) demonstrates the principle of this 
format.  
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Traditionally the hemagglutination assay was used to determine lectin 
specificity. The assay is based upon lectins ability to agglutinate red blood cells in a U-
bottomed well as opposed to red blood cells falling out of suspension by gravity. 
Therefore the assay is dependant on the lectin having a high specificity for the sugars 
displayed on red blood cells. The sugars displayed on red blood cells are species 
specific. The minimum amount of lectin required for agglutination of a fixed quantity of 
red blood cells is termed one hemagglutination unit (HU). Once HU is established 
inhibition assays can be carried out. The higher the affinity of the sugar for the lectin, 
the lower the concentration required to inhibit the agglutination reaction.  
PA-IIL was demonstrated to agglutinate rabbit, rat and sheep erythrocytes and 
did not react with cow erythrocytes (Zinger-Yosovich et al. 2006). Rat blood cells were 
the only erythrocytes available constantly for this work. Preliminary attempts to carry 
out hemagglutination assay of PA-IIL failed to agglutinate the erythrocytes. The 
hemagglutination assay was not carried out using ppxA/L as the lectin was found to be 
monomeric (see Section 4.6.2). Agglutination requires the presence of multiple binding 
sites in the lectin molecule.  
 








6.0 The PA-IIL superfamily and future work 
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6.1 The growing PA-IIL superfamily 
Searches of sequencing databases by bioinformatic analysis for proteins displaying 
similarities to the PA-IIL lectin of P. aeruginosa identified a number of homologous 
sequences to PA-IIL, such as the characterised RS-IIL from Ralstonia Solanacearum 
and CV-IIL from Chromobacterium violaceum (as discussed in Section 1.6) and 
uncharacterised homologous proteins from Photorhabdus luminescens and 
Photorhabdus asymbiotica. In this study two of the uncharacterised homologues were 
investigated, namely the lectin regions of Photopexin A and B. Additional 
uncharacterised homologues of the lectin PA-IIL in P. luminescens and P. asymbiotica 
were identified by a protein sequence query against the NCBI database using BLAST. 
The search reveals the two Photopexins and another 3 open reading frames in the 
unannoted genome of Photorhabdus luminescens and 2 open reading frames in the 
unannoted genome of Photorhabdus asymbiotica with significant sequence similarity 
(28%-33%) to PA-IIL. Nominally, functional annotation can be reliably transferred 
between proteins that share 30% sequence identity or above, confidence increasing with 
identity. These hypothetical genes were designated Plu4230, Plu4231 and Plu4238 from 
P. luminescens and P.asy1 and P.asy2 from P. asymbiotica. 
6.1.1 PA-IIL homologues from P. luminescens  
The uncharacterised hypothetical genes from P. luminescens would encode: 
 Plu4238 – 320 amino acid protein with a calculated MW of 34.8kDa 
 Plu4231 – 333 amino acid protein with a calculated MW of 36.77kDa 
 Plu4230 – 312 amino acid protein with a calculated MW of 34.35kDa 
Multiple protein alignment reveals a C-terminal domain with strong homology to PA-
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Figure 6.1: Sequence alignment of the lectin-like C-terminal domains of the homologues from P. 
luminescens TT01 and PA-IIL from P. aeruginosa.  
Amino acids involved in monosaccharide binding outlined in red and amino acids involved in calcium 
binding outlined in green. Image generated using ClustalW align and Genedoc. Identical residues 
highlighted in black and similar in grey. 
 
There is significant sequence similarity of the proteins within the P. luminescens strain 
(Figure 6.2), however within the sugar binding loop the amino acids are not as highly 









Figure 6.16: Homologous lectins; P. aeruginosa PA-IIL, lectin domains of P. luminescens plu4230, 
plu4231, plu4238, ppxA/L and ppxB/L. Percentage identity –black, percentage similarity – red, gap 
character – blue. Statistic report created using ClustalW and GenDoc. 
 
The percent identity (Figure 6.2, black numbering) refers to the percent of amino acids 
in the alignment which are identical between the proteins. The percent similarity (Figure 
6.2, red numbering) refers to the percent of amino acids in the alignment which are not 
identical between proteins but which have similar biochemical properties and are 
considered interchangeable in many situations. The gap character refers to padding or 
null characters to match homologous residues indicated by – in the alignment (see 
Figure 6.1). The alignment of PA-IIL to the homologous protein identified from P. 
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luminescens found lectin domains with exact identity of 26 to 37% and similarities of 56 
to 62%. Reviews of comparative protein modelling have found that high-accuracy 
comparative models are based on more than 50% sequence identity to their templates. 
Medium-accuracy comparative models are based on 30 to 50% sequence identity. Low 
accuracy comparative models are based on less than 30% (Sanchez, Sali 1998). The 
identity of each of the Plu4230, Plu4231 and Plu4238 proteins were found to have an 
identity greater then 30% to PA-IIL (Figure 6.2). Therefore, a 3D structure model of 
each of the unknown proteins was created using the crystal structure of PA-IIL as a 
template. The amino acid sequence for each of the proteins was submitted to SWISS-
MODEL web server (Section 2.14) which provides an automated protein homology-
modelling service (Schwede et al. 2003). The 3D structures were predicted using the 
PA-IIL PDB file 1OUX as a template. The binding pocket from each of the 3D-models 
was compared to the binding pocket of PA-IIL (Figure 6.3).  
 
Figure 6.3: Plu4230 (orange), Plu4231 (red) and Plu4238 (purple) 3D-model of the binding pockets 
compared to the binding pocket of PA-IIL (yellow). 
3D diagram of the binding pocket of the lectin domain of Plu4230 (orange), Plu4231 (red) and Plu4238 
(orange), which was predicted by SWISS-MODEL server (Section 2.14), taking the structure of PA-IIL 
(yellow) as a template. Image generated using Pymol.   
 
The variation of the amino acids within the sugar binding loop does appear to have an 
impact on the formation of the binding pocket. This impact may lead to variation of 
sugar binding preference of each of the proteins, as was observed for the binding pocket 
of RS-IIL. The topology of the binding pocket of RS-IIL accommodates the O6 of 
mannose, resulting in strong hydrogen binding of mannose and the RS-IIL preference of 
A B 
C D 
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mannose over fucose. In the binding pocket of PA-IIL there is no space for the O6 of 
mannose which is therefore directed towards the surface, away from the protein, 
resulting in mannose adopting a different orientation and ultimately resulting in weaker 
binding for mannose than found for RS-IIL-mannose binding (Sudakevitz et al. 2004). 
A BLAST of N terminal regions of Plu4230, Plu4231 and Plu4238 against the 
protein sequence database indicated sequence similarity of Plu4231 to matrix 
metalloproteinase (MMP) as was found for Photopexin A and B from P. luminescens. 
MMP are a family of structurally related, zinc and calcium dependent proteins that have 
been associated with the break down of connective tissue in pathogenic conditions, in 
wound healing and pregnancy (Borkakoti 1998). The N-terminal domain of Photopexin 
A and B were assigned a ‘haemopexin-like’ motif by Crennell, S. et al. (2000) based on 
protein alignments and protein modelling. Crennell, S. et al. (2000) speculated that 
ppxA and ppxB are involved in host surface attachment or the binding of haem-like iron 
containing compounds scavenged from the insect host. The significant sequence 
homolog between the N-terminal domain of Photopexin B and the N-terminal domain of 
Plu4231 could suggest a similar protein function (Figure 6.4).     
 
 
Figure 6.4: Sequence alignment of the N-terminal domains of PA-IIL homologs ppxA, ppxB and 
Plu4231, from P. luminescens TT01. Image and statistic reported generated using ClustalW align and 
Genedoc. Identical residues highlighted in black and similar in grey. Percentage identity –black, 
percentage similarity – red, gap character – blue.  
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No protein of significant sequence similarity to Plu4230 or Plu4238 was identified by a 
sequence database search although significant similarity was found between the proteins 
(Figure 6.5). Therefore a hypothesis for the putative biological role of the protein could 
not be formulated as there is no conserved protein or conserved motif upon which to 
base the hypothesis. 
 
 
Figure 6.5: Sequence alignment of the N-terminal domains of PA-IIL homologs Plu4230 and 
Plu4238, from P. luminescens TT01. Image generated using ClustalW align and Genedoc. Identical 
residues highlighted in black and similar in grey. 
 
Ultimately what is required is the purification and X-ray crystallography structural 
studies of each of these proteins, as only limited information can be obtained from a 
predicted model base on sequence homology.  
 
6.1.2 PA-IIL homologues from P. asymbiotica  
A BLAST search of the NCBI sequencing database identified two open reading frames 
in the recently sequenced genome of Photorhabdus asymbiotica as having significant 
sequence similarity to PA-IIL. There are 3 recognised Photorhabdus species currently, 
P. luminescens and P. temperate that form symbiotic relationships with nematodes that 
infect insects and P.asymbiotica. P. asymbiotica has only been isolated from human 
clinical samples and as yet an invertebrate vector has yet to be identified. Photorhabdus 
species are gram negative, motile, facultatively anaerobic and rob shaped bacteria (Peel 
et al. 1999). The hypothetical genes from P. asymbiotica would encode: 
 Pasy1 – 340 amino acid protein with a calculated MW of 37.7kDa 
 Pasy2 – 363 amino acid protein with a calculated MW of 40.39kDa 
Multiple protein alignment reveals a C-terminal domain with homology to PA-IIL in 
particular across the amino acids between the calcium binding loop. A higher sequence 
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homology was found for the homologs of P. asymbiotica and the Photopexins of P. 
luminescens then with PA-IIL (see Figure 6.6 and 6.7).  
 
 
Figure 6.6: Sequence alignment of the lectin-like C-terminal domains of the homologues from P. 
asymbiotica.  
Amino acids involved in monosaccharide binding outlined in red and amino acids involved in calcium 
binding outlined in green. Image generated using ClustalW align and Genedoc. Identical residues 
highlighted in black and similar in grey. 
 
There is significant sequence similarity of the proteins within the P. luminescens strain, 
however within the sugar binding region the amino acids are not as highly conserved 












Figure 6.7: Homologous lectins; P.aeruginosa PA-IIL, lectin domain of P. luminescens ppxA/L and 
ppxB/L and lectin region of P. asymbiotica P.asy1 and P.asy2.  
Percentage identity –black, percentage similarity – red, gap character – blue. Statistic report created using 
ClustalW and GenDoc. 
 
Sequence alignment of the protein sequence of PA-IIL to the lectin domains found 
within P. asymbiotica found that the proteins have an exact identity of 28-29%, with 
similarity of 51% (Figure 6.7). A greater number of null characters (Figure 6.7, blue 
numbering) were necessary to align the homologous residues of P. asymbiotica and PA-
IIL and the lowest percentage identity between the proteins indicate that the 
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homologous from the P. asymbiotica are the most distally related members of the PA-
IIL family. The lectin domain of P.asy1 and P.asy2 were found to have an identity 
slightly lower then 30% to PA-IIL. Therefore, it should be noted that a 3D structure 
model of each of the unknown proteins created using the crystal structure of PA-IIL as a 
template, is likely to contain errors. The amino acid sequence for each of the proteins 
was submitted to SWISS-MODEL web server (see Section 2.14) (Schwede et al. 2003). 
The 3D structures were predicted using the PA-IIL PDB file 1OUX as a template. The 
binding pocket from each of the 3D-models was compared to the binding pocket of PA-





Figure 6.8: P.asy1 (pink) and P.asy2 (blue) 3D-model of the binding pockets compared to the 
binding pocket of PA-IIL (yellow). 
3D diagram of the binding pocket of the lectin region of P.asy1 (pink) and P.asy2 (blue), which was 
predicted by SWISS-MODEL server (Section 2.14), taking the structure of PA-IIL (yellow) as a template. 
Image generated using Pymol.   
 
The variation of the amino acids within the sugar binding loop does appear to have an 
impact on the formation of the binding pocket. This impact may lead to variation of 
sugar binding preference of each of the proteins, as was observed for the binding pocket 
of RS-IIL.  
A BLAST of N terminal regions of P.asy1 and P.asy2 against the protein 
sequence database indicated sequence similarity to matrix metalloproteinase (MMP) as 
was found for Photopexin A and B from P. luminescens. The significant sequence 
homolog between the N-terminal domain of Photopexin B and the N-terminal domains 
of both P.asy1 and P.asy2 indicate a similar protein function, i.e. the hemaopexin motif 
A B 
C 
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assigned to the N-terminal domain of ppxB may be assigned to the N-terminal domains 
of P.asy1 and P.asy2 (Figure 9.6). Again, as with the PA-IIL homologues from P. 
luminescens, only limited information can be obtained from a predicted model base on 
sequence homology Therefore what is ultimately required is the purification and X-ray 
crystallography structural studies of each of these proteins.  
 
 
Figure 6.9: Sequence alignment of the N-terminal domains of PA-IIL homologs P.asy1 and P.asy2, 
from P. asymbiotica and the N terminal domain of Photopexin B from P. luminescens. Image 
generated using ClustalW align and Genedoc. Identical residues highlighted in black and similar in grey. 
 
6.2 Overview of the potential of the lectins of the PA-IIL 
superfamily  
To date all homologues of PA-IIL identified were proteins with a highly conserved 
calcium binding loop and diversity within the amino acids of the sugar binding loop 
(Figure 6.10). The protein crystal structure of PA-IIL revealed an unusual 
protein/carbohydrate interaction formed by the two Ca+ ions, the amino side chain that 
co-ordinates the Ca2+ ions and the sugar. This was thought to be the basis for the 
relatively strong binding affinity found for PA-IIL (Mitchell et al. 2002). It was 
theorized, due to the high degree of conservation of the amino acids of the calcium 
binding loop, that homologues of PA-IIL bind in a similar manner to PA-IIL and 
therefore potentially have a strong binding affinity in the range of PA-IIL (Ka 1.5 
X106M-1, (Garber et al. 1987)). The homologs CV-IIL, RS-IIL and BC-IIL 
(Burkholderia cenceopica lectin II) has been shown to bind in the same manner via Ca2+ 
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ions by Pokorná, M. et al. (2006), Sudakevitz, D. et al. (2004) and Lameignere, E. et al. 
(2008) respectively.  
 
Figure 6.10: The variation/ found within the sugar binding loop and the conserved amino acids of a 
number of PA-IIL homologues. 
B.cep – fucose lectin II Burkholderia cenocepacia AU1054, CV-IIL – fucose lectin II Chromobacterium 
violaceum, RS-IIL – mannose lectin II Ralstonia Solanacearum, PA-IIL – fucose lectin  II Pseudomonas 
aeruginosa, ppxA/L, ppxB/L, Plu4230, Plu4231 and Plu4238 – hypothetical proteins Photorhabdus 
luminescens, P.asy1 and P.asy2 hypothetical proteins Photorhabdus asymbiotica. Amino acids involved 
in monosaccharide binding outlined in red and amino acids involved in calcium binding outlined in green. 
Image generated using ClustalW align and Genedoc. Identical residues highlighted in black and similar in 
grey. 
 
A number of bacteria identified as containing homologues to PA-IIL are of 
interest as they have a high economic and social impact. There is a high mortality rate in 
immunodeficient individuals associated with infection by C. violaceum (Alves de Brito 
et al. 2004), P. aeruginosa (Bodey et al. 1983) and Burkholderia spp 
(Mahenthiralingam, Vandamme 2005) which has significant social impact, particularly 
in specific sections of society such as sufferers of Cystic Fibrosis (CF) and Acquired 
Immune Deficiency Syndrome (AIDS). P. asymbiotica has also been associated with 
infection of soft tissue of humans and disseminated bacteraemic infections. P. 
asymbiotica has been isolated from human clinical specimens from the USA and 
Australia (Gerrard et al. 2004). R. solanacearum is a plant pathogen that has a 
significant economic impact due to its extensive host range of over 200 plant species 
including economically important hosts such as potatoes, tomatoes and tobacco 
(Hayward 1995)  
A common means of adhesion, expressed by numerous bacteria, are surface 
lectins that combine with complementary carbohydrates present on the host cell surfaces 
as an initial stage of infection (Sharon, Lis 1989). This indicates that lectins may serve 
as virulence factors for these organisms. Detailed characterisation of the combining site 
of the bacterial surface lectins is important not only for gaining a better insight into the 
nature of the interaction between bacteria and cell surfaces, but also for the design of 
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more effective inhibitors of adhesion to surfaces and thus for the prevention of 
infection. Therefore, characterisation of the binding specificity of proteins of the PA-IIL 
superfamily may contribute to a better understanding of the mechanism of infection of a 
number of organisms and potential anti-adhesion therapies by the addition of 
carbohydrate analogues.   
The use of bacterial lectins in analytical platforms is more desirable then lectins 
from a eukaryotic source, such as plant and animal lectins. Eukaryotic lectins are often 
complex molecules that require post-translational modification (PTM). Therefore, E. 
coil expression systems often can’t be utilised to produce them as E. coli lacks the 
ability to carry out complex PTMs such as glycosylation. Lectins from prokaryotic 
sources, such as the PA-IIL superfamily, do not require PTM and can therefore exploit 
the E. coli system for the expression of high yields of recombinant protein. A broad 
range of cloning and expression vectors for recombinant protein expression from the E. 
coli are available enabling flexible control of protein expression, e.g. addition of fusion 
proteins to facilitate one-step-purification. The relatively inexpensive production of 
large quantities of recombinant lectin that can be highly purified produced via the E. 
coli expression system can then be utilised for the production of lectin microarrays 
(Figure 6.11).  
Figure 6.11: Fabrication of a recombinant lectin microarray. 
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A lectin microarray enables fast, sensitive and high throughput profiling of the 
sugar structures of a protein glycan composition with subtle differences. Previously they 
have been used for microbial typing (Hsu, Pilobello and Maha 2006) and differential 
profiling, e.g. differentiating between normal and cancerous epithelia (Matsudaa et al. 
2008). An ideal lectin microarray would consist of a high density array with a diverse 
panel of immobilized lectins in order to achieve a distinct and characteristic analysis of 
a glycome. A limitation to the development of lectin microarrays is the lack of 
commercial availability of lectins that diversely recognize unique sugar structures. The 
uncharacterised lectins of the PA-IIL superfamily are potentially novel lectins of 
prokaryotic origin, theoretically with a relatively high binding affinity due to the 
predicted unique protein/carbohydrate binding formed by Ca2+. Due to their prokaryotic 
origin these lectins can be cloned and expressed via the E. coli expression system, to 
produce high yields of protein and purified to a high degree by the addition of an 
affinity fusion tag. These fusion tags may also be used for directed orientation-specific 
immobilisation to an activated surface of a microfluidic platform. 
 
6.3 Summary  
In this work, protocols for the cloning, expression and purification of the PA-IIL gene 
from P. aeruginosa were optimised. Due to the significant sequence homology of PA-
IIL and the PA-IIL homologues it was hypothesised that the established protocols 
would be applicable for the cloning, expression and purification of the uncharacterised 
homologues. The establishment of general protocols for investigation of the PA-IIL 
superfamily was predicted to streamline the characterisation of these lectins.  
E. coli is one of the most commonly used hosts of recombinant expression as it 
facilitates protein expression by its relative simplicity, rapid high density growth rate on 
inexpensive substrates and well characterized genetics which allow for large scale 
protein production (Baneyx 1999). PA-IIL was successfully cloned into a number of 
pET vectors and expressed in the E. coli system in a number of studies, Loris, R. et al. 
(2003), Sabin, C. et al. (2006) and Tielker, D. et al. (2005). In all studies the protein 
was purified over mannose agarose as described by Gilboa-Garber, N. et al. (1983). 
Similarly the characterised members of the PA-IIL superfamily, RS-IIL, CV-IIL and 
BclA, were cloned into E. coli expression vectors and were purified over mannose 
agarose (Lameignere et al. 2008, Sudakeuitz, Datcoff and Gilboa-Garber 2002, Zinger-
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Yosovich et al. 2006). To purify a lectin over a resin displaying an immobilised 
oligosaccharide, such as mannose-agarose, requires knowledge of the specificity of the 
lectin. The requirement of prior knowledge of lectin specificity to facilitate purification 
limits the ability to investigate previously uncharacterised novel lectins. Utilising the 
affinity tag, 6HIS, facilitates the purification of a lectin regardless of the binding 
specificity of the lectin. The ability to highly purify novel lectins aids in the structural 
and functional characterisation of these proteins. Histidine tagging is also advantageous 
as it combines a number of desirable features such as small size, interaction with a 
relatively inexpensive matrix (Ni-NTA resin) which can tolerate multiple regeneration 
cycles and a high binding affinity of 6HIS to the matrix. Therefore the use of the E. coli 
expression system and 6HIS affinity tagging enables characterisation of novel lectins 
and the large scale production of highly purified lectins that can then be used for the 
development of diagnostic lection microarrays and other platforms. To data no work has 
been published on the use of the affinity tag 6HIS for the purification of PA-IIL or any 
of its homologs.  
The protocols established by this work for the expression of recombinant 6HIS 
tagged PA-IIL were successfully transferred to the expression and purification of the 
lectin domain of Photopexin A and B. The yield of each lectin expressed did vary. 
Sufficient yields of PA-IIL and ppxA/L were purified for subsequent characterisation 
studies. Some common traits were found for purified PA-IIL and ppxA/L: inherent 
instability in solution leading to precipitation, preferred temperature for storage in 
solution at 25oC and sugar specific interaction with BSA solutions.  Sufficient yields of 
ppxB/L were not obtained from the expression and purification of ppxB/L for 
characterisation studies. There are several options regarding further optimisation of the 
expression of ppxB/L to enhance protein yield, such as a 96 well plate clonal selection, 
expression from various strains of E. coli or media composition (LB was the only media 
used for expression). The protocols established in this work for the expression of PA-
IIL could be used as a basis for the production of the remaining uncharacterised lectins 
of P. luminescens and P. asymbiotica. The next step of this work would be to establish a 
suitable method for the characterisation of these lectins.  
Data from this work indicates that the ELLA may not be a suitable method for 
the investigation of sugar binding specificities of the PA-IIL superfamily and a number 
of alternative methods have been discussed (see Section 5.3).  
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A search of the literature found that the binding affinity of PA-IIL and homologs of PA-
IIL were investigated by a number of methods. The binding specificity of PA-IIL was 
originally determined by Gilboa-Garber, N. et al. (1983). These results were confirmed 
by Mitchell, E. et al. (2005) by repetition of the haemagglutination assay and also by 
ITC. This study confirmed the order of sugar preference of PA-IIL but found the 
binding affinity to be one order of magnitude lower (Ka; 1.5 x 106M-1) by ITC. A study 
by Sudakevitz, D. et al. (2004) successfully determined the binding specificity of the 
RS-IIL lectin and compared the binding to that of PA-IIL by the haemagglutination 
assays using human erythrocytes. The binding specificity of CV-IIL was also initially 
determined using the haemagglutination assay. The binding specificity of CV-IIL was 
compared to that of RS-IIL and PA-IIL using erythrocytes from a number of sources 
(human, cow, rabbit, rat and sheep). A study by Pokorna, M. et al. (2006) further 
investigated the binding mode of CV-IIL by ELLA and ITC. The results for CV-IIL 
were compared to that of PA-IIL. BSA was used as the blocking agent for the ELLA, 
however the data was not published in this paper and it was therefore not possible to 
compared background noise obtained by this group when using BSA to the results 
obtained during this work. Most recently the binding specificity of BclA was 
determined by the SPR based BIAcore system (Lameignere et al. 2008). Specific sugar 
was immobilised on the surface of a BIAcore chip and binding to the sugar by BclA was 
monitored. Although ITC and BIAcore have been proven as suitable methods for the 
investigation of the PA-IIL superfamily both methods require specialised equipment and 
in the case of BIAcore, specialised training. FAC whereby an oligosaccharide is 
immobilized onto a column and a GFP labelled lectin passed over the column 
potentially offers a relatively easy and inexpensive method for the characterisation of 
lectin binding. By GFP labelling lectins, protein elution from an oligosaccharide column 
can easily be monitored by a fluorescent detector or by visualisation using a UV light 
source. However this method has not been established and requires further 
investigation.  
Future work should also include both directed and random mutation of the 
specific sugar-binding residues/domains of PA-IIL. It was previously established by 
Adam, J. et al. (2007) that point mutation of these amino acids can alter the binding 
specificity of PA-IIL (see Section 1.6). Characterisation of the binding specificity of the 
homologues of PA-IIL may lead to the identification of a specific lectin of interest. It 
was theorized that the cloning of the binding site from one homologue of interest to the 
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PA-IIL molecule could be carried out by point mutation, in order to develop a larger 
range of lectins with diverse specificities. Therefore an array of diverse specificities 
may be created within the basic framework of one lectin molecule. Ultimately this may 
lead to the creation of a uniform recombinant lectin microarray where each well 
contains the same core lectin molecule, each having differing glycan specificity. The 
advantage to such a lectin-array would be having the same optimal conditions, e.g. pH, 
temperature, co-factor requirement, buffer composition, for each lectin. Also of interest 
would be the random mutagenesis of the specific sugar-binding residues to incorporate 
very different residues beyond those identified within the sugar binding loop of PA-IIL 
homologs for the creation of novel lectins. Recombinant lectins of the PA-IIL 
superfamily, as demonstrated in this work, can be produced to a high level of purity 
through the E. coli expression system and one-step-purification via a fusion protein. 
Introduction of immobilised tags into the protein structure also facilitates the 
orientation-specific immobilisation to an activated surface creating a more homogenous 
distribution of lectin on an array surface.   
In conclusion, the characterisation of the lectins of the PA-IIL superfamily and 
other novel lectins is increasingly important for the development of accurate, high 
throughput determination of glycosylation patterns of molecules. Expansion of our tools 
for the comprehensive glycoprofiling is essential for the increasingly relevant field of 
glycobiology. Compiling the necessary means of deciphering the glycoprofile is 
increasingly important for both basic research and the biopharmaceutical industry for 
the comprehensive determination of therapeutic biomolecules. It is also important for 
clinical diagnostics for the identification of disease states and creation of anti-adhesive 
therapeutics for bacterial infection. The identification or creation of diverse recombinant 
lectins will facilitate the production of the next generation of lectin microarrays.  
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